<SEC-DOCUMENT>0001013762-25-004217.txt : 20250328
<SEC-HEADER>0001013762-25-004217.hdr.sgml : 20250328
<ACCEPTANCE-DATETIME>20250328170008
ACCESSION NUMBER:		0001013762-25-004217
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20250326
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250328
DATE AS OF CHANGE:		20250328

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aeluma, Inc.
		CENTRAL INDEX KEY:			0001828805
		STANDARD INDUSTRIAL CLASSIFICATION:	SEMICONDUCTORS & RELATED DEVICES [3674]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				852807351
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42570
		FILM NUMBER:		25787396

	BUSINESS ADDRESS:	
		STREET 1:		27 CASTILIAN DRIVE
		CITY:			GOLETA
		STATE:			CA
		ZIP:			93117
		BUSINESS PHONE:		805-351-2707

	MAIL ADDRESS:	
		STREET 1:		27 CASTILIAN DRIVE
		CITY:			GOLETA
		STATE:			CA
		ZIP:			93117

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Parc Investments, Inc.
		DATE OF NAME CHANGE:	20201016
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0235943-8k_aeluma.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:ALMU="http://aeluma.com/20250326">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_039_ALMU_aeluma.com_20250326 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20250326_20250326 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DEntityCentralIndexKey_0001828805 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-03-26" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-03-26" id="Fact000004" name="dei:EntityCentralIndexKey">0001828805</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="almu-20250326.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-03-26">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001828805</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-03-26</xbrli:startDate>
        <xbrli:endDate>2025-03-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90E_edei--DocumentType_c20250326__20250326_zxCDwe3AoaKg"><ix:nonNumeric contextRef="AsOf2025-03-26" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Date of earliest event reported): March 28, 2025 <span>(<span id="xdx_90A_edei--DocumentPeriodEndDate_c20250326__20250326_zHveW2nY3mu1"><ix:nonNumeric contextRef="AsOf2025-03-26" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">March 26, 2025</ix:nonNumeric></span>)</span> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_908_edei--EntityRegistrantName_c20250326__20250326_zFLj9aXRzJL3"><ix:nonNumeric contextRef="AsOf2025-03-26" id="Fact000011" name="dei:EntityRegistrantName">Aeluma, Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact name of registrant as specified in its
charter)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20250326__20250326_zXyidq4j1nI9"><ix:nonNumeric contextRef="AsOf2025-03-26" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--EntityFileNumber_c20250326__20250326_zbv6aP6zLrma"><ix:nonNumeric contextRef="AsOf2025-03-26" id="Fact000013" name="dei:EntityFileNumber">001-42570</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityTaxIdentificationNumber_c20250326__20250326_zMhNhcg5jgr1"><ix:nonNumeric contextRef="AsOf2025-03-26" id="Fact000014" name="dei:EntityTaxIdentificationNumber">85-2807351</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(State or other jurisdiction</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>of incorporation)</b></p></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Commission File Number)</b></span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: top">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(IRS Employer</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Identification No.)</b></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 50%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90F_edei--EntityAddressAddressLine1_c20250326__20250326_zlG38XYXP4d3"><ix:nonNumeric contextRef="AsOf2025-03-26" id="Fact000015" name="dei:EntityAddressAddressLine1">27 Castilian Drive</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_900_edei--EntityAddressCityOrTown_c20250326__20250326_zMp7WSQknlt6"><ix:nonNumeric contextRef="AsOf2025-03-26" id="Fact000016" name="dei:EntityAddressCityOrTown">Goleta</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressStateOrProvince_c20250326__20250326_zJ2tzEXCz7hf"><ix:nonNumeric contextRef="AsOf2025-03-26" format="ixt-sec:stateprovnameen" id="Fact000017" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric> </span></b></p></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityAddressPostalZipCode_c20250326__20250326_zzwhpvIhdSyl"><ix:nonNumeric contextRef="AsOf2025-03-26" id="Fact000018" name="dei:EntityAddressPostalZipCode">93117</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Address of principal executive offices)</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Zip Code)</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_902_edei--CityAreaCode_c20250326__20250326_z8w2bxzZKEo4"><ix:nonNumeric contextRef="AsOf2025-03-26" id="Fact000019" name="dei:CityAreaCode">805</ix:nonNumeric></span>-<span id="xdx_902_edei--LocalPhoneNumber_c20250326__20250326_z8Mv0IHr198e"><ix:nonNumeric contextRef="AsOf2025-03-26" id="Fact000020" name="dei:LocalPhoneNumber">351-2707</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Registrant&#8217;s telephone number, including
area code)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--WrittenCommunications_c20250326__20250326_zDlluIyDiaM"><ix:nonNumeric contextRef="AsOf2025-03-26" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--SolicitingMaterial_c20250326__20250326_zX2YXUZnzxR4"><ix:nonNumeric contextRef="AsOf2025-03-26" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--PreCommencementTenderOffer_c20250326__20250326_z74NLWJ37xWd"><ix:nonNumeric contextRef="AsOf2025-03-26" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--PreCommencementIssuerTenderOffer_c20250326__20250326_zzp6lr7OvUCf"><ix:nonNumeric contextRef="AsOf2025-03-26" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Securities registered pursuant to Section 12(b) of the Act:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="text-align: center; width: 2%; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="text-align: center; width: 2%; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; vertical-align: bottom; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--Security12bTitle_c20250326__20250326_zg876PZDG3hd"><ix:nonNumeric contextRef="AsOf2025-03-26" id="Fact000025" name="dei:Security12bTitle">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></span></td>
    <td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--TradingSymbol_c20250326__20250326_zCTSQAktbdn"><ix:nonNumeric contextRef="AsOf2025-03-26" id="Fact000026" name="dei:TradingSymbol">ALMU</ix:nonNumeric></span></span></td>
    <td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span>The <span id="xdx_90C_edei--SecurityExchangeName_c20250326__20250326_zo41Kr8qvY7d"><ix:nonNumeric contextRef="AsOf2025-03-26" format="ixt-sec:exchnameen" id="Fact000027" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">Emerging growth company&#160;<span id="xdx_902_edei--EntityEmergingGrowthCompany_c20250326__20250326_zlGg2anTdzf"><ix:nonNumeric contextRef="AsOf2025-03-26" format="ixt:booleantrue" id="Fact000028" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.&#160;<span id="xdx_902_edei--EntityExTransitionPeriod_c20250326__20250326_zZy2K6gpKvd5"><ix:nonNumeric contextRef="AsOf2025-03-26" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 1.01 Entry Into a Material Definitive
Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>On March 26, 2025, Aeluma, Inc. (the &#8220;Company&#8221;)
entered into an Underwriting Agreement (the &#8220;Underwriting Agreement&#8221;) with Craig-Hallum Capital Group LLC, (the &#8220;Underwriter&#8221;),
relating to the public offering (the &#8220;Offering&#8221;) of 2,285,714 shares of common stock, par value $0.0001 per share, of the
Company (the &#8220;Shares&#8221;), at a public offering price of $5.25 per share. In addition, the Company granted the Underwriter
an option to purchase up to an additional 342,857 shares of its common stock at the public offering price per share, less the underwriting
discounts to cover over-allotments, if any, which option was exercised in its entirely on March 27, 2025. The Offering closed on March 28, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Shares were offered under the Company&#8217;s
registration statement on Form S-1, as amended (File No. 333-285469), which was declared effective by the U.S. Securities and Exchange
Commission (the &#8220;SEC&#8221;) on March 25, 2025, and a registration statement on Form S-1 filed pursuant to Rule 462(b) of the Securities
Act of 1933, as amended (the &#8220;Securities Act&#8221;) which was filed with the SEC and became effective upon filing on March 26,
2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The aggregate gross proceeds of the Offering were
approximately $13.8 million, prior to deducting underwriting discounts and other offering expenses, but including exercise in full of the over-allotment option. The net proceeds from the offering were
approximately $12.7 million, after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable
by us, but including exercise in full of the over-allotment option. The Company intends to use the net proceeds from the Offering for e<span style="background-color: white">xpanding business development
efforts, advancing manufacturing processes to support commercialization traction, and working capital and general business purposes</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Underwriting Agreement, the Company
agreed to an underwriting discount of 7.0% per Share, to issue warrants to the Underwriter (the &#8220;Warrant&#8221;) to purchase up
to 5.0% of the Shares sold in the Offering (including any shares sold in the Offering to cover over-allotments) at an exercise price equal
to 115% of the public offering price, and also to pay the expenses of the Underwriter in connection with the Offering, including filing
fees and Underwriter&#8217;s counsel legal fees, up to an aggregate of $125,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our officers and directors have agreed, subject
to certain exceptions, for a period of 90 days after the closing of this Offering, not to offer, pledge, sell, contract to sell, sell
any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or
otherwise transfer or dispose of, directly or indirectly, any shares of common stock of the Company or any securities convertible into
or exercisable or exchangeable for shares of common stock of the Company either owned as of the date of the Underwriting Agreement or
thereafter acquired without the prior written consent of the Underwriter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We, and any successor, have agreed, subject to
certain exceptions, not to for a period of 90 days after the closing of the offering, (i) offer, pledge, sell, contract to sell, sell
any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or
otherwise transfer or dispose of, directly or indirectly, or submit to, or file with, the Commission a registration statement under the
Securities Act relating to, any shares of Stock or any securities convertible into or exercisable or exchangeable for Stock, or publicly
disclose the intention to undertake any of the foregoing, or (ii) enter into any swap or other agreement that transfers, in whole or in
part, any of the economic consequences of ownership of the Stock or any such other securities, whether any such transaction described
in clause (i) or (ii) above is to be settled by delivery of Stock or such other securities, in cash or otherwise, without the prior written
consent of the Underwriter, which shall not be unreasonably withheld, other than the Shares to be sold hereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Underwriter may, in its sole discretion and
at any time or from time to time before the termination of the lock-up period, without notice, release all or any portion of the securities
subject to lock-up agreements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing descriptions of the Underwriting
Agreement, Warrant and the form of lock-up agreement do not purport to be complete and are qualified in their entirety by reference to
the full text of the Underwriting Agreement and Warrant, copies of which are attached hereto as Exhibit 1.1 and Exhibit 4.1 and are incorporated
herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This report shall not constitute an offer to sell
or the solicitation to buy nor shall there be any sale of the securities in any state or jurisdiction in which such offer, solicitation
or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Item 7.01 Regulation
FD Disclosure</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company&#8217;s Common
Stock was previously quoted on the OTCQB under the symbol &#8220;ALMU.&#8221; In connection with the Offering, its common stock was approved
for listing on the Nasdaq Capital Market (&#8220;Nasdaq&#8221;) under the symbol &#8220;ALMU&#8221; and commenced trading on the Nasdaq
on March 27, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On March 27, 2025, the
Company issued a press release regarding the pricing of the Offering. A copy of the press release is attached as Exhibit 99.1 hereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">On March 28, 2025, the
Company issued a press release regarding the closing of the Offering. A copy of the press release is attached as Exhibit 99.2 hereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The information in this
Item 7.01, including Exhibit 99.1 and Exhibit 99.2 attached hereto, is being furnished and shall not be deemed &#8220;filed&#8221; for
the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;<b>Exchange Act</b>&#8221;), nor shall it be
deemed incorporated by reference in any of the Company&#8217;s filings under the Securities Act, or the Exchange Act, whether made before
or after the date hereof, except as shall be expressly set forth by specific reference to this Report in such filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 9.01&#160;Financial Statements and Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit<br/>
Number</b></span></td>
    <td style="white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 89%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></td>
    <td>&#160;</td>
    <td><a href="ea023594301ex1-1_aeluma.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting Agreement </span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td>&#160;</td>
    <td><a href="ea023594301ex4-1_aeluma.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriter Warrant</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td>&#160;</td>
    <td><a href="ea023594301ex99-1_aeluma.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pricing Press Release dated March 27, 2025.</span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea023594301ex99-2_aeluma.htm">Closing Press Release dated March 28, 2025.</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AELUMA, INC.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 37%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: March 28, 2025</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Jonathan Klamkin</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jonathan Klamkin</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President, Chief Executive Officer, and Director</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">3</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LdpVVNylQ0WcIkPE2+oyKW7NSOvfI/mW1g0xBEJyzpcjRE8saWEqZDjO8gz2WDeV9gg5lshozxgc6WqdQJg5XozzrK1v1x+YUmAwMOO+PIV767wbh0UCcjhQk4EaQawSOYXdRkRfPSVbmgKtN7oCbQvYMTVs0Gt+dR/2+kmW6lebdEB2hmwCcV928huUjBVs6a4fxFcHWZaKqNdWJJZMtya45k+P9kvCvMI6xLmO/nf0Ac0JSl8= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ea023594301ex1-1_aeluma.htm
<DESCRIPTION>UNDERWRITING AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 1.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">Aeluma, Inc.</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">2,285,714 Shares of Common Stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Underwriting Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">March 26, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Craig-Hallum Capital Group LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">222 South Ninth Street, Suite 350</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Minneapolis, Minnesota 55402</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Aeluma, Inc., a Delaware corporation
(the &ldquo;Company&rdquo;), proposes to issue and sell to Craig-Hallum Capital Group LLC, in its capacity as underwriter (the &ldquo;Underwriter&rdquo;),
an aggregate of 2,285,714 shares of common stock, par value $ 0.0001 per share, of the Company (the &ldquo;Underwritten Shares&rdquo;)
and, at the option of the Underwriter, up to an additional 342,857 shares of common stock of the Company (the &ldquo;Option Shares&rdquo;).
The Underwritten Shares and the Option Shares are herein referred to as the &ldquo;Shares.&rdquo; The shares of common stock of the Company
to be outstanding after giving effect to the sale of the Shares are referred to herein as the &ldquo;Stock.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company hereby confirms
its agreement with the Underwriter concerning the purchase and sale of the Shares, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&nbsp;<U>Registration
Statement</U>. The Company has prepared and filed with the Securities and Exchange Commission (the &ldquo;Commission&rdquo;) under the
Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder (collectively, the &ldquo;Securities Act&rdquo;),
a registration statement on Form S-1 (File No. 333-285469), including a prospectus, relating to the Shares and the Underwriter Warrant
Shares (as defined below). Such registration statement, as amended at the time it became effective, including the information, if any,
deemed pursuant to Rule 430A, 430B or 430C under the Securities Act to be part of the registration statement at the time of its effectiveness
(&ldquo;Rule 430 Information&rdquo;), is referred to herein as the &ldquo;Registration Statement&rdquo;; and as used herein, the term
&ldquo;Preliminary Prospectus&rdquo; means each prospectus included in such registration statement (and any amendments thereto) before
effectiveness, any prospectus filed with the Commission pursuant to Rule 424(a) under the Securities Act and the prospectus included in
the Registration Statement at the time of its effectiveness that omits Rule 430 Information, and the term &ldquo;Prospectus&rdquo; means
the prospectus in the form first used (or made available upon request of purchasers pursuant to Rule 173 under the Securities Act) in
connection with confirmation of sales of the Shares. If the Company has filed an abbreviated registration statement pursuant to Rule 462(b)
under the Securities Act (the &ldquo;Rule 462 Registration Statement&rdquo;), then any reference herein to the term &ldquo;Registration
Statement&rdquo; shall be deemed to include such Rule 462 Registration Statement. Capitalized terms used but not defined herein shall
have the meanings given to such terms in the Registration Statement and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At or prior to the Applicable
Time (as defined below), the Company had prepared the following information (collectively with the pricing information set forth on Annex
A, the &ldquo;Pricing Disclosure Package&rdquo;): a Preliminary Prospectus dated March 24, 2025 and each &ldquo;free-writing prospectus&rdquo;
(as defined pursuant to Rule 405 under the Securities Act) listed on Annex A hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;Applicable Time&rdquo;
means 4:30 P.M., New York City time, on March 26, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&nbsp;<U>Purchase
of the Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;The
Company agrees to issue and sell the Underwritten Shares to the Underwriter as provided in this underwriting agreement (this &ldquo;Agreement&rdquo;),
and the Underwriter, on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set
forth herein, agrees to purchase at a price per share of $4.8825 (the &ldquo;Purchase Price&rdquo;) from the Company the number of Underwritten
Shares set forth opposite the Underwriter&rsquo;s name in Schedule 1 hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the Company agrees
to issue and sell the Option Shares to the Underwriter as provided in this Agreement, and the Underwriter, on the basis of the representations,
warranties and agreements set forth herein and subject to the conditions set forth herein, shall have the option to purchase from the
Company the Option Shares at the Purchase Price less an amount per share equal to any dividends or distributions declared by the Company
and payable on the Underwritten Shares but not payable on the Option Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Underwriter may exercise
the option to purchase Option Shares at any time in whole, or from time to time in part, on or before the thirtieth day following the
date of the Prospectus, by written notice from the Underwriter to the Company. Such notice shall set forth the aggregate number of Option
Shares as to which the option is being exercised and the date and time when the Option Shares are to be delivered and paid for, which
may be the same date and time as the Closing Date (as hereinafter defined) but shall not be earlier than the Closing Date nor later than
the tenth full business day (as hereinafter defined) after the date of such notice. Any such notice shall be given at least two business
days prior to the date and time of delivery specified therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;The
Company understands that the Underwriter intends to make a public offering of the Shares, and initially to offer the Shares on the terms
set forth in the Pricing Disclosure Package. The Company acknowledges and agrees that the Underwriter may offer and sell Shares to or
through any affiliate of an Underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;Payment
for the Shares shall be made by wire transfer in immediately available funds to the account specified by the Company to the Underwriter
in the case of the Underwritten Shares, at the offices of Faegre Drinker Biddle &amp; Reath LLP, at 2200 Wells Fargo Center 90 S. Seventh
Street, Minneapolis, Minnesota 55402 at 10:00 A.M. New York City time on March 28, 2025, or at such other time or place on the same or
such other date, not later than the fifth business day thereafter, as the Underwriter and the Company may agree upon in writing or, in
the case of the Option Shares, on the date and at the time and place specified by the Underwriter in the written notice of the Underwriter&rsquo;s
election to purchase such Option Shares. The time and date of such payment for the Underwritten Shares is referred to herein as the &ldquo;Closing
Date,&rdquo; and the time and date for such payment for the Option Shares, if other than the Closing Date, is herein referred to as the
&ldquo;Additional Closing Date.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Payment for the Shares to
be purchased on the Closing Date or the Additional Closing Date, as the case may be, shall be made against delivery to the Underwriter
of the Shares to be purchased on the Closing Date or the Additional Closing Date, as the case may be, with any transfer taxes payable
in connection with the sale of such Shares duly paid by the Company. Delivery of the Shares shall be made through the facilities of The
Depository Trust Company (&ldquo;DTC&rdquo;) unless the Underwriter shall otherwise instruct. The certificates for the Shares will be
made available for inspection and packaging by the Underwriter at the office of DTC or its designated custodian not later than 1:00 P.M.,
New York City time, on the business day prior to the Closing Date or the Additional Closing Date, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(d)&nbsp;On
the Closing Date and the Additional Closing Date, as applicable, the Company shall issue to the Underwriter (and/or it&rsquo;s designees)
a warrant</FONT>, substantially in the form of&nbsp;<U>Exhibit E</U>&nbsp;attached hereto <FONT STYLE="font-size: 10pt">(the &ldquo;Underwriter
Warrant&rdquo;) to purchase shares of common stock of the Company (the &ldquo;Underwriter Warrant Shares&rdquo;) pursuant to a warrant
agreement (the &ldquo;Warrant Agreement&rdquo;), for the purchase of an aggregate of 114,285 shares of Common Stock, and up to an aggregate
of 131,427 shares of Common Stock, in any event, in an amount equal to 5.0% of the Shares issued pursuant to this Agreement, which shall
be registered and shall be in such denominations as the Underwriter may request at least one (1) business day before the Closing Date
and Additional Closing Date, as applicable. The Underwriter Warrant shall be issued to the Underwriter at a price of $50, exercisable,
in whole or in part, commencing on the date that is one hundred eighty (180) day after the effective date of the Registration Statement
and expiring on the fifth-year anniversary of the effective date of the Registration Statement, at an initial exercise price of $6.0375
per share, which is equal to one hundred and fifteen percent (115%) of the Purchase Price. The Underwriter understands and agrees that
there are significant restrictions pursuant to the Financial Industry Regulatory Authority, Inc. (&ldquo;FINRA&rdquo;) Rule 5110 against
transferring the Underwriter Warrant and the underlying shares of Common Stock during the one hundred eighty (180) days from the commencement
of sales of the Shares and by its acceptance thereof agrees that it will not sell, transfer, assign, pledge or hypothecate the Underwriter
Warrant or any portion thereof, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in
the effective economic disposition of such Shares for a period of one hundred eighty (180) days from the commencement of sales of such
Shares to anyone other than (i) an underwriter or a selected dealer in connection with the offering and sale of the Shares hereunder,
or (ii) a bona fide officer or partner of the Underwriter or of any such underwriter or selected dealer; and only if any such transferee
agrees to the foregoing lock-up restrictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;The
Company acknowledges and agrees that the Underwriter is acting solely in the capacity of an arm&rsquo;s length contractual counterparty
to the Company with respect to the offering of Shares contemplated hereby (including in connection with determining the terms of the offering)
and not as a financial advisor or a fiduciary to, or an agent of, the Company or any other person. Additionally, the Underwriter is not
advising the Company or any other person as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction. The Company
shall consult with its own advisors concerning such matters and shall be responsible for making its own independent investigation and
appraisal of the transactions contemplated hereby, and the Underwriter shall not have any responsibility or liability to the Company with
respect thereto. Any review by the Underwriter of the Company, the transactions contemplated hereby or other matters relating to such
transactions will be performed solely for the benefit of the Underwriter and shall not be on behalf of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&nbsp;<U>Representations
and Warranties of the Company</U>. The Company represents and warrants to the Underwriter that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<I>Preliminary
Prospectus.</I> No order preventing or suspending the use of any Preliminary Prospectus has been issued by the Commission, and each Preliminary
Prospectus included in the Pricing Disclosure Package, at the time of filing thereof, complied in all material respects with the Securities
Act, and no Preliminary Prospectus, at the time of filing thereof, contained any untrue statement of a material fact or omitted to state
a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading;
<U>provided</U> that the Company makes no representation or warranty with respect to any statements or omissions made in reliance upon
and in conformity with information relating to the Underwriter furnished to the Company in writing by the Underwriter expressly for use
in any Preliminary Prospectus, it being understood and agreed that the only such information furnished by the Underwriter consists of
the information described as such in Section&nbsp;7(b) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<I>Pricing
Disclosure Package</I>. The Pricing Disclosure Package as of the Applicable Time did not, and as of the Closing Date and as of the Additional
Closing Date, as the case may be, will not, contain any untrue statement of a material fact or omit to state a material fact necessary
in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U>
that the Company makes no representation or warranty with respect to any statements or omissions made in reliance upon and in conformity
with information relating to the Underwriter furnished to the Company in writing by the Underwriter expressly for use in such Pricing
Disclosure Package, it being understood and agreed that the only such information furnished by the Underwriter consists of the information
described as such in Section&nbsp;7(b) hereof. No statement of material fact included in the Prospectus has been omitted from the Pricing
Disclosure Package and no statement of material fact included in the Pricing Disclosure Package that is required to be included in the
Prospectus has been omitted therefrom.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;<I>Issuer
Free Writing Prospectus. </I>Other than the Registration Statement, the Preliminary Prospectus and the Prospectus, the Company (including
its agents and representatives, other than the Underwriter in its capacity as such) has not prepared, made, used, authorized, approved
or referred to and will not prepare, make, use, authorize, approve or refer to any &ldquo;written communication&rdquo; (as defined in
Rule 405 under the Securities Act) that constitutes an offer to sell or solicitation of an offer to buy the Shares (each such communication
by the Company or its agents and representatives (other than a communication referred to in clause (i) below) an &ldquo;Issuer Free Writing
Prospectus&rdquo;) other than (i) any document not constituting a prospectus pursuant to Section&nbsp;2(a)(10)(a) of the Securities Act
or Rule 134 under the Securities Act or (ii) the documents listed on Annex A hereto, each electronic road show and any other written communications
approved in writing in advance by the Underwriter. Each such Issuer Free Writing Prospectus complies in all material respects with the
Securities Act, has been or will be (within the time period specified in Rule 433) filed in accordance with the Securities Act (to the
extent required thereby) and does not conflict with the information contained in the Registration Statement or the Pricing Disclosure
Package, and, when taken together with the Preliminary Prospectus, accompanying, or delivered prior to delivery of such Issuer Free Writing
Prospectus, did not, and as of the Closing Date and as of the Additional Closing Date, as the case may be, will not, contain any untrue
statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading; <U>provided</U> that the Company makes no representation or warranty with respect to any statements
or omissions made in each such Issuer Free Writing Prospectus or Preliminary Prospectus in reliance upon and in conformity with information
relating to the Underwriter furnished to the Company in writing by the Underwriter expressly for use in such Issuer Free Writing Prospectus
or Preliminary Prospectus, it being understood and agreed that the only such information furnished by the Underwriter consists of the
information described as such in Section&nbsp;7(b) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&nbsp;<I>Emerging
Growth Company</I>. From the time of initial confidential submission or filing, whichever is first, of the Registration Statement to the
Commission (or, if earlier, the first date on which the Company engaged directly or through any person authorized to act on its behalf
in any Testing-the-Waters Communication undertaken in reliance on Section&nbsp;5(d) of the Securities Act) through the date hereof, the
Company has been and is an &ldquo;emerging growth company,&rdquo; as defined in Section&nbsp;2(a) of the Securities Act (an &ldquo;Emerging
Growth Company&rdquo;). &ldquo;Testing-the-Waters Communication&rdquo; means any oral or written communication with potential investors
undertaken in reliance on either Section&nbsp;5(d) of, or Rule&nbsp;163B under, the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&nbsp;<I>Testing-the-Waters
Materials. </I>The Company (i) has not alone engaged in any Testing-the-Waters Communications other than Testing-the-Waters Communications
with the consent of the Underwriter (x) with entities that are qualified institutional buyers (&ldquo;QIBs&rdquo;) within the meaning
of Rule 144A under the Securities Act or institutions that are accredited investors within the meaning of Rule&nbsp;501(a)(1), (a)(2),
(a)(3), (a)(7) or (a)(8) under the Securities Act (&ldquo;IAIs&rdquo;) and otherwise in compliance with the requirements of Section&nbsp;5(d)
of the Securities Act or (y) with entities that the Company reasonably believed to be QIBs or IAIs and otherwise in compliance with the
requirements of Rule&nbsp;163B under the Securities Act and (ii) has not authorized anyone other than the Underwriter to engage in Testing-the-Waters
Communications. The Company reconfirms that the Underwriter has been authorized to act on its behalf in undertaking Testing-the-Waters
Communications by virtue of a writing substantially in the form of Exhibit A hereto. The Company has not distributed or approved for distribution
any Written Testing-the-Waters Communications other than those listed on Annex&nbsp;B hereto. &ldquo;Written Testing-the-Waters Communication&rdquo;
means any Testing-the-Waters Communication that is a written communication within the meaning of Rule&nbsp;405 under the Securities Act.
Any individual Written Testing-the-Waters Communication does not conflict with the information contained in the Registration Statement
or the Pricing Disclosure Package, complied in all material respects with the Securities Act, and when taken together with the Pricing
Disclosure Package as of the Applicable Time, did not, and as of the Closing Date and as of the Additional Closing Date, as the case may
be, will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)&nbsp;<I>Registration
Statement and Prospectus.</I> The Registration Statement has been declared effective by the Commission. No order suspending the effectiveness
of the Registration Statement has been issued by the Commission, and no proceeding for that purpose or pursuant to Section 8A of the Securities
Act against the Company or related to the offering of the Shares has been initiated or threatened by the Commission; as of the applicable
effective date of the Registration Statement and any post-effective amendment thereto, the Registration Statement and any such post-effective
amendment complied and will comply in all material respects with the Securities Act, and did not and will not contain any untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein
not misleading; and as of the date of the Prospectus and any amendment or supplement thereto and as of the Closing Date and as of the
Additional Closing Date, as the case may be, the Prospectus will comply in all material respects with the Securities Act and will not
contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation or
warranty with respect to any statements or omissions made in reliance upon and in conformity with information relating to the Underwriter
furnished to the Company in writing by the Underwriter expressly for use in the Registration Statement and the Prospectus and any amendment
or supplement thereto, it being understood and agreed that the only such information furnished by the Underwriter consists of the information
described as such in Section&nbsp;7(b) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)&nbsp;<I>Financial
Statements.</I> The financial statements (including the related notes thereto) of the Company and its consolidated subsidiary included
in the Registration Statement, the Pricing Disclosure Package and the Prospectus comply in all material respects with the applicable requirements
of the Securities Act and present fairly the financial position of the Company and its consolidated subsidiaries as of the dates indicated
and the results of their operations and the changes in their cash flows for the periods specified; such financial statements have been
prepared in conformity with generally accepted accounting principles (&ldquo;GAAP&rdquo;) in the United States applied on a consistent
basis throughout the periods covered thereby, and any supporting schedules included in the Registration Statement present fairly the information
required to be stated therein; the other financial information included in the Registration Statement, the Pricing Disclosure Package
and the Prospectus has been derived from the accounting records of the Company and its consolidated subsidiaries and presents fairly the
information shown thereby; all disclosures included in the Registration Statement, the Pricing Disclosure Package and the Prospectus regarding
&ldquo;non-GAAP financial measures&rdquo; (as such term is defined by the rules and regulations of Commission) comply with Regulation
G of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;) and Item 10 of Regulation S-K of the Securities
Act, to the extent applicable; and the <I>pro forma</I> financial information and the related notes thereto, if any, included in the Registration
Statement, the Pricing Disclosure Package and the Prospectus have been prepared in accordance with the applicable requirements of the
Securities Act and the assumptions underlying such pro forma financial information are reasonable and are set forth in the Registration
Statement, the Pricing Disclosure Package and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)&nbsp;<I>No
Material Adverse Change.</I> Since the date of the most recent financial statements of the Company included in the Registration Statement,
the Pricing Disclosure Package and the Prospectus, (i) there has not been any change in the capital stock (other than the issuance of
shares of Common Stock upon exercise of stock options and warrants described as outstanding in, and the grant of options and awards under
existing equity incentive plans described in, the Registration Statement, the Pricing Disclosure Package and the Prospectus), short-term
debt or long-term debt of the Company or any of its subsidiaries, or any dividend or distribution of any kind declared, set aside for
payment, paid or made by the Company on any class of capital stock, or any material adverse change, or any development involving a prospective
material adverse change, in or affecting the business, properties, management, financial position, stockholders&rsquo; equity, results
of operations or prospects of the Company and its subsidiaries taken as a whole; (ii) neither the Company nor any of its subsidiaries
has entered into any transaction or agreement (whether or not in the ordinary course of business) that is material to the Company and
its subsidiaries taken as a whole or incurred any liability or obligation, direct or contingent, that is material to the Company and its
subsidiaries taken as a whole; and (iii) neither the Company nor any of its subsidiaries has sustained any loss or interference with its
business that is material to the Company and its subsidiaries taken as a whole and that is either from fire, explosion, flood or other
calamity, whether or not covered by insurance, or from any labor disturbance or dispute or any action, order or decree of any court or
arbitrator or governmental or regulatory authority, except in each case as otherwise disclosed in the Registration Statement, the Pricing
Disclosure Package and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;<I>Organization
and Good Standing.</I> The Company and each of its subsidiaries have been duly organized and are validly existing and in good standing
under the laws of their respective jurisdictions of organization, are duly qualified to do business and are in good standing in each jurisdiction
in which their respective ownership or lease of property or the conduct of their respective businesses requires such qualification, and
have all power and authority necessary to own or hold their respective properties and to conduct the businesses in which they are engaged,
except where the failure to be so qualified or in good standing or have such power or authority would not, individually or in the aggregate,
have a material adverse effect on the business, properties, management, financial position, stockholders&rsquo; equity, results of operations
or prospects of the Company and its subsidiaries taken as a whole or on the performance by the Company of its obligations under this Agreement
(a &ldquo;Material Adverse Effect&rdquo;). The Company does not own or control, directly or indirectly, any corporation, association or
other entity other than the subsidiaries listed in Exhibit 21.1 to the Registration Statement. The subsidiaries listed in Schedule 2 to
this Agreement are the only significant subsidiaries of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j)&nbsp;<I>Capitalization.</I>
The Company has an authorized capitalization as set forth in the Registration Statement, the Pricing Disclosure Package and the Prospectus
under the heading &ldquo;Capitalization&rdquo;; all the outstanding shares of capital stock of the Company have been duly and validly
authorized and issued and are fully paid and non-assessable and are not subject to any pre-emptive or similar rights; except as described
in or expressly contemplated by the Registration Statement, the Pricing Disclosure Package and the Prospectus, there are no outstanding
rights (including, without limitation, pre-emptive rights), warrants or options to acquire, or instruments convertible into or exchangeable
for, any shares of capital stock or other equity interest in the Company or any of its subsidiaries, or any contract, commitment, agreement,
understanding or arrangement of any kind relating to the issuance of any capital stock of the Company or any such subsidiary, any such
convertible or exchangeable securities or any such rights, warrants or options; the capital stock of the Company conforms in all material
respects to the description thereof contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus; and all
the outstanding shares of capital stock or other equity interests of each subsidiary owned, directly or indirectly, by the Company have
been duly and validly authorized and issued, are fully paid and non-assessable (except, in the case of any foreign subsidiary, for directors&rsquo;
qualifying shares and except as otherwise described in the Registration Statement, the Pricing Disclosure Package and the Prospectus)
and are owned directly or indirectly by the Company, free and clear of any lien, charge, encumbrance, security interest, restriction on
voting or transfer or any other claim of any third party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k)&nbsp;<I>Stock
Options. </I>With respect to the stock options (the &ldquo;Stock Options&rdquo;) granted pursuant to the stock-based compensation plans
of the Company and its subsidiaries (the &ldquo;Company Stock Plans&rdquo;), (i) each Stock Option intended to qualify as an &ldquo;incentive
stock option&rdquo; under Section&nbsp;422 of the Code so qualifies, (ii) each grant of a Stock Option was duly authorized no later than
the date on which the grant of such Stock Option was by its terms to be effective (the &ldquo;Grant Date&rdquo;) by all necessary corporate
action, including, as applicable, approval by the board of directors of the Company (or a duly constituted and authorized committee thereof)
and any required stockholder approval by the necessary number of votes or written consents, and the award agreement governing such grant
(if any) was duly executed and delivered by each party thereto, (iii) each such grant was made in accordance with the terms of the Company
Stock Plans, the Exchange Act and all other applicable laws and regulatory rules or requirements, including the rules of the NASDAQ and
any other exchange on which Company securities are traded, and (iv)&nbsp;each such grant was properly accounted for in accordance with
GAAP in the financial statements (including the related notes) of the Company. The Company has not knowingly granted, and there is no
and has been no policy or practice of the Company of granting, Stock Options prior to, or otherwise coordinating the grant of Stock Options
with, the release or other public announcement of material information regarding the Company or its subsidiaries or their results of operations
or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l)&nbsp;<I>Due
Authorization.</I> The Company has full right, power and authority to execute and deliver this Agreement and to perform its obligations
hereunder; and all action required to be taken for the due and proper authorization, execution and delivery by it of this Agreement and
the consummation by it of the transactions contemplated hereby has been duly and validly taken.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m)&nbsp;<I>Underwriting
Agreement. </I>This Agreement has been duly authorized, executed and delivered by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(n)&nbsp;<I>The
Shares. </I>The Shares to be issued and sold by the Company hereunder have been duly authorized by the Company and, when issued and delivered
and paid for as provided herein, will be duly and validly issued, will be fully paid and nonassessable and will conform to the descriptions
thereof in the Registration Statement, the Pricing Disclosure Package and the Prospectus; and the issuance of the Shares is not subject
to any preemptive or similar rights. The Underwriter Warrant Shares, when issued, paid for and delivered upon due exercise of the Underwriter
Warrant, as applicable, will be duly and validly issued, will be fully paid and nonassessable, and will conform to the descriptions thereof
in the Registration Statement, the Pricing Disclosure Package and the Prospectus; and the issuance of the Underwriter Warrant Shares is
not subject to any preemptive or similar rights. The shares of common stock of the Company representing the Underwriter Warrant Shares
have been reserved for issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(o)&nbsp;<I>Description
of the Underwriting Agreement.</I> This Agreement conforms in all material respects to the description thereof contained in the Registration
Statement, the Pricing Disclosure Package and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(p)&nbsp;<I>No
Violation or Default.</I> Neither the Company nor any of its subsidiaries is (i)&nbsp;in violation of its charter or bylaws or similar
organizational documents; (ii)&nbsp;in default, and no event has occurred that, with notice or lapse of time or both, would constitute
such a default, in the due performance or observance of any term, covenant or condition contained in any indenture, mortgage, deed of
trust, loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company
or any of its subsidiaries is bound or to which any property or asset of the Company or any of its subsidiaries is subject; or (iii) in
violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority,
except, in the case of clauses (ii) and (iii) above, for any such default or violation that would not, individually or in the aggregate,
have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(q)&nbsp;<I>No
Conflicts. </I>The execution, delivery and performance by the Company of this Agreement, the issuance and sale of the Shares, the Underwriter
Warrant and the Underwriter Warrant Shares and the consummation of the transactions contemplated by this Agreement or the Pricing Disclosure
Package and the Prospectus will not (i) conflict with or result in a breach or violation of any of the terms or provisions of, or constitute
a default under, result in the termination, modification or acceleration of, or result in the creation or imposition of any lien, charge
or encumbrance upon any property, right or asset of the Company or any of its subsidiaries pursuant to, any indenture, mortgage, deed
of trust, loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company
or any of its subsidiaries is bound or to which any property, right or asset of the Company or any of its subsidiaries is subject, (ii)
result in any violation of the provisions of the charter or by-laws or similar organizational documents of the Company or any of its subsidiaries
or (iii) result in the violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental
or regulatory authority, except, in the case of clauses (i) and (iii) above, for any such conflict, breach, violation, default, lien,
charge or encumbrance that would not, individually or in the aggregate, have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(r)&nbsp;<I>No
Consents Required.</I> No consent, approval, authorization, order, registration or qualification of or with any court or arbitrator or
governmental or regulatory authority is required for the execution, delivery and performance by the Company of this Agreement, the issuance
and sale of the Shares, the Underwriter Warrant and the Underwriter Warrant Shares and the consummation of the transactions contemplated
by this Agreement, except for the registration of the Shares and the Underwriter Warrant Shares under the Securities Act and such consents,
approvals, authorizations, orders and registrations or qualifications as may be required by the Financial Industry Regulatory Authority,
Inc. (&ldquo;FINRA&rdquo;) and under applicable state securities laws in connection with the purchase and distribution of the Shares by
the Underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(s)&nbsp;<I>Legal
Proceedings.</I> Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, there are no legal,
governmental or regulatory investigations, actions, demands, claims, suits, arbitrations, inquiries or proceedings (&ldquo;Actions&rdquo;)
pending to which the Company or any of its subsidiaries is or may be a party or to which any property of the Company or any of its subsidiaries
is or may be the subject that, individually or in the aggregate, if determined adversely to the Company or any of its subsidiaries, could
reasonably be expected to have a Material Adverse Effect; no such Actions are threatened or, to the knowledge of the Company, contemplated
by any governmental or regulatory authority or threatened by others; and (i) there are no current or pending Actions that are required
under the Securities Act to be described in the Registration Statement, the Pricing Disclosure Package or the Prospectus that are not
so described in the Registration Statement, the Pricing Disclosure Package and the Prospectus and (ii) there are no statutes, regulations
or contracts or other documents that are required under the Securities Act to be filed as exhibits to the Registration Statement or described
in the Registration Statement, the Pricing Disclosure Package or the Prospectus that are not so filed as exhibits to the Registration
Statement or described in the Registration Statement, the Pricing Disclosure Package and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(t)&nbsp;<I>Independent
Accountants</I>. Rose, Snyder &amp; Jacobs LLP, who has certified certain financial statements of the Company and its subsidiaries is
an independent registered public accounting firm with respect to the Company and its subsidiaries within the applicable rules and regulations
adopted by the Commission and the Public Company Accounting Oversight Board (United States) and as required by the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(u)&nbsp;<I>Title
to Real and Personal Property</I>. The Company and its subsidiaries have good and marketable title in fee simple to, or have valid rights
to lease or otherwise use, all items of real and personal property that are material to the respective businesses of the Company and its
subsidiaries, in each case free and clear of all liens, encumbrances, claims and defects and imperfections of title except those that
(i) do not materially interfere with the use made and proposed to be made of such property by the Company and its subsidiaries or (ii)
could not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v)&nbsp;<I>Intellectual
Property.</I> (i) The Company and its subsidiaries own or have the right to use all patents, patent rights, statutory invention rights,
community designs, invention disclosures, rights in utility models and industrial designs, inventions, registered and unregistered copyrights
(including copyrights in software), intellectual property rights in technology and software, data, knowhow (including trade secrets and
other unpatented and/or unpatentable proprietary or confidential information, systems or procedures), trademarks, service marks, business
names, trade names, logos, slogans, trade dress, design rights, Internet domain names, social media accounts, any other designations of
source or origin, and any applications (including provisional applications), registrations, or renewals for any of the foregoing, rights
to publicity and privacy and/or other intellectual property (collectively, &ldquo;Intellectual Property&rdquo;) used in or necessary for
the conduct of their respective businesses; (ii) the Company&rsquo;s and its subsidiaries&rsquo; conduct of their respective businesses
does not infringe, misappropriate or otherwise violate, and has not infringed, misappropriated or otherwise violated, any Intellectual
Property of any person; (iii) the Company and its subsidiaries have not received any written notice of, or are otherwise aware of, any
claim relating to Intellectual Property, including any claim alleging any infringement, misappropriation or other violation of, or conflict
regarding, any Intellectual Property of a third party, and the Company and its subsidiaries are unaware of any fact which would form a
reasonable basis for any such claim; and (iv) to the knowledge of the Company, the Intellectual Property of the Company and its subsidiaries
is not being and has not been infringed, misappropriated or otherwise violated by any person and there is no pending or threatened action,
suit, proceeding or claim by the Company or any of its subsidiaries against a third party regarding the foregoing. As of the date hereof,
as of the Closing Date and as of the Additional Closing Date, as the case may be, the Company does not and will not have any license agreements
pursuant to which Intellectual Property has been licensed to the Company. All Intellectual Property owned by the Company (such Intellectual
Property, the &ldquo;Company Intellectual Property&rdquo;) is valid, subsisting and enforceable and there is no pending or, to the Company&rsquo;s
knowledge, threatened action, suit, proceeding or claim by any third party challenging the validity, ownership, registrability, scope
or enforceability of any Company Intellectual Property and the Company and its subsidiaries are unaware of any facts or circumstances
which would form a reasonable basis for any such claim. All Company Intellectual Property has been duly maintained and is in full force
and effect, and all actions or fees necessary to prosecute or maintain the Company Intellectual Property have been timely taken, met or
paid and there are no material defects in any of the Company Intellectual Property. Each person who is or was an employee or contractor
of the Company or any of its subsidiaries and who is, was or, in the case of current employees and contractors, is reasonably expected
to be involved in the creation or development of any Intellectual Property for or on behalf of the Company has executed a valid, written
agreement containing an effective, present and valid assignment to the Company or any of its subsidiaries of such person&rsquo;s rights
in and to such Intellectual Property. The Company is not aware of any violation by any current or former employee of the Company or any
of its subsidiaries of any term of any agreement or covenant to or with a former employer of such employee where the basis of such violation
relates to such employee&rsquo;s employment with the Company or any of its subsidiaries or actions undertaken by the employee while employed
with the Company or any of its subsidiaries. The Company has taken all reasonable steps necessary to maintain the confidentiality of the
trade secrets and other confidential Intellectual Property used in connection with the business of the Company and its subsidiaries, and
the confidentiality of such trade secrets and confidential Intellectual Property has not been compromised in such a matter would deprive
the Company&rsquo;s trade secrets from the protections afforded to trade secrets under the applicable law, or which would preclude the
Company from enforcing confidentiality obligations against persons who have agreed, or otherwise have a duty to, maintain the confidentiality
of such material confidential Intellectual Property. No Intellectual Property has been obtained or is being used by the Company or its
subsidiaries in violation of any material contractual obligations binding on the Company or its subsidiaries in violation of any contractual
rights of any person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(w)&nbsp;<I>No
Undisclosed Relationships</I>. No relationship, direct or indirect, exists between or among the Company or any of its subsidiaries, on
the one hand, and the directors, officers, stockholders, customers, suppliers or other affiliates of the Company or any of its subsidiaries,
on the other, that is required by the Securities Act to be described in each of the Registration Statement and the Prospectus and that
is not so described in such documents and in the Pricing Disclosure Package.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(x)&nbsp;<I>Investment
Company Act</I>. The Company is not and, after giving effect to the offering and sale of the Shares and the issuance of the Underwriter
Warrant Shares upon the exercise of the Underwriter Warrant, as applicable, and the application of the proceeds thereof as described in
the Registration Statement, the Pricing Disclosure Package and the Prospectus, will not be required to register as an &ldquo;investment
company&rdquo; or an entity &ldquo;controlled&rdquo; by an &ldquo;investment company&rdquo; within the meaning of the Investment Company
Act of 1940, as amended, and the rules and regulations of the Commission thereunder (collectively, the &ldquo;Investment Company Act&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(y)&nbsp;<I>Taxes.</I>
The Company and its subsidiaries have paid all federal, state, local and foreign taxes and filed all tax returns required to be paid or
filed through the date hereof; and except as otherwise disclosed in each of the Registration Statement, the Pricing Disclosure Package
and the Prospectus, there is no tax deficiency that has been, or could reasonably be expected to be, asserted against the Company or any
of its subsidiaries or any of their respective properties or assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(z)&nbsp;<I>Licenses
and Permits.</I> The Company and its subsidiaries possess all licenses, sub-licenses, certificates, permits and other authorizations issued
by, and have made all declarations and filings with, the appropriate federal, state, local or foreign governmental or regulatory authorities
that are necessary for the ownership or lease of their respective properties or the conduct of their respective businesses (including,
without limitation, all such permits, licenses, approvals, clearances, certificates, consents and other authorizations required by any
Governmental Authority (as defined below) engaged in the regulation of dentistry or orthodontics or activities related to the business
now operated by the Company and its subsidiaries in such jurisdictions) as described in each of the Registration Statement, the Pricing
Disclosure Package and the Prospectus, except where the failure to possess or make the same would not, individually or in the aggregate,
have a Material Adverse Effect; and except as described in each of the Registration Statement, the Pricing Disclosure Package and the
Prospectus, neither the Company nor any of its subsidiaries has received notice of any revocation or modification of any such license,
sub-license, certificate, permit or authorization or has any reason to believe that any such license, sub-license, certificate, permit
or authorization will not be renewed in the ordinary course. The Company and its subsidiaries (i) are, and at all times have been, in
compliance with all statutes, rules and regulations applicable to the services it, or its subsidiaries, or its affiliated dental partners
provide (&ldquo;Applicable Laws&rdquo;), except where such noncompliance would not, singly or in the aggregate, result in a Material Adverse
Effect; and (ii) have not received written notice of adverse finding, warning letter, untitled letter or other correspondence or written
notice from any court or arbitrator or Governmental Authority alleging or asserting noncompliance with (x) any Applicable Laws or (y)
any licenses required by any such Applicable Laws, except where being in contravention of any of the foregoing representations or warranties,
singly or in the aggregate, would not result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(aa)&nbsp;<I>No Labor
Disputes.</I> No labor disturbance by or dispute with employees of the Company or any of its subsidiaries exists or, to the knowledge
of the Company, is contemplated or threatened, and the Company is not aware of any existing or imminent labor disturbance by, or dispute
with, the employees of any of its or its subsidiaries&rsquo; principal suppliers, contractors or customers, except as would not have a
Material Adverse Effect. Neither the Company nor any of its subsidiaries has received any notice of cancellation or termination with respect
to any collective bargaining agreement to which it is a party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(bb)&nbsp;<I>Certain
Environmental Matters</I>. (i) The Company and its subsidiaries (x) are in compliance with all, and have not violated any, applicable
federal, state, local and foreign laws (including common law), rules, regulations, requirements, decisions, judgments, decrees, orders
and other legally enforceable requirements relating to pollution or the protection of human health or safety, the environment, natural
resources, hazardous or toxic substances or wastes, pollutants or contaminants (collectively, &ldquo;Environmental Laws&rdquo;); (y) have
received and are in compliance with all, and have not violated any, permits, licenses, certificates or other authorizations or approvals
required of them under any Environmental Laws to conduct their respective businesses; and (z) have not received notice of any actual or
potential liability or obligation under or relating to, or any actual or potential violation of, any Environmental Laws, including for
the investigation or remediation of any disposal or release of hazardous or toxic substances or wastes, pollutants or contaminants, and
have no knowledge of any event or condition that would reasonably be expected to result in any such notice; (ii) there are no costs or
liabilities associated with Environmental Laws of or relating to the Company or its subsidiaries, except in the case of each of (i) and
(ii) above, for any such matter as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect;
and (iii) except as described in each of the Pricing Disclosure Package and the Prospectus, (x) there is no proceeding that is pending,
or that is known to be contemplated, against the Company or any of its subsidiaries under any Environmental Laws in which a governmental
entity is also a party, other than such proceeding regarding which it is reasonably believed no monetary sanctions of $100,000 or more
will be imposed, (y) the Company and its subsidiaries are not aware of any facts or issues regarding compliance with Environmental Laws,
or liabilities or other obligations under Environmental Laws or concerning hazardous or toxic substances or wastes, pollutants or contaminants,
that could reasonably be expected to have a material effect on the capital expenditures, earnings or competitive position of the Company
and its subsidiaries, and (z) none of the Company or its subsidiaries anticipates material capital expenditures relating to any Environmental
Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(cc)&nbsp;<I>Compliance
with ERISA</I>. (i) Each employee benefit plan, within the meaning of Section&nbsp;3(3) of the Employee Retirement Income Security Act
of 1974, as amended (&ldquo;ERISA&rdquo;), for which the Company or any member of its &ldquo;Controlled Group&rdquo; (defined as any entity,
whether or not incorporated, that is under common control with the Company within the meaning of Section&nbsp;4001(a)(14) of ERISA or
any entity that would be regarded as a single employer with the Company under Section&nbsp;414(b),(c),(m) or (o) of the Internal Revenue
Code of 1986, as amended (the &ldquo;Code&rdquo;)) would have any liability (each, a &ldquo;Plan&rdquo;) has been maintained in compliance
with its terms and the requirements of any applicable statutes, orders, rules and regulations, including but not limited to ERISA and
the Code; (ii) no prohibited transaction, within the meaning of Section 406 of ERISA or Section 4975 of the Code, has occurred with respect
to any Plan, excluding transactions effected pursuant to a statutory or administrative exemption; (iii) for each Plan that is subject
to the funding rules of Section 412 of the Code or Section 302 of ERISA, no Plan has failed (whether or not waived), or is reasonably
expected to fail, to satisfy the minimum funding standards (within the meaning of Section 302 of ERISA or Section 412 of the Code) applicable
to such Plan; (iv) no Plan is, or is reasonably expected to be, in &ldquo;at risk status&rdquo; (within the meaning of Section 303(i)
of ERISA) and no Plan that is a &ldquo;multiemployer plan&rdquo; within the meaning of Section 4001(a)(3) of ERISA is in &ldquo;endangered
status&rdquo; or &ldquo;critical status&rdquo; (within the meaning of Sections 304 and 305 of ERISA) (v) the fair market value of the
assets of each Plan exceeds the present value of all benefits accrued under such Plan (determined based on those assumptions used to fund
such Plan); (vi) no &ldquo;reportable event&rdquo; (within the meaning of Section 4043(c) of ERISA and the regulations promulgated thereunder)
has occurred or is reasonably expected to occur; (vii) each Plan that is intended to be qualified under Section 401(a) of the Code is
so qualified, and nothing has occurred, whether by action or by failure to act, which would cause the loss of such qualification; (viii)
neither the Company nor any member of the Controlled Group has incurred, nor reasonably expects to incur, any liability under Title IV
of ERISA (other than contributions to the Plan or premiums to the Pension Benefit Guarantee Corporation, in the ordinary course and without
default) in respect of a Plan (including a &ldquo;multiemployer plan&rdquo; within the meaning of Section 4001(a)(3) of ERISA); and (ix)
none of the following events has occurred or is reasonably likely to occur: (A) a material increase in the aggregate amount of contributions
required to be made to all Plans by the Company or its Controlled Group affiliates in the current fiscal year of the Company and its Controlled
Group affiliates compared to the amount of such contributions made in the Company&rsquo;s and its Controlled Group affiliates&rsquo; most
recently completed fiscal year; or (B) a material increase in the Company and its subsidiaries&rsquo; &ldquo;accumulated post-retirement
benefit obligations&rdquo; (within the meaning of Accounting Standards Codification Topic 715-60) compared to the amount of such obligations
in the Company and its subsidiaries&rsquo; most recently completed fiscal year, except in each case with respect to the events or conditions
set forth in (i) through (ix) hereof, as would not, individually or in the aggregate, have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(dd)&nbsp;<I>Disclosure
Controls</I>. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company and its
subsidiaries maintain an effective system of &ldquo;disclosure controls and procedures&rdquo; (as defined in Rule 13a-15(e) of the Exchange
Act) that complies with the requirements of the Exchange Act and that has been designed to ensure that information required to be disclosed
by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time
periods specified in the Commission&rsquo;s rules and forms, including controls and procedures designed to ensure that such information
is accumulated and communicated to the Company&rsquo;s management as appropriate to allow timely decisions regarding required disclosure.
The Company and its subsidiaries have carried out evaluations of the effectiveness of their disclosure controls and procedures as required
by Rule 13a-15 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ee)&nbsp;<I>Accounting
Controls.</I> Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company and its
subsidiaries maintain systems of &ldquo;internal control over financial reporting&rdquo; (as defined in Rule 13a-15(f) of the Exchange
Act) that comply with the requirements of the Exchange Act and have been designed by, or under the supervision of, their respective principal
executive and principal financial officers, or persons performing similar functions, to provide reasonable assurance regarding the reliability
of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP. The Company and its
subsidiaries maintain internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance
with management&rsquo;s general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability; (iii) access to assets is permitted only in accordance with management&rsquo;s
general or specific authorization; and (iv) the recorded accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences. Except as disclosed in the Registration Statement, the Pricing
Disclosure Package and the Prospectus, there are no material weaknesses in the Company&rsquo;s internal controls. The Company&rsquo;s
auditors and the Audit Committee of the Board of Directors of the Company have been advised of: (i) all significant deficiencies and material
weaknesses in the design or operation of internal controls over financial reporting which have adversely affected or are reasonably likely
to adversely affect the Company&rsquo;s ability to record, process, summarize and report financial information; and (ii) any fraud, whether
or not material, that involves management or other employees who have a significant role in the Company&rsquo;s internal controls over
financial reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ff)&nbsp;<I>Insurance.
</I>The Company and its subsidiaries have insurance covering their respective properties, operations, personnel and businesses, including
business interruption insurance, which insurance is in amounts and insures against such losses and risks as are adequate to protect the
Company and its subsidiaries and their respective businesses; and, except as communicated to the Underwriter, neither the Company nor
any of its subsidiaries has (i) received notice from any insurer or agent of such insurer that capital improvements or other expenditures
are required or necessary to be made in order to continue such insurance or (ii) any reason to believe that it will not be able to renew
its existing insurance coverage as and when such coverage expires or to obtain similar coverage at reasonable cost from similar insurers
as may be necessary to continue its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(gg)&nbsp;<I>Cybersecurity;
Data Protection. </I>The Company and its subsidiaries&rsquo; information technology assets and equipment, computers, systems, networks,
hardware, software, websites, applications, technology, data and databases (collectively, &ldquo;IT Systems&rdquo;) are adequate for,
and operate and perform in all material respects as required in connection with the operation of the business of the Company and its subsidiaries
as currently conducted, free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware, viruses and other corruptants.
The Company and its subsidiaries have implemented and maintained commercially reasonable controls, policies, procedures, and safeguards
to maintain and protect their confidential information and the integrity, continuous operation, redundancy and security of all IT Systems
and data (including all personal, personally identifiable, sensitive, confidential or regulated data (&ldquo;Personal Data&rdquo;)) used
in connection with their businesses, and there have been no, and the Company and its subsidiaries have not been notified of, and have
no knowledge of any event or condition that would reasonably be expected to result in any, breaches, violations, outages or unauthorized
uses of or accesses to the same (&ldquo;Breach&rdquo;), nor are there any incidents under internal review or investigations relating to
any Breach. Neither the Company nor its subsidiaries has received any notice, claim, complaint, demand or letter from any person or governmental
agency in respect of their businesses under applicable data protection laws, regulations and standards regarding any Breach of the IT
Systems or any Personal Data used in connection with the operation of the Company&rsquo;s and its subsidiaries&rsquo; businesses. Neither
the Company nor its subsidiaries have been obligated to notify any third party, including, without limitation, any individual or data
protection authority, of any Breach. The Company and its subsidiaries have complied at all times and are presently in compliance with
all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory
authority, internal and external policies and contractual obligations relating to the privacy and security of IT Systems and the privacy,
security, collection, use, transfer, import, export, storage, protection, disposal, disclosure or other processing of Personal Data and
to the protection of such IT Systems and Personal Data from unauthorized use, access, misappropriation or modification (&ldquo;Data Security
Obligation&rdquo;). The Company and its subsidiaries have taken all necessary actions to comply with any Data Security Obligations to
which it is obligated to comply. Neither the Company nor its subsidiaries have received any notice, claim, complaint, demand, letter,
notification of or complaint regarding, and is unaware of any other facts that, individually or in the aggregate, would reasonably indicate
non-compliance with, any Data Security Obligation and there is no pending or threatened action, suit, investigation or proceeding by or
before any court or governmental agency, authority or body alleging non-compliance with any Data Security Obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(hh)&nbsp;<I>No Unlawful
Payments.</I> Neither the Company nor any of its subsidiaries nor any director, officer or employee of the Company or any of its subsidiaries
nor, to the knowledge of the Company, any agent, affiliate or other person associated with or acting on behalf of the Company or any of
its subsidiaries has (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense relating
to political activity; (ii) made or taken an act in furtherance of an offer, promise or authorization of any direct or indirect unlawful
payment or benefit to any foreign or domestic government official or employee, including of any government-owned or controlled entity
or of a public international organization, or any person acting in an official capacity for or on behalf of any of the foregoing, or any
political party or party official or candidate for political office; (iii) violated or is in violation of any provision of the Foreign
Corrupt Practices Act of 1977, as amended, or any applicable law or regulation implementing the OECD Convention on Combating Bribery of
Foreign Public Officials in International Business Transactions, or committed an offence under the Bribery Act 2010 of the United Kingdom
or any other applicable anti-bribery or anti-corruption law; or (iv) made, offered, agreed, requested or taken an act in furtherance of
any unlawful bribe or other unlawful benefit, including, without limitation, any rebate, payoff, influence payment, kickback or other
unlawful or improper payment or benefit. The Company and its subsidiaries have instituted, maintain and enforce, and will continue to
maintain and enforce policies and procedures designed to promote and ensure compliance with all applicable anti-bribery and anti-corruption
laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;<I>Compliance
with Anti-Money Laundering Laws</I>. The operations of the Company and its subsidiaries are and have been conducted at all times in compliance
with applicable financial recordkeeping and reporting requirements, including those of the Currency and Foreign Transactions Reporting
Act of 1970, as amended, the applicable money laundering statutes of all jurisdictions where the Company or any of its subsidiaries conducts
business, the rules and regulations thereunder and any related or similar rules, regulations or guidelines issued, administered or enforced
by any governmental agency (collectively, the &ldquo;Anti-Money Laundering Laws&rdquo;) and no action, suit or proceeding by or before
any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to
the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(jj)&nbsp;<I>No Conflicts
with Sanctions Laws. </I>Neither the Company nor any of its subsidiaries, directors, officers, or employees, nor, to the knowledge of
the Company, any agent, affiliate or other person associated with or acting on behalf of the Company or any of its subsidiaries is currently
the subject or the target of any sanctions administered or enforced by the U.S. government, (including, without limitation, the Office
of Foreign Assets Control of the U.S. Department of the Treasury (&ldquo;OFAC&rdquo;) or the U.S. Department of State and including, without
limitation, the designation as a &ldquo;specially designated national&rdquo; or &ldquo;blocked person&rdquo;), the United Nations Security
Council (&ldquo;UNSC&rdquo;), the European Union, His Majesty&rsquo;s Treasury (&ldquo;HMT&rdquo;) or other relevant sanctions authority
(collectively, &ldquo;Sanctions&rdquo;), nor is the Company or any of its subsidiaries located, organized or resident in a country or
territory that is the subject or target of Sanctions, including, without limitation, Crimea, Cuba, Iran, North Korea and Syria (each,
a &ldquo;Sanctioned Country&rdquo;); and the Company will not directly or indirectly use the proceeds of the offering of the Shares hereunder,
or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity (i) to
fund or facilitate any activities of or business with any person that, at the time of such funding or facilitation, is the subject or
target of Sanctions, (ii) to fund or facilitate any activities of or business in any Sanctioned Country or (iii) in any other manner that
will result in a violation by any person (including any person participating in the transaction, whether as underwriter, advisor, investor
or otherwise) of Sanctions. For the past five years, the Company and its subsidiaries have not knowingly engaged in and are not now knowingly
engaged in any dealings or transactions with any person that at the time of the dealing or transaction is or was the subject or the target
of Sanctions or with any Sanctioned Country.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(kk)&nbsp;<I>No Restrictions
on Subsidiaries</I>. No subsidiary of the Company is currently prohibited, directly or indirectly, under any agreement or other instrument
to which it is a party or is subject, from paying any dividends to the Company, from making any other distribution on such subsidiary&rsquo;s
capital stock or similar ownership interest, from repaying to the Company any loans or advances to such subsidiary from the Company or
from transferring any of such subsidiary&rsquo;s properties or assets to the Company or any other subsidiary of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ll)&nbsp;<I>No Broker&rsquo;s
Fees.</I> Neither the Company nor any of its subsidiaries is a party to any contract, agreement or understanding with any person (other
than this Agreement) that would give rise to a valid claim against any of them or the Underwriter for a brokerage commission, finder&rsquo;s
fee or like payment in connection with the offering and sale of the Shares and the issuance of the Underwriter Warrant Shares hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(mm)&nbsp;<I>No Registration
Rights</I>. Except for those persons included as Selling Shareholders in the Registration Statement, no person has the right to require
the Company or any of its subsidiaries to register any securities for sale under the Securities Act by reason of the filing of the Registration
Statement with the Commission or the issuance and sale of the Shares, other than those rights that have been disclosed in the Registration
Statement, the Pricing Disclosure Package and the Prospectus and have been waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(nn)&nbsp;<I>No Stabilization.</I>
Neither the Company nor any of its subsidiaries or affiliates has taken, directly or indirectly, any action designed to or that could
reasonably be expected to cause or result in any stabilization or manipulation of the price of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(oo)&nbsp;<I>Margin
Rules</I>. Neither the issuance, sale and delivery of the Shares nor the application of the proceeds thereof by the Company as described
in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus will violate Regulation T, U or X of the Board
of Governors of the Federal Reserve System or any other regulation of such Board of Governors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(pp)&nbsp;<I>Forward-Looking
Statements.</I> No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange
Act) included or incorporated by reference in any of the Registration Statement, the Pricing Disclosure Package or the Prospectus has
been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(qq)&nbsp;<I>Statistical
and Market Data.</I> Nothing has come to the attention of the Company that has caused the Company to believe that the statistical and
market-related data included in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus is not based on
or derived from sources that are reliable and accurate in all material respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(rr)&nbsp;<I>Sarbanes-Oxley
Act</I>. There is and has been no failure on the part of the Company or any of the Company&rsquo;s directors or officers, in their capacities
as such, to comply with any provision of the Sarbanes-Oxley Act of 2002, as amended and the rules and regulations promulgated in connection
therewith (the &ldquo;Sarbanes-Oxley Act&rdquo;), including Section 402 related to loans and Sections 302 and 906 related to certifications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ss)&nbsp;<I>Status
under the Securities Act</I>. At the time of filing the Registration Statement and any post-effective amendment thereto, at the earliest
time thereafter that the Company or any offering participant made a <I>bona fide</I> offer (within the meaning of Rule 164(h)(2) under
the Securities Act) of the Shares and at the date hereof, the Company was not and is not an &ldquo;ineligible issuer,&rdquo; as defined
in Rule 405 under the Securities Act. The Company has paid the registration fee for this offering pursuant to Rule 456(b)(1) under the
Securities Act or will pay such fee within the time period required by such rule (without giving effect to the proviso therein) and in
any event prior to the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(tt)&nbsp;<I>No Ratings</I>.
There are (and prior to the Closing Date, will be) no debt securities, convertible securities or preferred stock issued or guaranteed
by the Company or any of its subsidiaries that are rated by a &ldquo;nationally recognized statistical rating organization,&rdquo; as
such term is defined in Section 3(a)(62) under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(uu)&nbsp;<I>Passive
Foreign Investment Company</I>. The Company was not a &ldquo;passive foreign investment company&rdquo; (&ldquo;PFIC&rdquo;) as defined
in Section 1297 of the Code for its most recently completed taxable year and the Company does not expect to be a PFIC for the foreseeable
future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.&nbsp;<U>Further
Agreements of the Company</U>. The Company covenants and agrees with the Underwriter that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<I>Required
Filings.</I> The Company will file the final Prospectus with the Commission within the time periods specified by Rule 424(b) and Rule
430A, 430B or 430C under the Securities Act, will file any Issuer Free Writing Prospectus to the extent required by Rule 433 under the
Securities Act; and the Company will furnish copies of the Prospectus and each Issuer Free Writing Prospectus (to the extent not previously
delivered) to the Underwriter in New York City prior to 10:00 A.M., New York City time, on the business day next succeeding the date of
this Agreement in such quantities as the Underwriter may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<I>Delivery
of Copies.</I> The Company will deliver, without charge, (i) to the Underwriter, a signed copy of the Registration Statement as originally
filed and each amendment thereto, in each case including all exhibits and consents filed therewith; and (ii) to the Underwriter (A) a
conformed copy of the Registration Statement as originally filed and each amendment thereto (without exhibits) and (B) during the Prospectus
Delivery Period (as defined below), as many copies of the Prospectus (including all amendments and supplements thereto and each Issuer
Free Writing Prospectus) as the Underwriter may reasonably request. As used herein, the term &ldquo;Prospectus Delivery Period&rdquo;
means such period of time after the first date of the public offering of the Shares as in the opinion of counsel for the Underwriter a
prospectus relating to the Shares is required by law to be delivered (or required to be delivered but for Rule 172 under the Securities
Act) in connection with sales of the Shares by the Underwriter or dealer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;<I>Amendments
or Supplements, Issuer Free Writing Prospectuses.</I> Before making, preparing, using, authorizing, approving, referring to or filing
any Issuer Free Writing Prospectus, and before filing any amendment or supplement to the Registration Statement, the Pricing Disclosure
Package or the Prospectus, the Company will furnish to the Underwriter and counsel for the Underwriter a copy of the proposed Issuer Free
Writing Prospectus, amendment or supplement for review and will not make, prepare, use, authorize, approve, refer to or file any such
Issuer Free Writing Prospectus or file any such proposed amendment or supplement to which the Underwriter reasonably objects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&nbsp;<I>Notice
to the Underwriter.</I> The Company will advise the Underwriter promptly, and confirm such advice in writing, including by electronic
mail, (i) when the Registration Statement has become effective; (ii) when any amendment to the Registration Statement has been filed or
becomes effective; (iii) when any supplement to the Pricing Disclosure Package, the Prospectus, any Issuer Free Writing Prospectus or
any Written Testing-the-Waters Communication or any amendment to the Prospectus has been filed or distributed; (iv) of any request by
the Commission for any amendment to the Registration Statement or any amendment or supplement to the Prospectus or the receipt of any
comments from the Commission relating to the Registration Statement or any other request by the Commission for any additional information
including, but not limited to, any request for information concerning any Testing-the-Waters Communication; (v) of the issuance by the
Commission or any other governmental or regulatory authority of any order suspending the effectiveness of the Registration Statement or
preventing or suspending the use of any Preliminary Prospectus, any of the Pricing Disclosure Package, the Prospectus or any Written Testing-the-Waters
Communication or the initiation or threatening of any proceeding for that purpose or pursuant to Section 8A of the Securities Act; (vi)
of the occurrence of any event or development within the Prospectus Delivery Period as a result of which the Prospectus, any of the Pricing
Disclosure Package, any Issuer Free Writing Prospectus or any Written Testing-the-Waters Communication as then amended or supplemented
would include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein,
in the light of the circumstances existing when the Prospectus, the Pricing Disclosure Package, any such Issuer Free Writing Prospectus
or any Written Testing-the-Waters Communication is delivered to a purchaser, not misleading; and (vii) of the receipt by the Company of
any notice with respect to any suspension of the qualification of the Shares for offer and sale in any jurisdiction or the initiation
or threatening of any proceeding for such purpose; and the Company will use its reasonable best efforts to prevent the issuance of any
such order suspending the effectiveness of the Registration Statement, preventing or suspending the use of any Preliminary Prospectus,
any of the Pricing Disclosure Package or the Prospectus or any Written Testing-the-Waters Communication or suspending any such qualification
of the Shares and, if any such order is issued, will obtain as soon as possible the withdrawal thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&nbsp;<I>Ongoing
Compliance.</I> (1) If during the Prospectus Delivery Period (i) any event or development shall occur or condition shall exist as a result
of which the Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit to state any material
fact necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus is delivered to
a purchaser, not misleading or (ii) it is necessary to amend or supplement the Prospectus to comply with law, the Company will immediately
notify the Underwriter thereof and forthwith prepare and, subject to paragraph (c) above, file with the Commission and furnish to the
Underwriter and to such dealers as the Underwriter may designate such amendments or supplements to the Prospectus as may be necessary
so that the statements in the Prospectus as so amended or supplemented will not, in the light of the circumstances existing when the Prospectus
is delivered to a purchaser, be misleading or so that the Prospectus will comply with law and (2) if at any time prior to the Closing
Date (i) any event or development shall occur or condition shall exist as a result of which the Pricing Disclosure Package as then amended
or supplemented would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the
statements therein, in the light of the circumstances existing when the Pricing Disclosure Package is delivered to a purchaser, not misleading
or (ii) it is necessary to amend or supplement the Pricing Disclosure Package to comply with law, the Company will immediately notify
the Underwriter thereof and forthwith prepare and, subject to paragraph (c) above, file with the Commission (to the extent required) and
furnish to the Underwriter and to such dealers as the Underwriter may designate such amendments or supplements to the Pricing Disclosure
Package as may be necessary so that the statements in the Pricing Disclosure Package as so amended or supplemented will not, in the light
of the circumstances existing when the Pricing Disclosure Package is delivered to a purchaser, be misleading or so that the Pricing Disclosure
Package will comply with law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)&nbsp;<I>Blue
Sky Compliance.</I> The Company will qualify the Shares for offer and sale under the securities or Blue Sky laws of such jurisdictions
as the Underwriter shall reasonably request and will continue such qualifications in effect so long as required for distribution of the
Shares; <U>provided</U> that the Company shall not be required to (i) qualify as a foreign corporation or other entity or as a dealer
in securities in any such jurisdiction where it would not otherwise be required to so qualify, (ii) file any general consent to service
of process in any such jurisdiction or (iii) subject itself to taxation in any such jurisdiction if it is not otherwise so subject.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)&nbsp;<I>Earning
Statement. </I>The Company will make generally available (which includes filings pursuant to the Exchange Act made publicly through the
EDGAR system) to its security holders and the Underwriter as soon as practicable an earning statement that satisfies the provisions of
Section 11(a) of the Securities Act and Rule 158 of the Commission promulgated thereunder covering a period of at least twelve months
beginning with the first fiscal quarter of the Company occurring after the &ldquo;effective date&rdquo; (as defined in Rule 158) of the
Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)&nbsp;<I>Clear
Market.</I> For a period of 90 days after the date of the Prospectus (the &ldquo;Restricted Period&rdquo;), the Company will not (i) offer,
pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right
or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, or submit to, or file with, the Commission
a registration statement under the Securities Act relating to, any shares of Stock or any securities convertible into or exercisable or
exchangeable for Stock, or publicly disclose the intention to undertake any of the foregoing, or (ii) enter into any swap or other agreement
that transfers, in whole or in part, any of the economic consequences of ownership of the Stock or any such other securities, whether
any such transaction described in clause (i) or (ii) above is to be settled by delivery of Stock or such other securities, in cash or
otherwise, without the prior written consent of the Underwriter, which shall not be unreasonably withheld, other than the Shares to be
sold hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in">The restrictions described above do not
apply to (i) the Shares to be sold hereunder; (ii) the issuance of shares of Stock or securities convertible into or exercisable for shares
of Stock pursuant to the conversion or exchange of convertible or exchangeable securities or the exercise of warrants or options (including
net exercise) or the settlement of RSUs (including net settlement), in each case outstanding on the date of this Agreement and described
in the Prospectus; (iii) grants of stock options, stock awards, restricted stock, RSUs, or other equity awards and the issuance of shares
of Stock or securities convertible into or exercisable or exchangeable for shares of Stock (whether upon the exercise of stock options
or otherwise) to the Company&rsquo;s employees, officers, directors, advisors, or consultants pursuant to the terms of an equity compensation
plan in effect as of the Closing Date and described in the Prospectus, provided that such recipients enter into a lock-up agreement with
the Underwriter; (iv) the filing of any registration statement on Form S-8 relating to securities granted or to be granted pursuant to
any plan in effect on the date of this Agreement and described in the Prospectus or any assumed benefit plan pursuant to an acquisition
or similar strategic transaction; or (v) the establishment of an issuer trading plan pursuant to&nbsp;Rule&nbsp;10b5-1&nbsp;under&nbsp;the
Exchange Act for the transfer of shares of Common Stock,&nbsp;provided&nbsp;that (a)&nbsp;such plan does not provide for the transfer
of shares of Common Stock during the Restricted Period and (b)&nbsp;to the extent a public announcement or filing under the Exchange Act,
if any, is required of or voluntarily made by the Company regarding the establishment of such plan, such announcement or filing shall
include a statement to the effect that no transfer of shares of Common Stock may be made under such plan during the Restricted Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">If the Underwriter,
in its sole discretion, agree to release or waive the restrictions set forth in a lock-up letter described in Section&nbsp;6(l) hereof
for an officer or director of the Company and provide the Company with notice of the impending release or waiver substantially in the
form of Exhibit&nbsp;B hereto at least three business days before the effective date of the release or waiver, the Company agrees to announce
the impending release or waiver substantially in the form of Exhibit&nbsp;C hereto through a major news service at least two business
days before the effective date of the release or waiver.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;<I>Use
of Proceeds.</I> The Company will apply the net proceeds from the sale of the Shares as described in each of the Registration Statement,
the Pricing Disclosure Package and the Prospectus under the heading &ldquo;Use of Proceeds.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j)&nbsp;<I>No
Stabilization.</I> Neither the Company nor its subsidiaries or affiliates will take, directly or indirectly, any action designed to or
that could reasonably be expected to cause or result in any stabilization or manipulation of the price of the Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k)&nbsp;<I>Exchange
Listing.</I> The Company will use its reasonable best efforts to list for quotation the Shares on The Nasdaq Stock Market(the &ldquo;NASDAQ&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l)&nbsp;<I>Reports.</I>
So long as the Shares are outstanding, the Company will furnish to the Underwriter, as soon as they are available, copies of all reports
or other communications (financial or other) furnished to holders of the Shares, and copies of any reports and financial statements furnished
to or filed with the Commission or any national securities exchange or automatic quotation system; <U>provided</U> the Company will be
deemed to have furnished such reports and financial statements to the Underwriter to the extent they are filed on the Commission&rsquo;s
Electronic Data Gathering, Analysis, and Retrieval system.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m)&nbsp;<I>Record
Retention</I>. The Company will, pursuant to reasonable procedures developed in good faith, retain copies of each Issuer Free Writing
Prospectus that is not filed with the Commission in accordance with Rule 433 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(n)&nbsp;<I>Filings.</I>
The Company will file with the Commission such reports as may be required by Rule 463 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(o)&nbsp;<I>Emerging
Growth Company</I>. The Company will promptly notify the Underwriter if the Company ceases to be an Emerging Growth Company at any time
prior to the later of (i) completion of the distribution of Shares within the meaning of the Securities Act and (ii) completion of the
90-day restricted period referred to in Section&nbsp;4(h) hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.&nbsp;<U>Certain
Agreements of the Underwriter</U>. The Underwriter hereby represents and agrees that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;It
has not and will not use, authorize use of, refer to or participate in the planning for use of, any &ldquo;free writing prospectus,&rdquo;
as defined in Rule 405 under the Securities Act (which term includes use of any written information furnished to the Commission by the
Company and not incorporated by reference into the Registration Statement and any press release issued by the Company) other than (i)
a free writing prospectus that contains no &ldquo;issuer information&rdquo; (as defined in Rule 433(h)(2) under the Securities Act) that
was not included (including through incorporation by reference) in the Preliminary Prospectus or a previously filed Issuer Free Writing
Prospectus, (ii) any Issuer Free Writing Prospectus listed on Annex A or prepared pursuant to Section&nbsp;3(c) or Section&nbsp;4(c) above
(including any electronic road show), or (iii) any free writing prospectus prepared by the Underwriter and approved by the Company in
advance in writing (each such free writing prospectus referred to in clauses (i) or (iii), an &ldquo;Underwriter Free Writing Prospectus&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;It
has not and will not, without the prior written consent of the Company, use any free writing prospectus that contains the final terms
of the Shares unless such terms have previously been included in a free writing prospectus filed with the Commission; <I>provided</I>
that Underwriter may use a term sheet substantially in the form of Annex C hereto without the consent of the Company; <I>provided further</I>
that the Underwriter using such term sheet shall notify the Company, and provide a copy of such term sheet to the Company, prior to, or
substantially concurrently with, the first use of such term sheet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;It
is not subject to any pending proceeding under Section 8A of the Securities Act with respect to the offering (and will promptly notify
the Company if any such proceeding against it is initiated during the Prospectus Delivery Period).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&nbsp;It
has not and will not take any action that would result in the Company being required to file with the Commission under Rule 433(d) a free
writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder,
but for the action of such Underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.&nbsp;<U>Conditions
of Underwriter&rsquo;s Obligations.</U> The obligation of the Underwriter to purchase the Underwritten Shares on the Closing Date or the
Option Shares on the Additional Closing Date, as the case may be, as provided herein is subject to the performance by the Company of its
covenants and other obligations hereunder and to the following additional conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<I>Registration
Compliance; No Stop Order.</I> No order suspending the effectiveness of the Registration Statement shall be in effect, and no proceeding
for such purpose or pursuant to Section 8A under the Securities Act shall be pending before or threatened by the Commission; the Prospectus
and each Issuer Free Writing Prospectus shall have been timely filed with the Commission under the Securities Act (in the case of an Issuer
Free Writing Prospectus, to the extent required by Rule 433 under the Securities Act) and in accordance with Section&nbsp;4(a) hereof;
and all requests by the Commission for additional information shall have been complied with to the reasonable satisfaction of the Underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<I>Representations
and Warranties.</I> The representations and warranties of the Company contained herein shall be true and correct on the date hereof and
on and as of the Closing Date or the Additional Closing Date, as the case may be; and the statements of the Company and its officers made
in any certificates delivered pursuant to this Agreement shall be true and correct on and as of the Closing Date or the Additional Closing
Date, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;<I>No
Material Adverse Change.</I> No event or condition of a type described in Section 3(h) hereof shall have occurred or shall exist, which
event or condition is not described in the Pricing Disclosure Package (excluding any amendment or supplement thereto) and the Prospectus
(excluding any amendment or supplement thereto) and the effect of which in the judgment of the Underwriter makes it impracticable or inadvisable
to proceed with the offering, sale or delivery of the Shares on the Closing Date or the Additional Closing Date, as the case may be, on
the terms and in the manner contemplated by this Agreement, the Pricing Disclosure Package and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&nbsp;<I>Officer&rsquo;s
Certificate.</I> The Underwriter shall have received on and as of the Closing Date or the Additional Closing Date, as the case may be,
a certificate of the chief financial officer or chief accounting officer of the Company (i) confirming that such officer has carefully
reviewed the Registration Statement, the Pricing Disclosure Package and the Prospectus and, to the knowledge of such officer, the representations
set forth in Sections&nbsp;3(b) and 3(d) hereof are true and correct, (ii) confirming that the other representations and warranties of
the Company in this Agreement are true and correct and that the Company has complied with all agreements and satisfied all conditions
on its part to be performed or satisfied hereunder at or prior to the Closing Date or the Additional Closing Date, as the case may be,
and (iii) to the effect set forth in paragraphs (a), (b) and (c) above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&nbsp;<I>Comfort
Letters.</I> (i) On the date of this Agreement and on the Closing Date or the Additional Closing Date, as the case may be, Rose, Snyder
&amp; Jacobs LLP shall have furnished to the Underwriter, at the request of the Company, letters, dated the respective dates of delivery
thereof and addressed to the Underwriter, in form and substance reasonably satisfactory to the Underwriter, containing statements and
information of the type customarily included in accountants&rsquo; &ldquo;comfort letters&rdquo; to underwriters with respect to the financial
statements and certain financial information contained in each of the Registration Statement, the Pricing Disclosure Package and the Prospectus;
provided, that the letter delivered on the Closing Date or the Additional Closing Date, as the case may be, shall use a &ldquo;cut-off&rdquo;
date no more than two business days prior to such Closing Date or such Additional Closing Date, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) On the date of
this Agreement and on the Closing Date or the Additional Closing Date, as the case may be, the Company shall have furnished to the Underwriter
a certificate, dated the respective dates of delivery thereof and addressed to the Underwriter, of its chief financial officer with respect
to certain financial data contained in the Pricing Disclosure Package and the Prospectus, providing &ldquo;management comfort&rdquo; with
respect to such information, in form and substance reasonably satisfactory to the Underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)&nbsp;<I>Opinion
and Negative Assurance Letter of Counsel for the Company.</I> Hunter Taubman Fischer &amp; Li LLC, counsel for the Company, shall have
furnished to the Underwriter, at the request of the Company, its written opinion and 10b-5 statement, dated the Closing Date or the Additional
Closing Date, as the case may be, and addressed to the Underwriter, in form and substance reasonably satisfactory to the Underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)&nbsp;<I>Opinion
and Negative Assurance Statement of Counsel for the Underwriter.</I> The Underwriter shall have received on and as of the Closing Date
or the Additional Closing Date, as the case may be, an opinion that includes a negative assurance statement, addressed to the Underwriter,
of Faegre Drinker Biddle &amp; Reath LLP, counsel for the Underwriter, with respect to such matters as the Underwriter may reasonably
request, and such counsel shall have received such documents and information as they may reasonably request to enable them to pass upon
such matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)&nbsp;<I>No
Legal Impediment to Issuance and Sale.</I> No action shall have been taken and no statute, rule, regulation or order shall have been enacted,
adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing Date or the Additional
Closing Date, as the case may be, prevent the issuance or sale of the Shares; and no injunction or order of any federal, state or foreign
court shall have been issued that would, as of the Closing Date or the Additional Closing Date, as the case may be, prevent the issuance
or sale of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;<I>Good
Standing</I>. The Underwriter shall have received on and as of the Closing Date or the Additional Closing Date, as the case may be, satisfactory
evidence of the good standing of the Company and its subsidiaries in their respective jurisdictions of organization, in each case in writing
or any standard form of telecommunication from the appropriate governmental authorities of such jurisdictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j)&nbsp;<I>Exchange
Listing.</I> The Shares to be delivered on the Closing Date or the Additional Closing Date, as the case may be, shall have been approved
for listing on the NASDAQ, subject to official notice of issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k)&nbsp;<I>Lock-up
Agreements</I>. The &ldquo;lock-up&rdquo; agreements, each substantially in the form of Exhibit D hereto, between the Underwriter, officers
and directors of the Company relating to sales and certain other dispositions of shares of Stock or certain other securities, delivered
to the Underwriter on or before the date hereof, shall be full force and effect on the Closing Date or the Additional Closing Date, as
the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l)&nbsp;<I>FINRA</I>.
FINRA shall not have raised any objection with respect to the fairness or reasonableness of the underwriting or other arrangements of
the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m)&nbsp;<I>Additional
Documents.</I> On or prior to the Closing Date or the Additional Closing Date, as the case may be, the Company shall have furnished to
the Underwriter such further certificates and documents as the Underwriter may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All opinions, letters, certificates
and evidence mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof only if they
are in form and substance reasonably satisfactory to counsel for the Underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.&nbsp;<U>Indemnification
and Contribution</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;<I>Indemnification
of the Underwriter.</I> The Company agrees to indemnify and hold harmless the Underwriter, its affiliates, directors and officers and
each person, if any, who controls the Underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange
Act, from and against any and all losses, claims, damages and liabilities (including, without limitation, legal fees and other expenses
incurred in connection with any suit, action or proceeding or any claim asserted, as such fees and expenses are incurred), joint or several,
that arise out of, or are based upon, (i) any untrue statement or alleged untrue statement of a material fact contained in the Registration
Statement or caused by any omission or alleged omission to state therein a material fact required to be stated therein or necessary in
order to make the statements therein, not misleading, or (ii) any untrue statement or alleged untrue statement of a material fact contained
in the Prospectus (or any amendment or supplement thereto), any Preliminary Prospectus, any Issuer Free Writing Prospectus, any &ldquo;issuer
information&rdquo; filed or required to be filed pursuant to Rule 433(d) under the Securities Act, any Written Testing-the-Waters Communication,
any road show as defined in Rule 433(h) under the Securities Act (a &ldquo;road show&rdquo;) or any Pricing Disclosure Package (including
any Pricing Disclosure Package that has subsequently been amended), or caused by any omission or alleged omission to state therein a material
fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, in each
case except insofar as such losses, claims, damages or liabilities arise out of, or are based upon, any untrue statement or omission or
alleged untrue statement or omission made in reliance upon and in conformity with any information relating to the Underwriter furnished
to the Company in writing by the Underwriter expressly for use therein, it being understood and agreed that the only such information
furnished by the Underwriter consists of the information described as such in paragraph (b) below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;<I>Indemnification
of the Company.</I> The Underwriter agrees to indemnify and hold harmless the Company, its directors, its officers who signed the Registration
Statement and each person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the
Exchange Act to the same extent as the indemnity set forth in paragraph (a) above, but only with respect to any losses, claims, damages
or liabilities that arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in
reliance upon and in conformity with any information relating to the Underwriter furnished to the Company in writing by the Underwriter
expressly for use in the Registration Statement, the Prospectus (or any amendment or supplement thereto), any Preliminary Prospectus,
any Issuer Free Writing Prospectus, any Written Testing-the-Waters Communication, any road show or any Pricing Disclosure Package (including
any Pricing Disclosure Package that has subsequently been amended), it being understood and agreed upon that the only such information
furnished by the Underwriter consists of the following information in the Prospectus furnished on behalf of the Underwriter: (i) the concession
and reallowance figures appearing in the second paragraph under the caption &ldquo;Underwriting,&rdquo; (ii) paragraphs one, two and three
under the caption &ldquo;Price Stabilization, Short Positions and Penalty Bids,&rdquo; and (iii) the first and second sentences in the
paragraph under the caption &ldquo;Electronic Offer, Sale and Distribution of Shares.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;<I>Notice
and Procedures.</I> If any suit, action, proceeding (including any governmental or regulatory investigation), claim or demand shall be
brought or asserted against any person in respect of which indemnification may be sought pursuant to the preceding paragraphs of this
Section&nbsp;7, such person (the &ldquo;Indemnified Person&rdquo;) shall promptly notify the person against whom such indemnification
may be sought (the &ldquo;Indemnifying Person&rdquo;) in writing; <U>provided</U> that the failure to notify the Indemnifying Person shall
not relieve it from any liability that it may have under the preceding paragraphs of this Section&nbsp;7 except to the extent that it
has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure; and <U>provided</U>, <U>further</U>,
that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have to an Indemnified Person otherwise
than under the preceding paragraphs of this Section&nbsp;7. If any such proceeding shall be brought or asserted against an Indemnified
Person and it shall have notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably satisfactory
to the Indemnified Person (who shall not, without the consent of the Indemnified Person, be counsel to the Indemnifying Person) to represent
the Indemnified Person and any others entitled to indemnification pursuant to this Section that the Indemnifying Person may designate
in such proceeding and shall pay the fees and expenses in such proceeding and shall pay the fees and expenses of such counsel related
to such proceeding, as incurred. In any such proceeding, any Indemnified Person shall have the right to retain its own counsel, but the
fees and expenses of such counsel shall be at the expense of such Indemnified Person unless (i) the Indemnifying Person and the Indemnified
Person shall have mutually agreed to the contrary; (ii) the Indemnifying Person has failed within a reasonable time to retain counsel
reasonably satisfactory to the Indemnified Person; (iii) the Indemnified Person shall have reasonably concluded that there may be legal
defenses available to it that are different from or in addition to those available to the Indemnifying Person; or (iv) the named parties
in any such proceeding (including any impleaded parties) include both the Indemnifying Person and the Indemnified Person and representation
of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. It is understood
and agreed that the Indemnifying Person shall not, in connection with any proceeding or related proceeding in the same jurisdiction, be
liable for the fees and expenses of more than one separate firm (in addition to any local counsel) for all Indemnified Persons, and that
all such fees and expenses shall be paid or reimbursed as they are incurred. Any such separate firm for the Underwriter, its affiliates,
directors and officers and any control persons of the Underwriter shall be designated in writing by the Underwriter and any such separate
firm for the Company, its directors, its officers who signed the Registration Statement and any control persons of the Company shall be
designated in writing by the Company. The Indemnifying Person shall not be liable for any settlement of any proceeding effected without
its written consent, but if settled with such consent, the Indemnifying Person agrees to indemnify each Indemnified Person from and against
any loss or liability by reason of such settlement. Notwithstanding the foregoing sentence, if at any time an Indemnified Person shall
have requested that an Indemnifying Person reimburse the Indemnified Person for fees and expenses of counsel as contemplated by this paragraph,
the Indemnifying Person shall be liable for any settlement of any proceeding effected without its written consent if (i) such settlement
is entered into more than 30 days after receipt by the Indemnifying Person of such request and (ii) the Indemnifying Person shall not
have reimbursed the Indemnified Person in accordance with such request prior to the date of such settlement. No Indemnifying Person shall,
without the written consent of the Indemnified Person, effect any settlement of any pending or threatened proceeding in respect of which
any Indemnified Person is or could have been a party and indemnification could have been sought hereunder by such Indemnified Person,
unless such settlement (x) includes an unconditional release of such Indemnified Person, in form and substance reasonably satisfactory
to such Indemnified Person, from all liability on claims that are the subject matter of such proceeding and (y) does not include any statement
as to or any admission of fault, culpability or a failure to act by or on behalf of any Indemnified Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;<I>Contribution.</I>
If the indemnification provided for in paragraphs (a) or (b) above is unavailable to an Indemnified Person or insufficient in respect
of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu of indemnifying
such Indemnified Person thereunder, shall contribute to the amount paid or payable by such Indemnified Person as a result of such losses,
claims, damages or liabilities (i) in such proportion as is appropriate to reflect the relative benefits received by the Company, on the
one hand, and the Underwriter on the other, from the offering of the Shares or (ii) if the allocation provided by clause (i) is not permitted
by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) but also the
relative fault of the Company, on the one hand, and the Underwriter on the other, in connection with the statements or omissions that
resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations. The relative benefits
received by the Company, on the one hand, and the Underwriter on the other, shall be deemed to be in the same respective proportions as
the net proceeds (before deducting expenses) received by the Company from the sale of the Shares and the total underwriting discounts
and commissions received by the Underwriter in connection therewith, in each case as set forth in the table on the cover of the Prospectus,
bear to the aggregate offering price of the Shares. The relative fault of the Company, on the one hand, and the Underwriter on the other,
shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission
or alleged omission to state a material fact relates to information supplied by the Company or by the Underwriter and the parties&rsquo;
relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;<I>Limitation
on Liability.</I> The Company and the Underwriter agree that it would not be just and equitable if contribution pursuant to paragraph
(d) above were determined by <U>pro rata</U> allocation or by any other method of allocation that does not take account of the equitable
considerations referred to in paragraph (d) above. The amount paid or payable by an Indemnified Person as a result of the losses, claims,
damages and liabilities referred to in paragraph (d) above shall be deemed to include, subject to the limitations set forth above, any
legal or other expenses incurred by such Indemnified Person in connection with any such action or claim. Notwithstanding the provisions
of paragraphs (d) and (e), in no event shall an Underwriter be required to contribute any amount in excess of the amount by which the
total underwriting discounts and commissions received by the Underwriter with respect to the offering of the Shares exceeds the amount
of any damages that the Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission
or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall
be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;<I>Non-Exclusive
Remedies.</I> The remedies provided for in this Section&nbsp;7 paragraphs (a) through (e) are not exclusive and shall not limit any rights
or remedies which may otherwise be available to any Indemnified Person at law or in equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.&nbsp;<U>Effectiveness
of Agreement</U>. This Agreement shall become effective as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.&nbsp;<U>Termination</U>.
This Agreement may be terminated in the absolute discretion of the Underwriter, by notice to the Company, if after the execution and delivery
of this Agreement and on or prior to the Closing Date or, in the case of the Option Shares, prior to the Additional Closing Date (i) trading
generally shall have been suspended or materially limited on or by any of the New York Stock Exchange or The Nasdaq Stock Market; (ii)
trading of any securities issued or guaranteed by the Company shall have been suspended on any exchange or in any over-the-counter market;
(iii) a general moratorium on commercial banking activities shall have been declared by federal or New York State authorities; or (iv)
there shall have occurred any outbreak or escalation of hostilities or any change in financial markets or any calamity or crisis, either
within or outside the United States, that, in the judgment of the Underwriter, is material and adverse and makes it impracticable or inadvisable
to proceed with the offering, sale or delivery of the Shares on the Closing Date or the Additional Closing Date, as the case may be, on
the terms and in the manner contemplated by this Agreement, the Pricing Disclosure Package and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.&nbsp;<U>Payment
of Expenses</U><I>.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Whether or not the transactions
contemplated by this Agreement are consummated or this Agreement is terminated, the Company will pay or cause to be paid reasonable, actual
and accountable costs, fees and expenses incurred in connection with the transactions contemplated hereby including without limitation,
(i)&nbsp;the costs incident to the authorization, issuance, sale, preparation and delivery of the Shares and any taxes payable in that
connection; (ii)&nbsp;the costs incident to the preparation, printing and filing under the Securities Act of the Registration Statement,
the Preliminary Prospectus, any Issuer Free Writing Prospectus, any Pricing Disclosure Package and the Prospectus (including all exhibits,
amendments and supplements thereto) and the distribution thereof; (iii)&nbsp;the fees and expenses of the Company&rsquo;s counsel and
independent accountants; (iv)&nbsp;the fees and expenses incurred in connection with the registration or qualification and determination
of eligibility for investment of the Shares under the laws of such jurisdictions as the Underwriter may designate and the preparation,
printing and distribution of a Blue Sky Memorandum (including the related fees and expenses of counsel for the Underwriter); (v)&nbsp;the
cost of preparing stock certificates; (vi)&nbsp;the costs and charges of any transfer agent and any registrar; (vii)&nbsp;all expenses
and application fees incurred in connection with any filing with, and clearance of the offering by, FINRA; (vii)&nbsp;all expenses incurred
by the Company in connection with any &ldquo;road show&rdquo; presentation to potential investors; (ix)&nbsp;all expenses and application
fees related to the listing of the Shares on the NASDAQ; and (x) all of the Underwriter&rsquo;s accountable expenses and fees in connection
with the offer, sale and marketing of the Shares, including reasonable fees and disbursements of the Underwriter&rsquo;s legal counsel,
but such reimbursement pursuant to this Section 10(x) will not exceed, without your prior written approval, $125,000 of total reimbursable
expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;If
(i) this Agreement is terminated pursuant to Section&nbsp;9, (ii)&nbsp;the Company for any reason fails to tender the Shares for delivery
to the Underwriter or (iii)&nbsp;the Underwriter decline to purchase the Shares for any reason permitted under this Agreement, the Company
agrees to reimburse the Underwriter for all out-of-pocket costs and expenses (including the fees and expenses of its counsel) reasonably
and actually incurred by the Underwriter in connection with this Agreement and the offering contemplated hereby, not to exceed $125,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.&nbsp;<U>Persons
Entitled to Benefit of Agreement</U>. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective
successors and the officers and directors and any controlling persons referred to herein, and the affiliates of the Underwriter referred
to in Section&nbsp;7 hereof. Nothing in this Agreement is intended or shall be construed to give any other person any legal or equitable
right, remedy or claim under or in respect of this Agreement or any provision contained herein. No purchaser of Shares from the Underwriter
shall be deemed to be a successor merely by reason of such purchase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.&nbsp;<U>Survival</U>.
The respective indemnities, rights of contribution, representations, warranties and agreements of the Company and the Underwriter contained
in this Agreement or made by or on behalf of the Company or the Underwriter pursuant to this Agreement or any certificate delivered pursuant
hereto shall survive the delivery of and payment for the Shares and shall remain in full force and effect, regardless of any termination
of this Agreement or any investigation made by or on behalf of the Company or the Underwriter or the directors, officers, controlling
persons or affiliates referred to in Section&nbsp;7 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">13.&nbsp;<U>Certain
Defined Terms</U>. For purposes of this Agreement, (a) except where otherwise expressly provided, the term &ldquo;affiliate&rdquo; has
the meaning set forth in Rule 405 under the Securities Act; (b) the term &ldquo;business day&rdquo; means any day other than a day on
which banks are permitted or required to be closed in New York City; (c) the term &ldquo;subsidiary&rdquo; has the meaning set forth in
Rule 405 under the Securities Act ; and (d) the term &ldquo;significant subsidiary&rdquo; has the meaning set forth in Rule 1-02 of Regulation
S-X under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">14.&nbsp;<U>Compliance
with USA Patriot Act</U>. In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October
26, 2001)), the Underwriter is required to obtain, verify and record information that identifies its clients, including the Company, which
information may include the name and address of its clients, as well as other information that will allow the Underwriter to properly
identify its clients.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.&nbsp;<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;<I>Notices.</I>
All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed or transmitted
and confirmed by any standard form of telecommunication. Notices to the Underwriter shall be given to the Underwriter at Craig-Hallum
Capital Group LLC, 222 South Ninth Street, Suite 350 Minneapolis, Minnesota 55402, Attention: Investment Banking, with a copy (which shall
not constitute notice) to Faegre Drinker Biddle &amp; Reath LLP, 200 Wells Fargo Center 90 S. Seventh Street, Minneapolis, Minnesota 55402
Attention: Jonathan Zimmerman. Notices to the Company shall be given to it at 27 Castilian Drive, Goleta, CA 93117, Attention: Jonathan
Klamkin with a copy (which shall not constitute notice) to Hunter Taubman Fischer &amp; Li LLC, 950 Third Ave., New York, NY 10022, Attention:
Louis Taubman.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;<I>Governing
Law.</I> This Agreement and any claim, controversy or dispute arising under or related to this Agreement shall be governed by and construed
in accordance with the laws of the State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;<I>Submission
to Jurisdiction</I>. The Company hereby submits to the exclusive jurisdiction of the U.S. federal and New York state courts in the Borough
of Manhattan in The City of New York in any suit or proceeding arising out of or relating to this Agreement or the transactions contemplated
hereby. The Company waives any objection which it may now or hereafter have to the laying of venue of any such suit or proceeding in such
courts. The Company agrees that final judgment in any such suit, action or proceeding brought in such court shall be conclusive and binding
upon the Company and may be enforced in any court to the jurisdiction of which Company is subject by a suit upon such judgment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;<I>Waiver
of Jury Trial.</I> Each of the parties hereto hereby waives any right to trial by jury in any suit or proceeding arising out of or relating
to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;<I>Recognition
of the U.S. Special Resolution Regimes</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) In the event
that the Underwriter is a Covered Entity and becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from
the Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as
the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were
governed by the laws of the United States or a state of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii) In the event
that the Underwriter is a Covered Entity and becomes subject, or a BHC Act Affiliate of the Underwriter becomes subject, to a proceeding
under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against the Underwriter is permitted
to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement
were governed by the laws of the United States or a state of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">As used in this Section&nbsp;15(e):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&ldquo;BHC Act Affiliate&rdquo;
has the meaning assigned to the term &ldquo;affiliate&rdquo; in, and shall be interpreted in accordance with, 12 U.S.C. &sect; 1841(k).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&ldquo;Covered Entity&rdquo;
means any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0in">(i) a &ldquo;covered
entity&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 252.82(b);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0in">(ii) a &ldquo;covered
bank&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 47.3(b); or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0in">(iii) a &ldquo;covered
FSI&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 382.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&ldquo;Default Right&rdquo;
has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &sect;&sect; 252.81, 47.2 or 382.1, as
applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&ldquo;U.S. Special
Resolution Regime&rdquo; means each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title
II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;<I>Counterparts</I>.
This Agreement may be signed in counterparts (which may include counterparts delivered by any standard form of telecommunication), each
of which shall be an original and all of which together shall constitute one and the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;<I>Amendments
or Waivers</I>. No amendment or waiver of any provision of this Agreement, nor any consent or approval to any departure therefrom, shall
in any event be effective unless the same shall be in writing and signed by the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;<I>Headings</I>.
The headings herein are included for convenience of reference only and are not intended to be part of, or to affect the meaning or interpretation
of, this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;<I>Partial
Unenforceability</I>. The invalidity or unenforceability of any Section, paragraph or provision of this Agreement shall not affect the
validity or enforceability of any other Section, paragraph, or provision hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the foregoing is in accordance
with your understanding, please indicate your acceptance of this Agreement by signing in the space provided below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aeluma, Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 37%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Jonathan Klamkin</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Jonathan Klamkin</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: CEO</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page to Underwriting Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->-</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accepted: As of the date first written above</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CRAIG-HALLUM CAPITAL GROUP LLC</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Rick Hartfiel </FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rick Hartfiel</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Head of Investment Banking</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page to Underwriting Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Schedule 1</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid">Underwriter</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Number of Shares</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 91%; text-align: left">Craig-Hallum Capital Group LLC</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 6%; text-align: right">2,285,714</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: right; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-align: left; padding-bottom: 4pt">Total</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">2,285,714</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 35; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Sch 1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Schedule 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Significant Subsidiaries</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">1.</TD><TD STYLE="text-align: justify">Aeluma Operating Co., a Delaware corporation.</TD>
</TR></TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Sch 2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Annex A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">a.</TD><TD STYLE="text-align: justify"><B>Pricing Disclosure Package</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">b.</TD><TD STYLE="text-align: justify"><B>Pricing Information Provided Orally by Underwriter</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt">Underwritten Shares: 2,285,714
shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt">Option Shares: 342,857 shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt">Public Offering Price Per
Share: $5.25</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 37; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Annex A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Annex B</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Written Testing-the-Waters Communications</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 38; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Annex B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Annex C</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aeluma, Inc.<BR>
<BR>
<U>Pricing Term Sheet</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 39; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Annex C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Exhibit A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Testing the waters authorization (to be delivered
by the issuer to Craig-Hallum in email or letter form)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In reliance on Rule 163B under the Securities
Act of 1933, as amended (the &ldquo;Act&rdquo;), Aeluma, Inc. (the &ldquo;Issuer&rdquo;) hereby authorizes Craig-Hallum Capital Group
LLC (&ldquo;Craig-Hallum&rdquo;) and its affiliates and employees to engage on behalf of the Issuer in oral and written communications
with potential investors that are reasonably believed to be &ldquo;qualified institutional buyers,&rdquo; as defined in Rule 144A under
the Act, or institutions that are &ldquo;accredited investors,&rdquo; within the meaning of Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or
(a)(8) under the Act, to determine whether such investors might have an interest in the Issuer&rsquo;s contemplated public offering (&ldquo;Testing-the-Waters
Communications&rdquo;). A &ldquo;Written Testing-the Waters Communication&rdquo; means any Testing-the-Waters Communication that is a
written communication within the meaning of Rule 405 under the Act. Craig-Hallum agrees that it shall not distribute any Written Testing-the-Waters
Communication that has not been approved by the Issuer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If at any time following the distribution of any
Written Testing-the-Waters Communication there occurs an event or development as a result of which such Written Testing-the-Waters Communication
included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order
to make the statements therein, in the light of the circumstances existing at that subsequent time, not misleading, the Issuer will promptly
notify Craig-Hallum and will promptly amend or supplement, at its own expense, such Written Testing-the-Waters Communication to eliminate
or correct such untrue statement or omission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nothing in this authorization is intended to limit
or otherwise affect the ability of Craig-Hallum and its affiliates and employees to engage in communications in which they could otherwise
lawfully engage in the absence of this authorization, including, without limitation, any written communication containing only one or
more of the statements specified under Rule 134(a) under the Act. This authorization shall remain in effect until the Issuer has provided
to Craig-Hallum a written notice revoking this authorization. All notices as described herein shall be sent by email to the attention
of Rick Hartfiel at [ ], with copies to Jonathan Zimmerman at [ &nbsp;&nbsp;].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 40; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in">Exhibit B</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>Form of Waiver of Lock-up</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>CRAIG-HALLUM CAPITAL GROUP
LLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Aeluma, Inc.<BR>
Public Offering of Common Stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.75in; text-align: right; text-indent: -0.25in">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 20__</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[Name and Address of<BR>
Officer or Director<BR>
Requesting Waiver]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Mr./Ms. [Name]:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">This letter is being delivered
to you in connection with the offering by Aeluma, Inc. (the &ldquo;Company&rdquo;) of ______ shares of common stock, $___ par value (the
&ldquo;Common Stock&rdquo;), of the Company and the lock-up letter dated__________________, 20__ (the &ldquo;Lock-up Letter&rdquo;), executed
by you in connection with such offering, and your request for a [waiver] [release] dated__________________, 20__, with respect to ______
shares of Common Stock (the &ldquo;Shares&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Craig-Hallum Capital Group
LLC hereby agrees to [waive] [release] the transfer restrictions set forth in the Lock-up Letter, but only with respect to the Shares,
effective __________________, 20__; <U>provided</U>, <U>however</U>, that such [waiver] [release] is conditioned on the Company announcing
the impending [waiver] [release] by press release through a major news service at least two business days before effectiveness of such
[waiver] [release]. This letter will serve as notice to the Company of the impending [waiver] [release].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Except as expressly [waived]
[released] hereby, the Lock-up Letter shall remain in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-indent: 0in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yours very truly,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CRAIG-HALLUM CAPITAL GROUP LLC</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 37%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">cc: Aeluma, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 41; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in">Exhibit C</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>Form of Press Release</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Aeluma, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>[Date]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Aeluma, Inc. (the &ldquo;Company&rdquo;) announced
today that Craig-Hallum Capital Group LLC, the sole book-running manager in the Company&rsquo;s recent public sale of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common
stock, is [waiving] [releasing] a lock-up restriction with respect to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of the Company&rsquo;s common stock held by [certain officers
or directors] [an officer or director] of the Company. The [waiver] [release] will take effect on ____________________, 20__, and the
shares may be sold on or after such date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>This press release is not an offer for sale
of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered
or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as
amended. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 42; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">Exhibit D</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM OF LOCK-UP AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">[&#9679;], 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Craig-Hallum Capital Group LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">222 South Ninth Street, Suite 350</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Minneapolis, Minnesota 55402</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Re:</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Aeluma, Inc. &mdash; Public Offering </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">The undersigned understands
that you, as underwriter (the &ldquo;Underwriter&rdquo;), propose to enter into an underwriting agreement (the &ldquo;Underwriting Agreement&rdquo;)
with Aeluma, Inc., a Delaware corporation (the &ldquo;Company&rdquo;), providing for the public offering (the &ldquo;Public Offering&rdquo;)
by the Underwriter, of common stock, par value $0.0001 per share (the &ldquo;Common Stock&rdquo;), of the Company (the &ldquo;Securities&rdquo;).
Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Underwriting Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">In consideration of the Underwriter&rsquo;s
agreement to purchase and make the Public Offering of the Securities, and for other good and valuable consideration receipt of which is
hereby acknowledged, the undersigned hereby agrees that, without the prior written consent of the Underwriter, the undersigned will not,
and will not cause any direct or indirect affiliate to, during the period beginning on the date hereof and ending at the close of business
90 days after the date of the final prospectus relating to the Public Offering (the &ldquo;Prospectus&rdquo;) (such period, the &ldquo;Restricted
Period&rdquo;), (1) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to
sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of
Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock (including without limitation, Common
Stock or such other securities which may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations
of the Securities and Exchange Commission and securities which may be issued upon exercise of a stock option or warrant) (collectively
with the Common Stock, the &ldquo;Lock-Up Securities&rdquo;), (2) enter into any hedging, swap or other agreement or transaction that
transfers, in whole or in part, any of the economic consequences of ownership of the Lock-Up Securities, whether any such transaction
described in clause (1) or (2) above is to be settled by delivery of Lock-Up Securities, in cash or otherwise, (3) make any demand for
or exercise any right with respect to the registration of any Lock-Up Securities, or (4) publicly disclose the intention to do any of
the foregoing. The undersigned acknowledges and agrees that the foregoing precludes the undersigned from engaging during the restricted
period in any hedging or other transactions or arrangements (including, without limitation, any short sale or the purchase or sale of,
or entry into, any put or call option, or combination thereof, forward, swap or any other derivative transaction or instrument, however
described or defined) designed or intended, or which could reasonably be expected to lead to or result in, a sale or disposition or transfer
(whether by the undersigned or any other person) of any economic consequences of ownership, in whole or in part, directly or indirectly,
of any Lock-Up Securities, whether any such transaction or arrangement (or instrument provided for thereunder) would be settled by delivery
of Lock-Up Securities, in cash or otherwise. The undersigned further confirms that it has furnished the Underwriter with the details of
any transaction the undersigned, or any of its affiliates, is a party to as of the date hereof, which transaction would have been restricted
by this Letter Agreement (the &ldquo;Letter Agreement&rdquo;) if it had been entered into by the undersigned during the Restricted Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">Notwithstanding the foregoing,
the undersigned may:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">(a) transfer or dispose of
the undersigned&rsquo;s Lock-Up Securities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt">(i) as a bona fide gift or
gifts, or for bona fide estate planning purposes,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt">(ii) by will or intestacy,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt"></P>

<!-- Field: Page; Sequence: 43; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt">(iii) to any (A) immediate
family of the undersigned or (B) trust for the direct or indirect benefit of the undersigned or the immediate family of the undersigned,
or if the undersigned is a trust, to a trustor or beneficiary of the trust or to the estate of a beneficiary of such trust (for purposes
of this Letter Agreement, &ldquo;immediate family&rdquo; shall mean any relationship by blood, current or former marriage, domestic partnership
or adoption, not more remote than first cousin),</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt">(iv) to a corporation, partnership,
limited liability company, trust or other entity of which the undersigned and/or the immediate family of the undersigned are the legal
and beneficial owner of all of the outstanding equity securities or similar interests,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt">(v) to a nominee or custodian
of a person or entity to whom a disposition or transfer would be permissible under clauses (i) through (iv) above,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt">(vi) if the undersigned is
a corporation, partnership, limited liability company, trust or other business entity, (A) to another corporation, partnership, limited
liability company, trust or other business entity that is an affiliate (as defined in Rule 405 promulgated under the Securities Act of
1933, as amended) of the undersigned, or to any investment fund or other entity controlling, controlled by, managing or managed by or
under common control with the undersigned or affiliates of the undersigned (including, for the avoidance of doubt, where the undersigned
is a partnership, to its general partner or a successor partnership or fund, or any other funds managed by such partnership), or (B) as
part of a distribution to members, partners, shareholders or other equityholders of the undersigned,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt">(vii) by operation of law,
such as pursuant to a qualified domestic order, divorce settlement, divorce decree or separation agreement, or related court order,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt">(viii) to the Company from
an employee of the Company upon death, disability or termination of employment, in each case, of such employee,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt">(ix) as part of a sale of
the undersigned&rsquo;s Lock-Up Securities acquired in open market transactions after the completion of the Public Offering,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt">(x) to the Company in connection
with the vesting, settlement, or exercise of restricted stock units, options, warrants or other rights to purchase shares of Common Stock
(including, in each case, by way of &ldquo;net&rdquo; or &ldquo;cashless&rdquo; exercise), including for the payment of exercise price
and tax and remittance payments due as a result of the vesting, settlement, or exercise of such restricted stock units, options, warrants
or rights, provided that any such shares of Common Stock received upon such exercise, vesting or settlement (other than such shares as
are transferred or surrendered to the Company in connection with such vesting, settlement or exercise event) shall be subject to the terms
of this Letter Agreement, and provided further that any such restricted stock units, options, warrants or rights are held by the undersigned
pursuant to an agreement or equity awards granted under a stock incentive plan or other equity award plan, each such agreement or plan
which is described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 55.1pt">(xi) pursuant to a bona fide
third-party tender offer, merger, consolidation or other similar transaction that is approved by the Board of Directors of the Company
and made to all holders of the Company&rsquo;s capital stock involving a Change of Control (as defined below) of the Company (for purposes
hereof, &ldquo;Change of Control&rdquo; shall mean the transfer (whether by tender offer, merger, consolidation or other similar transaction),
in one transaction or a series of related transactions, to a person or group of affiliated persons (other than the Underwriter pursuant
to the Public Offering), of shares of capital stock if, after such transfer, such person or group of affiliated persons would hold more
than 75% of the outstanding voting securities of the Company (or the surviving entity)); provided that in the event that such tender offer,
merger, consolidation or other similar transaction is not completed, the undersigned&rsquo;s Lock-Up Securities shall remain subject to
the provisions of this Letter Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"></P>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in"><U>provided</U> that (A)
in the case of any transfer or distribution pursuant to clauses (a)(i), (ii), (iii), (iv), (v) and (vi), such transfer shall not involve
a disposition for value, (B) in the case of any transfer or distribution pursuant to clauses (a)(i), (ii), (iii), (iv), (v), (vi) and
(vii), each donee, devisee, transferee or distributee shall execute and deliver to the Underwriter a lock-up letter in the form of this
Letter Agreement, (C) in the case of any transfer or distribution pursuant to clause (a)(ii), (iii), (iv), (v) and (vi), no filing by
any party (donor, donee, devisee, transferor, transferee, distributer or distributee) under the Exchange Act, or other public announcement
reporting a reduction in beneficial ownership of shares of Common Stock shall be required or shall be made voluntarily in connection with
such transfer or distribution (other than a filing on a Form 5 made after the expiration of the Restricted Period referred to above) and
(D) in the case of any transfer or distribution pursuant to clauses (a)(i), (vii), (viii), (ix) and (x) it shall be a condition to such
transfer that no public filing, report or announcement shall be voluntarily made and if any filing under Section 16(a) of the Exchange
Act, or other public filing, report or announcement reporting a reduction in beneficial ownership of shares of Common Stock in connection
with such transfer or distribution shall be legally required during the Restricted Period, such filing, report or announcement shall clearly
indicate in the footnotes thereto the nature and conditions of such transfer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">(b) exercise outstanding
options, settle restricted stock units or other equity awards or exercise outstanding warrants pursuant to plans described in the Registration
Statement, the Pricing Disclosure Package and the Prospectus; provided that any Lock-up Securities received upon such exercise, vesting
or settlement shall be subject to the terms of this Letter Agreement; <U>provided</U> that if the undersigned is required to make any
filing under Section 16(a) of the Exchange Act, or other public filing, report or announcement during the Restricted Period, the undersigned
shall clearly indicate in the footnotes thereto that the filing relates to the circumstances described in this clause and that the shares
of Common Stock received upon the exercise or settlement, as applicable, of the stock option, warrant or restricted stock unit or other
right or vesting event are subject to this Letter Agreement, and no public filing, report or announcement shall be voluntarily made;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">(c) convert outstanding preferred
stock into shares of Common Stock; provided that any such shares of Common Stock received upon such conversion shall be subject to the
terms of this Letter Agreement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">(d) establish trading plans
pursuant to Rule 10b5-1 under the Exchange Act (&ldquo;10b5-1 Trading Plans&rdquo;) for the transfer of shares of Lock-Up Securities;
<U>provided</U> that (1) such plans do not provide for the transfer of Lock-Up Securities during the Restricted Period and (2) no filing
by any party under the Exchange Act or other public announcement shall be made voluntarily during the Restricted Period in connection
with such trading plan and if any such filing or public announcement shall be legally required during the Restricted Period, such filing
or public announcement shall clearly indicate therein that that none of the securities subject to such plan may be transferred, sold,
or otherwise disposed of pursuant to such plan until after the expiration of the Restricted Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">The terms of this Letter
Agreement shall not apply to any Lock-Up Securities that are sold or transferred pursuant to the terms of any 10b5-1 Trading Plans that
are outstanding and in effect as of the date of this Letter Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">If the undersigned is not
a natural person, the undersigned represents and warrants that no single natural person, entity or &ldquo;group&rdquo; (within the meaning
of Section 13(d)(3) of the Exchange Act) other than a natural person, entity or &ldquo;group&rdquo; (as described above) that has executed
a Letter Agreement in substantially the same form as this Letter Agreement, beneficially owns, directly or indirectly, 50% or more of
the common equity interests, or 50% or more of the voting power, in the undersigned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">If the undersigned is an
officer or director of the Company, the undersigned further agrees that the foregoing provisions shall be equally applicable to any Company-directed
Securities the undersigned may purchase in the Public Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">If the undersigned is an
officer or director of the Company, (i) the Underwriters agrees that, at least three business days before the effective date of any release
or waiver of the foregoing restrictions in connection with a transfer of shares of Lock-Up Securities, the Underwriter will notify the
Company of the impending release or waiver, and (ii) the Company has agreed in the Underwriting Agreement to announce the impending release
or waiver through a major news service at least two business days before the effective date of the release or waiver. Any release or waiver
granted by the Underwriter hereunder to any such officer or director shall only be effective two business days after the publication date
of such announcement. The provisions of this paragraph will not apply if (a) the release or waiver is effected solely to permit a transfer
not for consideration or that is to an immediate family member as defined in FINRA Rule 5130(i)(5) and (b) the transferee has agreed in
writing to be bound by the same terms described in this Letter Agreement to the extent and for the duration that such terms remain in
effect at the time of the transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"></P>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">In furtherance of the foregoing,
the Company, and any duly appointed transfer agent for the registration or transfer of the securities described herein, are hereby authorized
to decline to make any transfer of securities if such transfer would constitute a violation or breach of this Letter Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">The undersigned hereby represents
and warrants that the undersigned has full power and authority to enter into this Letter Agreement. All authority herein conferred or
agreed to be conferred and any obligations of the undersigned shall be binding upon the successors, assigns, heirs or personal representatives
of the undersigned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">The undersigned acknowledges
and agrees that the Underwriter has not provided any recommendation or investment advice nor has the Underwriter solicited any action
from the undersigned with respect to the Public Offering of the Securities and the undersigned has consulted its own legal, accounting,
financial, regulatory and tax advisors to the extent deemed appropriate. The undersigned further acknowledges and agrees that, although
the Underwriter may be required or choose to provide certain Regulation Best Interest and Form CRS disclosures to you in connection with
the Public Offering, the Underwriter is not making a recommendation to you to enter into this Letter Agreement and nothing set forth in
such disclosures is intended to suggest that the Underwriter is making such a recommendation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">The undersigned understands
that, (i) if the Underwriting Agreement does not become effective by June 30, 2025, (ii) if the Underwriting Agreement (other than the
provisions thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the Common Stock to
be sold thereunder, (iii) the Company notifies the Underwriter in writing prior to the execution of the Underwriting Agreement that it
does not intend to proceed with the Public Offering, or (iv) prior to payment for the Securities, the Registration Statement is withdrawn
prior to the execution of the Underwriting Agreement, the Letter Agreement shall automatically terminate and be of no further force or
effect and undersigned shall be released from all obligations under this Letter Agreement. The undersigned understands that the Underwriter
is entering into the Underwriting Agreement and proceeding with the Public Offering in reliance upon this Letter Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">The undersigned hereby consents
to receipt of this Letter Agreement in electronic form and understands and agrees that this Letter Agreement may be signed electronically.
In the event that any signature is delivered by facsimile transmission, electronic mail, or otherwise by electronic transmission (including
any electronic signature complying with the U.S. federal ESIGN Act of 2000, <I>e.g.</I>, www.docusign.com) evidencing an intent to sign
this Letter Agreement, such facsimile transmission, electronic mail or other electronic transmission shall create a valid and binding
obligation of the undersigned with the same force and effect as if such signature were an original. Execution and delivery of this Letter
Agreement by facsimile transmission, electronic mail or other electronic transmission is legal, valid and binding for all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature page follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I></P>


<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">This Letter Agreement and
any claim, controversy or dispute arising under or related to this Letter Agreement shall be governed by and construed in accordance with
the laws of the State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Name of Security Holder <I>(Print exact name)</I></FONT></TD></TR>
  <TR>
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 37%">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; white-space: nowrap; vertical-align: bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Signature</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">If not signing in an individual capacity:</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Name of Authorized Signatory <I>(Print)</I></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Title of Authorized Signatory <I>(Print)</I></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><I>(indicate capacity of person signing if signing as custodian, trustee, or on behalf of an entity)</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature page to Lock-up Agreement]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">Exhibit E</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM OF UNDERWRITER WARRANT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">THE REGISTERED HOLDER OF THIS WARRANT BY ITS ACCEPTANCE
HEREOF, AGREES THAT THIS WARRANT SHALL NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, OR HYPOTHECATED, OR BE THE SUBJECT OF ANY HEDGING,
SHORT SALE, DERIVATIVE, PUT, OR CALL TRANSACTION THAT WOULD RESULT IN THE EFFECTIVE ECONOMIC DISPOSITION OF THE SECURITIES FOR A PERIOD
OF ONE HUNDRED EIGHTY (180 DAYS) IMMEDIATELY FOLLOWING THE EFFECTIVE DATE, AS HEREAFTER DEFINED. THIS WARRANT IS NOT EXERCISABLE AFTER
[&#9679;], 2030.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">WARRANT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FOR THE PURCHASE OF</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[&#9679;] SHARES OF COMMON STOCK OF</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">AELUMA, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[&#9679;], 2025</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">1.&nbsp;Purchase
Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">THIS CERTIFIES THAT, Craig-Hallum Capital Group
LLC (&ldquo;<B>Holder</B>&rdquo;), as registered owner of this Warrant, is entitled, at any time or from time to time commencing six
months from the date hereof (the &ldquo;<B>Commencement Date</B>&rdquo;), and at or before 5:00 p.m., New York City local time, [&#9679;],
2030 (&ldquo;<B>Expiration Date</B>&rdquo;), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [&#9679;]
shares of common stock (&ldquo;<B>Shares</B>&rdquo;), par value $0.0001 per share (the &ldquo;<B>Common Stock</B>&rdquo;) of Aeluma,
Inc. (&ldquo;<B>Company</B>&rdquo;). If the Expiration Date is a day on which banking institutions are authorized by law to close, then
this Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period
ending on the Expiration Date, the Company agrees not to take any action that would terminate this Warrant. This Warrant is initially
exercisable at $[&#9679;]<SUP>1</SUP> per Share so purchased; <I>provided, however, </I>that upon the occurrence of any of the events
specified in <U>Section 6</U> hereof, the rights granted by this Warrant, including the exercise price per Share and the number of Shares
to be received upon such exercise, shall be adjusted as therein specified (as adjusted, depending on the context, the &ldquo;<B>Exercise
Price</B>&rdquo;).</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">2.&nbsp;Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1&nbsp;<U>Exercise
Form</U>. To exercise this Warrant, the exercise form (the &ldquo;<B>Exercise Form</B>&rdquo;) attached hereto must be duly executed and
completed and delivered to the Company, together with this Warrant and payment of the Exercise Price for the Shares being purchased payable
in cash or by certified check or official bank check or wire transfer. If the subscription rights represented hereby shall not be exercised
at or before 5:00 p.m., New York City local time, on the Expiration Date this Warrant shall become and be void without further force or
effect, and all rights represented hereby shall cease and expire.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><SUP>1</SUP></TD><TD STYLE="text-align: justify">115% of the initial public offering price per share to the public.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 48; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2&nbsp;<U>Cashless
Exercise</U>. If a registration statement under the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;), covering
the issuance or resale of the Shares for which the Holder has delivered as Exercise Form is not available for the issuance or resale of
such Shares, the Holder may, in its sole discretion, exercise this Warrant in whole or in part and,&nbsp;in lieu of the payment of the
Exercise Price multiplied by the number of Shares for which this Warrant is exercisable (and in lieu of being entitled to receive Shares)
in the manner required by <U>Section 2.1</U>, the Holder shall have the right (but not the obligation) to convert any exercisable but
unexercised portion of this Warrant into a number of Shares (&ldquo;<B>Cashless Exercise Right</B>&rdquo;) equal to the product of (i)
X and (ii) the quotient obtained by dividing [A-B] by (A):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(A)</TD>
    <TD STYLE="text-align: center; width: 0.25in">= </TD><TD STYLE="text-align: justify">as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Exercise
Form if such Exercise Form is (1) both executed and delivered pursuant to <U>Section 2.1</U> on a day that is not a Trading Day or (2)
both executed and delivered pursuant to <U>Section 2.1</U> on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo;
(as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option
of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Exercise Form or (z) the Bid Price
of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder&rsquo;s execution of the
applicable Exercise Form if such Exercise Form is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered
within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day)
pursuant to <U>Section 2.1</U>, which Bid Price shall be shown on supporting documents provided by the Holder to the Company within two
Trading Days of delivery of the Exercise Form, or (iii) the VWAP on the date of the applicable Exercise Form if the date of such exercise
form is a Trading Day and such Exercise Form is both executed and delivered pursuant to <U>Section 2.1</U> after the close of &ldquo;regular
trading hours&rdquo; on such Trading Day;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(B)</TD>
    <TD STYLE="text-align: center; width: 0.25in">= </TD><TD STYLE="text-align: justify">the Exercise Price, as adjusted hereunder; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(X)</TD>
    <TD STYLE="text-align: center; width: 0.25in">= </TD><TD STYLE="text-align: justify">the number of Shares that would be issuable upon exercise of this Warrant to the extent being exercised
in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York
City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the
Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed
or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock is then reported on the Pink Open Market (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)
in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith
by the Holders of a majority in interest of the Common Stock then outstanding and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York
Stock Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock so
reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected
in good faith by the holders of a majority in interest of the Common Stock then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Cashless Exercise Right
may be exercised by the Holder on any business day on or after the Commencement Date and not later than the Expiration Date by delivering
the Warrant with the duly executed Exercise Form attached hereto with the cashless exercise section completed to the Company, exercising
the Cashless Exercise Right and specifying the total number of Shares the Holder will purchase pursuant to such Cashless Exercise Right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.3&nbsp;<U>No
Obligation to Net Cash Settle</U>. Notwithstanding anything to the contrary contained in this Warrant, in no event will the Company be
required to net cash settle the exercise of the Warrant. The holder of the Warrant will not be entitled to exercise the Warrant unless
a registration is effective, or an exemption from the registration requirements is available at such time and, if the holder is not able
to exercise the Warrant, the Warrant will expire worthless.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">3.&nbsp;Transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1&nbsp;<U>General
Restrictions</U>. The registered Holder of this Warrant, by its acceptance hereof, agrees that it will not sell, transfer, assign, pledge
or hypothecate this Warrant for a period of one hundred eighty (180) days from effective date (the &ldquo;<B>Effective Date</B>&rdquo;)
of the Company&rsquo;s registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission (file number 333-285469)
to anyone other than (i) a sales agent or selected dealer in connection with the public offering, or (ii) a bona fide officer or partner
of such sales agent or selected dealer. Additionally, pursuant to Rule 5110(g), the Warrant (and the Shares underlying this Warrant) will
not be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the
securities by any person for a period of 180 days immediately following the Effective Date. On and after the 181-day anniversary of the
Effective Date, transfers to others may be made subject to compliance with or exemptions from applicable securities laws. To make any
permitted assignment, the Holder must deliver to the Company the assignment form attached hereto duly executed and completed, together
with the Warrant and payment of all transfer taxes, if any, payable in connection therewith. The Company shall within five business days
transfer this Warrant on the books of the Company and shall execute and deliver a new Warrant or Warrants of like tenor to the appropriate
assignee(s) expressly evidencing the right to purchase the aggregate number of Shares purchasable hereunder or such portion of such number
as shall be contemplated by any such assignment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2&nbsp;<U>Restrictions
Imposed by the Act</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any
exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing
or reselling such Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.&nbsp;New
Warrants to be Issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1&nbsp;<U>Partial
Exercise or Transfer</U>. Subject to the restrictions in <U>Section 3</U>, this Warrant may be exercised or assigned in whole or in part.
In the event of the exercise or assignment hereof in part only, upon surrender of this Warrant for cancellation, together with the duly
executed exercise or assignment form and funds sufficient to pay any Exercise Price and/or transfer tax, the Company shall cause to be
delivered to the Holder without charge a new Warrant of like tenor to this Warrant in the name of the Holder evidencing the right of the
Holder to purchase the number of Shares purchasable hereunder as to which this Warrant has not been exercised or assigned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in">4.2&nbsp;<U>Lost
Certificate</U>. Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation of this Warrant
and of reasonably satisfactory indemnification or the posting of a bond, the Company shall execute and deliver a new Warrant of like tenor
and date. Any such new Warrant executed and delivered as a result of such loss, theft, mutilation or destruction shall constitute a substitute
contractual obligation on the part of the Company.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">5.&nbsp;Adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.1&nbsp;<U>Adjustments
to Exercise Price and Number of Securities</U>. The Exercise Price and the number of Shares underlying the Warrant shall be subject to
adjustment from time to time as hereinafter set forth:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">5.1.1&nbsp;<U>Stock
Dividends - Split-Ups</U>. If after the date hereof, and subject to the provisions of <U>Section 5.2</U> below, the number of outstanding
shares of Common Stock is increased by a stock dividend payable in Common Stock or by a split-up of shares of Common Stock or other similar
event, then the number of shares of Common Stock underlying each of the Shares purchasable hereunder shall be increased in proportion
to such increase in outstanding shares. In such event the Exercise Price shall be proportionately decreased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">5.1.2&nbsp;<U>Aggregation
of Shares</U>. If after the date hereof, and subject to the provisions of <U>Section 5.2</U>, the number of outstanding shares of Common
Stock is decreased by a consolidation, combination or reclassification of Common Stock or other similar event, then the number of shares
of Common Stock underlying each of the Shares purchasable hereunder shall be decreased in proportion to such decrease in outstanding shares.
In such event the Exercise Price shall be proportionately increased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">5.1.3&nbsp;<U>Replacement
of Securities upon Reorganization, etc</U>. In case of any reclassification or reorganization of the outstanding Common Stock other than
a change covered by <U>Section 5.1.1</U> or <U>5.1.2</U> hereof or that solely affects the par value of such Common Stock, or in the case
of any merger or consolidation of the Company with or into another corporation (other than a consolidation or merger in which the Company
is the continuing corporation and that does not result in any reclassification or reorganization of the outstanding Common Stock), or
in the case of any sale or conveyance to another corporation or entity of the property of the Company as an entirety or substantially
as an entirety in connection with which the Company is dissolved, the Holder of this Warrant shall have the right thereafter (until the
expiration of the right of exercise of this Warrant) to receive upon the exercise hereof, for the same aggregate Exercise Price payable
hereunder immediately prior to such event, the kind and amount of shares of stock or other securities or property (including cash) receivable
upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, by a Holder
of the number of shares of Common Stock of the Company obtainable upon exercise of this Warrant immediately prior to such event; and if
any reclassification also results in a change in the shares of Common Stock covered by <U>Section 5.1.1</U> or <U>5.1.2</U>, then such
adjustment shall be made pursuant to <U>Sections 5.1.1</U>, <U>5.1.2</U> and this <U>Section 5.1.3</U>. The provisions of this <U>Section
5.1.3</U> shall similarly apply to successive reclassifications, reorganizations, mergers or consolidations, sales or other transfers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">5.1.4&nbsp;<U>Changes
in Form of Warrant</U>. This form of Warrant need not be changed because of any change pursuant to this Section, and Warrants issued after
such change may state the same Exercise Price and the same number of Shares as are stated in the Warrants initially issued pursuant to
this Agreement. The acceptance by any Holder of the issuance of new Warrants reflecting a required or permissive change shall not be deemed
to waive any rights to an adjustment occurring after the Commencement Date or the computation thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in">5.2&nbsp;<U>Substitute
Warrant</U>. In case of any consolidation of the Company with, or merger of the Company with, or merger of the Company into, another corporation
(other than a consolidation or merger which does not result in any reclassification or change of the outstanding Common Stock), the corporation
formed by such consolidation or merger shall execute and deliver to the Holder a supplemental Warrant providing that the holder of each
Warrant then outstanding or to be outstanding shall have the right thereafter (until the stated expiration of such Warrant) to receive,
upon exercise of such Warrant, the kind and amount of shares of stock and other securities and property receivable upon such consolidation
or merger, by a holder of the number of shares of Common Stock of the Company for which such Warrant might have been exercised immediately
prior to such consolidation, merger, sale or transfer. Such supplemental Warrant shall provide for adjustments which shall be identical
to the adjustments provided in <U>Section 5</U>. The above provision of this Section shall similarly apply to successive consolidations
or mergers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in">5.3&nbsp;<U>Elimination
of Fractional Interests</U>. The Company shall not be required to issue certificates representing fractions of shares of Common Stock
upon the exercise of the Warrant, nor shall it be required to issue scrip or pay cash in lieu of any fractional interests, it being the
intent of the parties that all fractional interests shall be eliminated by rounding any fraction up to the nearest whole number of shares
of Common Stock or other securities, properties or rights.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">6.&nbsp;Reservation
and Listing<FONT STYLE="font-weight: normal">. The Company shall at all times reserve and keep available out of its authorized Common
Stock, solely for the purpose of issuance upon exercise of this Warrant, such number of shares of Common Stock or other securities, properties
or rights as shall be issuable upon the exercise thereof. The Company covenants and agrees that, upon exercise of this Warrant and payment
of the Exercise Price therefor, all shares of Common Stock shall be duly and validly issued, fully paid and non-assessable and not subject
to preemptive rights of any shareholder. As long as this Warrant shall be outstanding, the Company shall use its best efforts to cause
all Shares issuable upon exercise of this Warrant to be listed (subject to official notice of issuance) on all securities exchanges (or,
if applicable on the OTC Market or any successor trading market) on which the Shares issued to the public in connection the Company&rsquo;s
registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission (file number 333-285469) may then be listed
and/or quoted.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">7.&nbsp;Certain
Notice Requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.1&nbsp;<U>Holder&rsquo;s
Right to Receive Notice</U>. Nothing herein shall be construed as conferring upon the Holders the right to vote or consent as a shareholder
for the election of directors or any other matter, or as having any rights whatsoever as a shareholder of the Company. If, however, at
any time prior to the expiration of this Warrant and its exercise, any of the events described in <U>Section 7.2</U> shall occur, then,
in one or more of said events, the Company shall give written notice of such event at least fifteen (15) days prior to the date fixed
as a record date or the date of closing the transfer books for the determination of the shareholders entitled to such dividend, distribution,
conversion or exchange of securities or subscription rights, or entitled to vote on such proposed dissolution, liquidation, winding up
or sale. Such notice shall specify such record date or the date of the closing of the transfer books, as the case may be. Notwithstanding
the foregoing, the Company shall deliver to each Holder a copy of each notice given to the other shareholders of the Company at the same
time and in the same manner that such notice is given to the shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.2&nbsp;<U>Events
Requiring Notice</U>. The Company shall be required to give the notice described in this <U>Section 7</U> upon one or more of the following
events: (i) if the Company shall take a record of the holders of its Common Stock for the purpose of entitling them to receive a dividend
or distribution payable otherwise than in cash, or a cash dividend or distribution payable otherwise than out of retained earnings, as
indicated by the accounting treatment of such dividend or distribution on the books of the Company, or (ii) the Company shall offer to
all the holders of its Common Stock any additional shares of capital stock of the Company or securities convertible into or exchangeable
for shares of capital stock of the Company, or any option, right or warrant to subscribe therefor, (iii) a dissolution, liquidation or
winding up of the Company (other than in connection with a consolidation or merger) or a sale of all or substantially all of its property,
assets and business shall be proposed, or (iv) prior to an adjustment pursuant to <U>Section 5.1.3</U> or <U>5.2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.3&nbsp;<U>Notice
of Change in Exercise Price</U>. The Company shall, promptly after an event requiring a change in the number of Shares and Exercise Price
pursuant to <U>Section 5</U>, send notice to the Holders of such event and change (&ldquo;<B>Price Notice</B>&rdquo;). The Price Notice
shall describe the event causing the change and the method of calculating same and shall be certified as being true and accurate by the
Company&rsquo;s President or Chief Financial Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.4&nbsp;<U>Transmittal
of Notices</U>. All notices, requests, consents and other communications under this Warrant shall be in writing and shall be mailed (registered
or certified mail, return receipt requested), personally delivered or sent by electronic mail (email) and confirmed and shall be deemed
given when so delivered or sent via email and confirmed or if mailed, two (2) days after such mailing:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) if to the registered Holder
of this Warrant, to the address of such Holder as shown on the books of the Company, with a copy to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Faegre Drinker Biddle &amp; Reath LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">2200 Wells Fargo Center</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">90 S. Seventh Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Attn:&nbsp;Jonathan Zimmerman</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Email:&nbsp;[ &nbsp;&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">or (ii) if to the Company,
to the following address or to such other address as the Company may designate by notice to the Holders:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Aeluma, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">27 Castilian Drive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Goleta, California 93117</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Attn:&nbsp;Jonathan Klamkin, Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in">&nbsp;&nbsp;&nbsp;Email:&nbsp;[&nbsp;&nbsp;&nbsp; ]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With a copy to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Hunter Taubman Fischer &amp; Li LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">950 Third Ave., 19th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">New York, New York 10022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Attn:&nbsp;Louis Taubman<BR>
Email:&nbsp;ltaubman@htflawyers.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">8.&nbsp;Miscellaneous.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.1&nbsp;<U>Amendments</U>.
The Company and the Holder may from time to time supplement or amend this Warrant without the approval of any of the Holders in order
to cure any ambiguity, to correct or supplement any provision contained herein that may be defective or inconsistent with any other provisions
herein, or to make any other provisions in regard to matters or questions arising hereunder that the Company and the Holder may deem necessary
or desirable and that the Company and the Holder deem shall not adversely affect the interest of the Holders. All other modifications
or amendments shall require the written consent of and be signed by the party against whom enforcement of the modification or amendment
is sought.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.2&nbsp;<U>Headings</U>.
The headings contained herein are for the sole purpose of convenience of reference and shall not in any way limit or affect the meaning
or interpretation of any of the terms or provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.3&nbsp;<U>Entire
Agreement</U>. This Warrant (together with the other agreements and documents being delivered pursuant to or in connection with this Warrant)
constitutes the entire agreement of the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and
understandings of the parties, oral and written, with respect to the subject matter hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in">8.4&nbsp;<U>Binding
Effect</U>. This Warrant shall inure solely to the benefit of and shall be binding upon, the Holder and the Company and their permitted
assignees, respective successors, legal representative and assigns, and no other person shall have or be construed to have any legal or
equitable right, remedy or claim under or in respect of or by virtue of this Warrant or any provisions herein contained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in">8.5&nbsp;<U>Governing
Law; Submission to Jurisdiction</U>. This Warrant shall be governed by and construed and enforced in accordance with the laws of the State
of New York, without giving effect to conflict of laws. The Company hereby agrees that any action, proceeding or claim against it arising
out of, or relating in any way to this Warrant shall be brought and enforced in the courts of the State of New York or of the United States
of America for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive.
The Company hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. Any process
or summons to be served upon the Company may be served by transmitting a copy thereof by registered or certified mail, return receipt
requested, postage prepaid, addressed to it at the address set forth in <U>Section 7.4</U>. Such mailing shall be deemed personal service
and shall be legal and binding upon the Company in any action, proceeding or claim. The Company and the Holder agree that the prevailing
party(ies) in any such action shall be entitled to recover from the other party(ies) all of its reasonable attorneys&rsquo; fees and expenses
relating to such action or proceeding and/or incurred in connection with the preparation therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in">8.6&nbsp;<U>Waiver,
Etc</U>. The failure of the Company or the Holder to at any time enforce any of the provisions of this Warrant shall not be deemed or
construed to be a waiver of any such provision, nor to in any way affect the validity of this Warrant or any provision hereof or the right
of the Company or any Holder to thereafter enforce each and every provision of this Warrant. No waiver of any breach, non-compliance or
non-fulfillment of any of the provisions of this Warrant shall be effective unless set forth in a written instrument executed by the party
or parties against whom or which enforcement of such waiver is sought; and no waiver of any such breach, non-compliance or non-fulfillment
shall be construed or deemed to be a waiver of any other or subsequent breach or non-compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page Follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be signed by its duly authorized officer as of the date first set forth above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aeluma, Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 37%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Form to be used to exercise Warrant:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Aeluma, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">27 Castilian Drive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Goleta, California 93117</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn:&nbsp;Jonathan Klamkin, Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: __________, 202__</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned hereby elects irrevocably to exercise
all or a portion of the within Warrant and to purchase _______shares of Common Stock of Aeluma, Inc. and hereby makes payment of $ ______
(at the rate of $ ________ per Share) in payment of the Exercise Price pursuant thereto. Please issue the shares of Common Stock as to
which this Warrant is exercised in accordance with the instructions given below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned hereby elects irrevocably to convert
its right to purchase ____________ Shares purchasable under the within Warrant by surrender of the unexercised portion of the attached
Warrant (with a value based of $ ____________ based on a market price of $__________). Please issue the Shares as to which this Warrant
is exercised in accordance with the instructions given below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NOTICE: The signature to this assignment must
correspond with the name as written upon the face of the Warrant in every particular, without alteration or enlargement or any change
whatever.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Signature(s) Guaranteed:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE
GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE
MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">INSTRUCTIONS FOR REGISTRATION OF SECURITIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(Print in Block Letters)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Form to be used to assign Warrant:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ASSIGNMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(To be executed by the registered Holder to effect
a transfer of the within Warrant):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR VALUE RECEIVED, ______________________does
hereby sell, assign and transfer unto <U>____________</U> the right to purchase ____________ shares of Common Stock of Aeluma, Inc. (&ldquo;<B><U>Company</U></B>&rdquo;)
evidenced by the within Warrant and does hereby authorize the Company to transfer such right on the books of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dated: ________, 202_</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Signature</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NOTICE: The signature to this assignment must
correspond with the name as written upon the face of the Warrant in every particular, without alteration or enlargement or any change
whatever.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Signature(s) Guaranteed:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE
GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE
MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>






<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">E-11</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>ea023594301ex4-1_aeluma.htm
<DESCRIPTION>UNDERWRITER WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNDERWRITER WARRANT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">THE REGISTERED HOLDER OF THIS WARRANT BY ITS ACCEPTANCE
HEREOF, AGREES THAT THIS WARRANT SHALL NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, OR HYPOTHECATED, OR BE THE SUBJECT OF ANY HEDGING,
SHORT SALE, DERIVATIVE, PUT, OR CALL TRANSACTION THAT WOULD RESULT IN THE EFFECTIVE ECONOMIC DISPOSITION OF THE SECURITIES FOR A PERIOD
OF ONE HUNDRED EIGHTY (180 DAYS) IMMEDIATELY FOLLOWING THE EFFECTIVE DATE, AS HEREAFTER DEFINED. THIS WARRANT IS NOT EXERCISABLE AFTER
MARCH 28, 2030.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">WARRANT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FOR THE PURCHASE OF</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">131,427 SHARES OF COMMON STOCK OF</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">AELUMA, INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">March 28, 2025</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">1.&nbsp;Purchase
Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">THIS CERTIFIES THAT, <U>Craig-Hallum Capital Group
LLC</U> (&ldquo;<B>Holder</B>&rdquo;), as registered owner of this Warrant, is entitled, at any time or from time to time commencing six
months from the date hereof (the &ldquo;<B>Commencement Date</B>&rdquo;), and at or before 5:00 p.m., New York City local time, March
28, 2030 (&ldquo;<B>Expiration Date</B>&rdquo;), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to
<U>One Hundred Thirty One Thousand Four Hundred and Twenty Seven (131,427)</U> shares of common stock (&ldquo;<B>Shares</B>&rdquo;), par
value $0.0001 per share (the &ldquo;<B>Common Stock</B>&rdquo;) of Aeluma, Inc. (&ldquo;<B>Company</B>&rdquo;). If the Expiration Date
is a day on which banking institutions are authorized by law to close, then this Warrant may be exercised on the next succeeding day which
is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take
any action that would terminate this Warrant. This Warrant is initially exercisable at $6.0375 per Share so purchased; <I>provided, however,
</I>that upon the occurrence of any of the events specified in <U>Section 6</U> hereof, the rights granted by this Warrant, including
the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified (as adjusted,
depending on the context, the &ldquo;<B>Exercise Price</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">2.&nbsp;Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1&nbsp;<U>Exercise
Form</U>. To exercise this Warrant, the exercise form (the &ldquo;<B>Exercise Form</B>&rdquo;) attached hereto must be duly executed and
completed and delivered to the Company, together with this Warrant and payment of the Exercise Price for the Shares being purchased payable
in cash or by certified check or official bank check or wire transfer. If the subscription rights represented hereby shall not be exercised
at or before 5:00 p.m., New York City local time, on the Expiration Date this Warrant shall become and be void without further force or
effect, and all rights represented hereby shall cease and expire.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2&nbsp;<U>Cashless
Exercise</U>. If a registration statement under the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;), covering
the issuance or resale of the Shares for which the Holder has delivered as Exercise Form is not available for the issuance or resale of
such Shares, the Holder may, in its sole discretion, exercise this Warrant in whole or in part and,&nbsp;in lieu of the payment of the
Exercise Price multiplied by the number of Shares for which this Warrant is exercisable (and in lieu of being entitled to receive Shares)
in the manner required by <U>Section 2.1</U>, the Holder shall have the right (but not the obligation) to convert any exercisable but
unexercised portion of this Warrant into a number of Shares (&ldquo;<B>Cashless Exercise Right</B>&rdquo;) equal to the product of (i)
X and (ii) the quotient obtained by dividing [A-B] by (A):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(A)</TD>
    <TD STYLE="text-align: center; width: 0.25in">= </TD><TD STYLE="text-align: justify">as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Exercise
Form if such Exercise Form is (1) both executed and delivered pursuant to <U>Section 2.1</U> on a day that is not a Trading Day or (2)
both executed and delivered pursuant to <U>Section 2.1</U> on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo;
(as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option
of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Exercise Form or (z) the Bid Price
of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder&rsquo;s execution of the
applicable Exercise Form if such Exercise Form is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered
within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day)
pursuant to <U>Section 2.1</U>, which Bid Price shall be shown on supporting documents provided by the Holder to the Company within two
Trading Days of delivery of the Exercise Form, or (iii) the VWAP on the date of the applicable Exercise Form if the date of such exercise
form is a Trading Day and such Exercise Form is both executed and delivered pursuant to <U>Section 2.1</U> after the close of &ldquo;regular
trading hours&rdquo; on such Trading Day;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(B)</TD>
    <TD STYLE="text-align: center; width: 0.25in">= </TD><TD STYLE="text-align: justify">the Exercise Price, as adjusted hereunder; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(X)</TD>
    <TD STYLE="text-align: center; width: 0.25in">= </TD><TD STYLE="text-align: justify">the number of Shares that would be issuable upon exercise of this Warrant to the extent being exercised
in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York
City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the
Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed
or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock is then reported on the Pink Open Market (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)
in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith
by the Holders of a majority in interest of the Common Stock then outstanding and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the Common Stock is traded on a Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York
Stock Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock so
reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected
in good faith by the holders of a majority in interest of the Common Stock then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Cashless Exercise Right
may be exercised by the Holder on any business day on or after the Commencement Date and not later than the Expiration Date by delivering
the Warrant with the duly executed Exercise Form attached hereto with the cashless exercise section completed to the Company, exercising
the Cashless Exercise Right and specifying the total number of Shares the Holder will purchase pursuant to such Cashless Exercise Right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.3&nbsp;<U>No
Obligation to Net Cash Settle</U>. Notwithstanding anything to the contrary contained in this Warrant, in no event will the Company be
required to net cash settle the exercise of the Warrant. The holder of the Warrant will not be entitled to exercise the Warrant unless
a registration is effective, or an exemption from the registration requirements is available at such time and, if the holder is not able
to exercise the Warrant, the Warrant will expire worthless.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">3.&nbsp;Transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1&nbsp;<U>General
Restrictions</U>. The registered Holder of this Warrant, by its acceptance hereof, agrees that it will not sell, transfer, assign, pledge
or hypothecate this Warrant for a period of one hundred eighty (180) days from effective date (the &ldquo;<B>Effective Date</B>&rdquo;)
of the Company&rsquo;s registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission (file number 333-285469)
to anyone other than (i) a sales agent or selected dealer in connection with the public offering, or (ii) a bona fide officer or partner
of such sales agent or selected dealer. Additionally, pursuant to Rule 5110(g), the Warrant (and the Shares underlying this Warrant) will
not be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the
securities by any person for a period of 180 days immediately following the Effective Date. On and after the 181-day anniversary of the
Effective Date, transfers to others may be made subject to compliance with or exemptions from applicable securities laws. To make any
permitted assignment, the Holder must deliver to the Company the assignment form attached hereto duly executed and completed, together
with the Warrant and payment of all transfer taxes, if any, payable in connection therewith. The Company shall within five business days
transfer this Warrant on the books of the Company and shall execute and deliver a new Warrant or Warrants of like tenor to the appropriate
assignee(s) expressly evidencing the right to purchase the aggregate number of Shares purchasable hereunder or such portion of such number
as shall be contemplated by any such assignment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2&nbsp;<U>Restrictions
Imposed by the Act</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any
exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing
or reselling such Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.&nbsp;New
Warrants to be Issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1&nbsp;<U>Partial
Exercise or Transfer</U>. Subject to the restrictions in <U>Section 3</U>, this Warrant may be exercised or assigned in whole or in part.
In the event of the exercise or assignment hereof in part only, upon surrender of this Warrant for cancellation, together with the duly
executed exercise or assignment form and funds sufficient to pay any Exercise Price and/or transfer tax, the Company shall cause to be
delivered to the Holder without charge a new Warrant of like tenor to this Warrant in the name of the Holder evidencing the right of the
Holder to purchase the number of Shares purchasable hereunder as to which this Warrant has not been exercised or assigned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in">4.2&nbsp;<U>Lost
Certificate</U>. Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation of this Warrant
and of reasonably satisfactory indemnification or the posting of a bond, the Company shall execute and deliver a new Warrant of like tenor
and date. Any such new Warrant executed and delivered as a result of such loss, theft, mutilation or destruction shall constitute a substitute
contractual obligation on the part of the Company.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">5.&nbsp;Adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.1&nbsp;<U>Adjustments
to Exercise Price and Number of Securities</U>. The Exercise Price and the number of Shares underlying the Warrant shall be subject to
adjustment from time to time as hereinafter set forth:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">5.1.1&nbsp;<U>Stock
Dividends - Split-Ups</U>. If after the date hereof, and subject to the provisions of <U>Section 5.2</U> below, the number of outstanding
shares of Common Stock is increased by a stock dividend payable in Common Stock or by a split-up of shares of Common Stock or other similar
event, then the number of shares of Common Stock underlying each of the Shares purchasable hereunder shall be increased in proportion
to such increase in outstanding shares. In such event the Exercise Price shall be proportionately decreased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">5.1.2&nbsp;<U>Aggregation
of Shares</U>. If after the date hereof, and subject to the provisions of <U>Section 5.2</U>, the number of outstanding shares of Common
Stock is decreased by a consolidation, combination or reclassification of Common Stock or other similar event, then the number of shares
of Common Stock underlying each of the Shares purchasable hereunder shall be decreased in proportion to such decrease in outstanding shares.
In such event the Exercise Price shall be proportionately increased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">5.1.3&nbsp;<U>Replacement
of Securities upon Reorganization, etc</U>. In case of any reclassification or reorganization of the outstanding Common Stock other than
a change covered by <U>Section 5.1.1</U> or <U>5.1.2</U> hereof or that solely affects the par value of such Common Stock, or in the case
of any merger or consolidation of the Company with or into another corporation (other than a consolidation or merger in which the Company
is the continuing corporation and that does not result in any reclassification or reorganization of the outstanding Common Stock), or
in the case of any sale or conveyance to another corporation or entity of the property of the Company as an entirety or substantially
as an entirety in connection with which the Company is dissolved, the Holder of this Warrant shall have the right thereafter (until the
expiration of the right of exercise of this Warrant) to receive upon the exercise hereof, for the same aggregate Exercise Price payable
hereunder immediately prior to such event, the kind and amount of shares of stock or other securities or property (including cash) receivable
upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, by a Holder
of the number of shares of Common Stock of the Company obtainable upon exercise of this Warrant immediately prior to such event; and if
any reclassification also results in a change in the shares of Common Stock covered by <U>Section 5.1.1</U> or <U>5.1.2</U>, then such
adjustment shall be made pursuant to <U>Sections 5.1.1</U>, <U>5.1.2</U> and this <U>Section 5.1.3</U>. The provisions of this <U>Section
5.1.3</U> shall similarly apply to successive reclassifications, reorganizations, mergers or consolidations, sales or other transfers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">5.1.4&nbsp;<U>Changes
in Form of Warrant</U>. This form of Warrant need not be changed because of any change pursuant to this Section, and Warrants issued after
such change may state the same Exercise Price and the same number of Shares as are stated in the Warrants initially issued pursuant to
this Agreement. The acceptance by any Holder of the issuance of new Warrants reflecting a required or permissive change shall not be deemed
to waive any rights to an adjustment occurring after the Commencement Date or the computation thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in">5.2&nbsp;<U>Substitute
Warrant</U>. In case of any consolidation of the Company with, or merger of the Company with, or merger of the Company into, another corporation
(other than a consolidation or merger which does not result in any reclassification or change of the outstanding Common Stock), the corporation
formed by such consolidation or merger shall execute and deliver to the Holder a supplemental Warrant providing that the holder of each
Warrant then outstanding or to be outstanding shall have the right thereafter (until the stated expiration of such Warrant) to receive,
upon exercise of such Warrant, the kind and amount of shares of stock and other securities and property receivable upon such consolidation
or merger, by a holder of the number of shares of Common Stock of the Company for which such Warrant might have been exercised immediately
prior to such consolidation, merger, sale or transfer. Such supplemental Warrant shall provide for adjustments which shall be identical
to the adjustments provided in <U>Section 5</U>. The above provision of this Section shall similarly apply to successive consolidations
or mergers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in">5.3&nbsp;<U>Elimination
of Fractional Interests</U>. The Company shall not be required to issue certificates representing fractions of shares of Common Stock
upon the exercise of the Warrant, nor shall it be required to issue scrip or pay cash in lieu of any fractional interests, it being the
intent of the parties that all fractional interests shall be eliminated by rounding any fraction up to the nearest whole number of shares
of Common Stock or other securities, properties or rights.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">6.&nbsp;Reservation
and Listing<FONT STYLE="font-weight: normal">. The Company shall at all times reserve and keep available out of its authorized Common
Stock, solely for the purpose of issuance upon exercise of this Warrant, such number of shares of Common Stock or other securities, properties
or rights as shall be issuable upon the exercise thereof. The Company covenants and agrees that, upon exercise of this Warrant and payment
of the Exercise Price therefor, all shares of Common Stock shall be duly and validly issued, fully paid and non-assessable and not subject
to preemptive rights of any shareholder. As long as this Warrant shall be outstanding, the Company shall use its best efforts to cause
all Shares issuable upon exercise of this Warrant to be listed (subject to official notice of issuance) on all securities exchanges (or,
if applicable on the OTC Market or any successor trading market) on which the Shares issued to the public in connection the Company&rsquo;s
registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission (file number 333-285469) may then be listed
and/or quoted.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">7.&nbsp;Certain
Notice Requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.1&nbsp;<U>Holder&rsquo;s
Right to Receive Notice</U>. Nothing herein shall be construed as conferring upon the Holders the right to vote or consent as a shareholder
for the election of directors or any other matter, or as having any rights whatsoever as a shareholder of the Company. If, however, at
any time prior to the expiration of this Warrant and its exercise, any of the events described in <U>Section 7.2</U> shall occur, then,
in one or more of said events, the Company shall give written notice of such event at least fifteen (15) days prior to the date fixed
as a record date or the date of closing the transfer books for the determination of the shareholders entitled to such dividend, distribution,
conversion or exchange of securities or subscription rights, or entitled to vote on such proposed dissolution, liquidation, winding up
or sale. Such notice shall specify such record date or the date of the closing of the transfer books, as the case may be. Notwithstanding
the foregoing, the Company shall deliver to each Holder a copy of each notice given to the other shareholders of the Company at the same
time and in the same manner that such notice is given to the shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.2&nbsp;<U>Events
Requiring Notice</U>. The Company shall be required to give the notice described in this <U>Section 7</U> upon one or more of the following
events: (i) if the Company shall take a record of the holders of its Common Stock for the purpose of entitling them to receive a dividend
or distribution payable otherwise than in cash, or a cash dividend or distribution payable otherwise than out of retained earnings, as
indicated by the accounting treatment of such dividend or distribution on the books of the Company, or (ii) the Company shall offer to
all the holders of its Common Stock any additional shares of capital stock of the Company or securities convertible into or exchangeable
for shares of capital stock of the Company, or any option, right or warrant to subscribe therefor, (iii) a dissolution, liquidation or
winding up of the Company (other than in connection with a consolidation or merger) or a sale of all or substantially all of its property,
assets and business shall be proposed, or (iv) prior to an adjustment pursuant to <U>Section 5.1.3</U> or <U>5.2</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.3&nbsp;<U>Notice
of Change in Exercise Price</U>. The Company shall, promptly after an event requiring a change in the number of Shares and Exercise Price
pursuant to <U>Section 5</U>, send notice to the Holders of such event and change (&ldquo;<B>Price Notice</B>&rdquo;). The Price Notice
shall describe the event causing the change and the method of calculating same and shall be certified as being true and accurate by the
Company&rsquo;s President or Chief Financial Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.4&nbsp;<U>Transmittal
of Notices</U>. All notices, requests, consents and other communications under this Warrant shall be in writing and shall be mailed (registered
or certified mail, return receipt requested), personally delivered or sent by electronic mail (email) and confirmed and shall be deemed
given when so delivered or sent via email and confirmed or if mailed, two (2) days after such mailing:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) if to the registered Holder
of this Warrant, to the address of such Holder as shown on the books of the Company, with a copy to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Faegre Drinker Biddle &amp; Reath LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">2200 Wells Fargo Center</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">90 S. Seventh Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Attn:&nbsp;Jonathan Zimmerman</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Email:&nbsp;[ &nbsp;&nbsp;&nbsp;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">or (ii) if to the Company,
to the following address or to such other address as the Company may designate by notice to the Holders:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Aeluma, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">27 Castilian Drive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Goleta, California 93117</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Attn:&nbsp;Jonathan Klamkin, Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in">&nbsp;&nbsp;&nbsp;Email:&nbsp;[&nbsp;&nbsp;&nbsp; ]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With a copy to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Hunter Taubman Fischer &amp; Li LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">950 Third Ave., 19th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">New York, New York 10022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Attn:&nbsp;Louis Taubman<BR>
Email:&nbsp;ltaubman@htflawyers.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">8.&nbsp;Miscellaneous.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.1&nbsp;<U>Amendments</U>.
The Company and the Holder may from time to time supplement or amend this Warrant without the approval of any of the Holders in order
to cure any ambiguity, to correct or supplement any provision contained herein that may be defective or inconsistent with any other provisions
herein, or to make any other provisions in regard to matters or questions arising hereunder that the Company and the Holder may deem necessary
or desirable and that the Company and the Holder deem shall not adversely affect the interest of the Holders. All other modifications
or amendments shall require the written consent of and be signed by the party against whom enforcement of the modification or amendment
is sought.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.2&nbsp;<U>Headings</U>.
The headings contained herein are for the sole purpose of convenience of reference and shall not in any way limit or affect the meaning
or interpretation of any of the terms or provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.3&nbsp;<U>Entire
Agreement</U>. This Warrant (together with the other agreements and documents being delivered pursuant to or in connection with this Warrant)
constitutes the entire agreement of the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and
understandings of the parties, oral and written, with respect to the subject matter hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in">8.4&nbsp;<U>Binding
Effect</U>. This Warrant shall inure solely to the benefit of and shall be binding upon, the Holder and the Company and their permitted
assignees, respective successors, legal representative and assigns, and no other person shall have or be construed to have any legal or
equitable right, remedy or claim under or in respect of or by virtue of this Warrant or any provisions herein contained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in">8.5&nbsp;<U>Governing
Law; Submission to Jurisdiction</U>. This Warrant shall be governed by and construed and enforced in accordance with the laws of the State
of New York, without giving effect to conflict of laws. The Company hereby agrees that any action, proceeding or claim against it arising
out of, or relating in any way to this Warrant shall be brought and enforced in the courts of the State of New York or of the United States
of America for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive.
The Company hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. Any process
or summons to be served upon the Company may be served by transmitting a copy thereof by registered or certified mail, return receipt
requested, postage prepaid, addressed to it at the address set forth in <U>Section 7.4</U>. Such mailing shall be deemed personal service
and shall be legal and binding upon the Company in any action, proceeding or claim. The Company and the Holder agree that the prevailing
party(ies) in any such action shall be entitled to recover from the other party(ies) all of its reasonable attorneys&rsquo; fees and expenses
relating to such action or proceeding and/or incurred in connection with the preparation therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0; text-align: justify; text-indent: 0.5in">8.6&nbsp;<U>Waiver,
Etc</U>. The failure of the Company or the Holder to at any time enforce any of the provisions of this Warrant shall not be deemed or
construed to be a waiver of any such provision, nor to in any way affect the validity of this Warrant or any provision hereof or the right
of the Company or any Holder to thereafter enforce each and every provision of this Warrant. No waiver of any breach, non-compliance or
non-fulfillment of any of the provisions of this Warrant shall be effective unless set forth in a written instrument executed by the party
or parties against whom or which enforcement of such waiver is sought; and no waiver of any such breach, non-compliance or non-fulfillment
shall be construed or deemed to be a waiver of any other or subsequent breach or non-compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page Follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be signed by its duly authorized officer as of the date first set forth above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aeluma, Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 37%">/s/ &nbsp;Jonathan Klamkin</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Jonathan Klamkin</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: President, Chief Executive Officer, and Director</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Form to be used to exercise Warrant:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Aeluma, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">27 Castilian Drive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Goleta, California 93117</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn:&nbsp;Jonathan Klamkin, Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: __________, 202__</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned hereby elects irrevocably to exercise
all or a portion of the within Warrant and to purchase _______shares of Common Stock of Aeluma, Inc. and hereby makes payment of $ ______
(at the rate of $ ________ per Share) in payment of the Exercise Price pursuant thereto. Please issue the shares of Common Stock as to
which this Warrant is exercised in accordance with the instructions given below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned hereby elects irrevocably to convert
its right to purchase ____________ Shares purchasable under the within Warrant by surrender of the unexercised portion of the attached
Warrant (with a value based of $ ____________ based on a market price of $__________). Please issue the Shares as to which this Warrant
is exercised in accordance with the instructions given below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NOTICE: The signature to this assignment must
correspond with the name as written upon the face of the Warrant in every particular, without alteration or enlargement or any change
whatever.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Signature(s) Guaranteed:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE
GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE
MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">INSTRUCTIONS FOR REGISTRATION OF SECURITIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(Print in Block Letters)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Form to be used to assign Warrant:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ASSIGNMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(To be executed by the registered Holder to effect
a transfer of the within Warrant):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR VALUE RECEIVED, ______________________does
hereby sell, assign and transfer unto <U>____________</U> the right to purchase ____________ shares of Common Stock of Aeluma, Inc. (&ldquo;<B><U>Company</U></B>&rdquo;)
evidenced by the within Warrant and does hereby authorize the Company to transfer such right on the books of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dated: ________, 202_</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Signature</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NOTICE: The signature to this assignment must
correspond with the name as written upon the face of the Warrant in every particular, without alteration or enlargement or any change
whatever.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Signature(s) Guaranteed:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE
GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE
MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">11</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ea023594301ex99-1_aeluma.htm
<DESCRIPTION>PRICING PRESS RELEASE DATED MARCH 27, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B><IMG SRC="ex99-1_001.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Aeluma Announces Nasdaq Uplisting and Pricing
of $12 Million Public Offering </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Aeluma common stock expected to begin trading
on Nasdaq under the symbol &ldquo;ALMU&rdquo;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>GOLETA, CA</B> &ndash; Mar. 27, 2025 &ndash;<B>&nbsp;</B>Aeluma,
Inc. (OTCQB:ALMU) (&ldquo;Aeluma&rdquo; or &ldquo;the Company&rdquo;), a semiconductor company specializing in high performance, scalable
technologies for mobile, automotive, AI, defense &amp; aerospace, communication, and quantum computing, today announced the pricing of
an underwritten public offering of 2,285,714 shares of its common stock, at a price of $5.25 per share. The offering is expected to yield
approximately $12 million in gross proceeds before offering expenses and underwriting discounts and commissions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Aeluma intends to use the net proceeds from the
offering for expanding business development efforts, advancing manufacturing processes to support commercialization traction, and working
capital and general business purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the offering, the Company has
also granted the underwriter a 30-day option to purchase up to 342,857 additional shares of common stock. The offering is expected to
close on March 28, 2025, subject to customary closing conditions. On March 25, 2025, the Company received approval to list its common
stock on the Nasdaq Capital Market stock exchange (&ldquo;Nasdaq&rdquo;). Trading on Nasdaq is expected to commence on March 27, 2025.
Shareholders are not required to take any action as a result of the uplisting, and the Company&rsquo;s ticker symbol &ldquo;ALMU&rdquo;
will remain unchanged.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Craig-Hallum is acting as sole underwriter for
the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A registration statement on Form S-1 relating
to these securities was declared effective by the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;) on March 25, 2025. These
securities may not be sold, nor may offers to buy these securities be accepted, prior to the time the registration statement becomes effective.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these
securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification
under the securities laws of any such state or jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The proposed offering will be made only by means
of a prospectus. Copies of the prospectus will be filed with the SEC and, when available, may be obtained from Craig-Hallum Capital Group
LLC, Attention: Equity Capital Markets, 222 South Ninth Street, Suite 350, Minneapolis, MN 55402, by telephone at (612) 334-6300 or by
email at prospectus@chlm.com. Electronic copies of the preliminary prospectus supplement and accompanying prospectus will also be available
on the SEC&rsquo;s website at http://www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Aeluma, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Aeluma develops novel optoelectronics for sensing
and communication applications. Aeluma has pioneered a technique to manufacture semiconductor chips using high-performance compound semiconductor
materials on large-diameter substrates that are commonly used for mass-market microelectronics. The technology has the potential to enhance
performance and scale manufacturing, both of which are critical for emerging applications. Aeluma is developing a streamlined business
model from its headquarters in Santa Barbara, California that has a state-of-the-art manufacturing cleanroom. Its transformative semiconductor
chip technology may impact a variety of markets including automotive LiDAR, mobile, defense &amp; aerospace, AR/VR, AI, quantum, and communication.
Aeluma differentiates itself with unique semiconductor manufacturing capability, proprietary technology, the ability to perform rapid
prototyping, and a broad set of product offerings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All statements in this press release that are
not historical are forward-looking statements, including, among other things, statements relating to the Company&rsquo;s expectations regarding
its market position and market opportunity, expectations and plans as to its product development, manufacturing and sales, and relations
with its partners and investors. These statements are not historical facts but rather are based on the Company&rsquo;s current expectations,
estimates, and projections regarding its business, operations and other similar or related factors. Words such as &ldquo;may,&rdquo; &ldquo;will,&rdquo;
&ldquo;could,&rdquo; &ldquo;would,&rdquo; &ldquo;should,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;predict,&rdquo; &ldquo;potential,&rdquo;
&ldquo;continue,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;project,&rdquo; &ldquo;believe,&rdquo;
&ldquo;estimate,&rdquo; and other similar or related expressions are used to identify these forward-looking statements, although not all
forward-looking statements contain these words. You should not place undue reliance on forward-looking statements because they involve
known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond the Company&rsquo;s
control. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including,
without limitation, risks and uncertainties related to market conditions, the risk that the proposed public offering will not be consummated
on the terms or in the amounts contemplated or otherwise, and the satisfaction of customary closing conditions related to the proposed
public offering, as well as those risks described under &ldquo;Risk Factors&rdquo; in the prospectus related to the proposed offering
and those described in the Company&rsquo;s filings with the SEC. The Company undertakes no obligation to revise or update information
in this release to reflect events or circumstances in the future, even if new information becomes available.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Company</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Aeluma, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(805) 351-2707</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">info@aeluma.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Bishop IR</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mike Bishop</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(415) 894-9633</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ir@aeluma.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>5
<FILENAME>ea023594301ex99-2_aeluma.htm
<DESCRIPTION>CLOSING PRESS RELEASE DATED MARCH 28, 2025
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><IMG SRC="ex99-2_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Aeluma Announces Closing of Oversubscribed Public
Offering with $13.8 Million Gross Proceeds and Uplisting to Nasdaq Under Ticker &ldquo;ALMU&rdquo; </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Full Exercise of Over-Allotment Option</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>GOLETA, CA</B> &ndash; March 28, 2025 &ndash;<B>&nbsp;</B>Aeluma,
Inc. (OTCQB:ALMU) (&ldquo;Aeluma&rdquo; or &ldquo;the Company&rdquo;), a semiconductor company specializing in high performance, scalable
technologies for mobile, automotive, AI, defense &amp; aerospace, communication, and quantum computing, today announced the closing of
its underwritten public offering of 2,628,571 shares of its common stock, including a fully exercised over-allotment option, at a price
of $5.25 per share, for approximately $13.8 million in gross proceeds before offering expenses and underwriting discounts and commissions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Aeluma intends to use the net proceeds from the
offering for expanding business development efforts, advancing manufacturing processes to support commercialization traction, and working
capital and general business purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 27, 2028, Aeluma&rsquo;s common stock
is listed on The Nasdaq Capital Market (&ldquo;Nasdaq&rdquo;) under the ticker symbol &ldquo;ALMU&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Craig-Hallum acted as sole underwriter for the
offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The shares sold in the offering were offered under
the Company&rsquo;s registration statement on Form S-1, as amended (File No. 333-285469), which was declared effective by the U.S. Securities
and Exchange Commission (the &ldquo;SEC&rdquo;) on March 25, 2025, and a registration statement on Form S-1 filed pursuant to Rule 462(b)
of the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), which was filed with the SEC and became effective upon filing
on March 26, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These securities may not be sold, nor may offers
to buy these securities be accepted, prior to the time the registration statement becomes effective. This press release shall not constitute
an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction
in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such
state or jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Aeluma, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Aeluma develops novel optoelectronics for sensing
and communication applications. Aeluma has pioneered a technique to manufacture semiconductor chips using high-performance compound semiconductor
materials on large-diameter substrates that are commonly used for mass-market microelectronics. The technology has the potential to enhance
performance and scale manufacturing, both of which are critical for emerging applications. Aeluma is developing a streamlined business
model from its headquarters in Santa Barbara, California that has a state-of-the-art manufacturing cleanroom. Its transformative semiconductor
chip technology may impact a variety of markets including automotive LiDAR, mobile, defense &amp; aerospace, AR/VR, AI, quantum, and communication.
Aeluma differentiates itself with unique semiconductor manufacturing capability, proprietary technology, the ability to perform rapid
prototyping, and a broad set of product offerings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All statements in this press release that are
not historical are forward-looking statements, including, among other things, statements relating to the Company's expectations regarding
its market position and market opportunity, expectations and plans as to its product development, manufacturing and sales, and relations
with its partners and investors. These statements are not historical facts but rather are based on the Company's current expectations,
estimates, and projections regarding its business, operations and other similar or related factors. Words such as &ldquo;may,&rdquo; &ldquo;will,&rdquo;
&ldquo;could,&rdquo; &ldquo;would,&rdquo; &ldquo;should,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;predict,&rdquo; &ldquo;potential,&rdquo;
&ldquo;continue,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;project,&rdquo; &ldquo;believe,&rdquo;
&ldquo;estimate,&rdquo; and other similar or related expressions are used to identify these forward-looking statements, although not all
forward-looking statements contain these words. You should not place undue reliance on forward-looking statements because they involve
known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond the Company's
control. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including,
without limitation, risks and uncertainties related to market conditions, the risk that the proposed public offering will not be consummated
on the terms or in the amounts contemplated or otherwise, and the satisfaction of customary closing conditions related to the proposed
public offering, as well as those risks described under &ldquo;Risk Factors&rdquo; in the prospectus related to the proposed offering
and those described in the Company&rsquo;s filings with the SEC. The Company undertakes no obligation to revise or update information
in this release to reflect events or circumstances in the future, even if new information becomes available.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Company</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Aeluma, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(805) 351-2707</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">info@aeluma.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investor Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Bishop IR</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mike Bishop</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(415) 894-9633</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ir@aeluma.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  R (4# 2(  A$! Q$!_\0
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-%6;A1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex99-2_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  R (4# 2(  A$! Q$!_\0
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-%6;A1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>almu-20250326.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aBZo7xRiXgen8uEb3JcWa+HKcPtzpR3KelBtmp4bakaPyskXEisHya8ZBVWAa8C -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:ALMU="http://aeluma.com/20250326" elementFormDefault="qualified" targetNamespace="http://aeluma.com/20250326">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://aeluma.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="almu-20250326_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="almu-20250326_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>almu-20250326_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>almu-20250326_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://aeluma.com/role/Cover" xlink:href="almu-20250326.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://aeluma.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Mar. 26, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 26,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-42570<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Aeluma, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001828805<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">85-2807351<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">27 Castilian Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Goleta<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">93117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">805<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">351-2707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ALMU<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    (  .(?%I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    (  .(?%JXW8M5[P   "L"   1
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M@2";_-;;I/;=X Q\U*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F
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M?KH\C$'@R'4WX.]+I>S'B=M45_^)C/X#4$L#!!0    (  .(?%J?H!OPL0(
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M3AI_YHOA/UY_ 5!+ 0(4 Q0    (  .(?%I&QTU(E0   ,T    0
M      "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @  XA\6KC=
MBU7O    *P(  !$              ( !PP   &1O8U!R;W!S+V-O<F4N>&UL
M4$L! A0#%     @  XA\6IE<G",0!@  G"<  !,              ( !X0$
M 'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "  #B'Q:R"A8X&@$   ?
M$0  &               @($B"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
M4$L! A0#%     @  XA\6I^@&_"Q @  X@P   T              ( !P P
M 'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  #B'Q:EXJ[',     3 @  "P
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52P4&      D "0 ^ @  %!0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea0235943-8k_aeluma.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aeluma.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>almu-20250326.xsd</File>
    <File>almu-20250326_lab.xml</File>
    <File>almu-20250326_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea0235943-8k_aeluma.htm">ea0235943-8k_aeluma.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0235943-8k_aeluma.htm": {
   "nsprefix": "ALMU",
   "nsuri": "http://aeluma.com/20250326",
   "dts": {
    "schema": {
     "local": [
      "almu-20250326.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "almu-20250326_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "almu-20250326_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ea0235943-8k_aeluma.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://aeluma.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-03-26",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235943-8k_aeluma.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-03-26",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0235943-8k_aeluma.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://aeluma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001013762-25-004217-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001013762-25-004217-xbrl.zip
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MD#G-A%D>! N *9.!0H:4#A5"+SVO[Q*P3#W$"#;'E+DEP&ZR24%3$Q )5F,
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MP"IW[&*_67$*9)^RJEQ!T&%1<V"1!($"[,NDX8:C4HH*K8_L5 VSEN88Y:X
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MICXZ:Q+2T]%M4+:)9FA>V?83UX<!)]-JG'L2(,\N!M!*-UA$/U =*S9W7&K
M[BB!?'NH?"N\-8RY/'8>Z)2Y_KJNN%,M=1O#XX*G"!#\">9($72+%($K(3+"
M'^A<JAKPNTH@[S>8O*N\(6'^.R/*4,57$-('8B#LMYBP/0Z1>#\J(C1S?"#
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M#!5ANN@<^+JU&]R[:8MOW"_W_E6[Y7]02P,$%     @  XA\6AH$<3H$&@
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MYM$5.,LMI2%3C\/-V8ES"KXZ&)458<$'Q;OI?NG<U,?#-88%]96'7@ RV^H
M\6!Q4U\Z/5E@F52]'NB%/Y_H"\IUJLV?X?9MI9'SU (<&]]T>W6,=S,=V]>]
ML=:?&X]GT,9*6B4@R+::E7*Y_G!?[Z&Z>/V>B#P>9DQL![A0MZE!V(RIO@>*
M"RZ#^63N2L_D-D9;/_! #H+T6 )O[9;]Q92U(L4!%63;872U #2FRF!V\^V@
M:U4?+P")(DM\3XAQEGM$),KSJX ^M(#'3\>6>6M(WCBZ+O7^=LK-!GLTX$HB
MC[RX;[8%D5E>J9=N%]DUYR>CO.E__]-0RO4=%X8:S$8XB<D!S6$(9/CH&F8H
M8![.'W+W2U11UEQ+^>Z#6S2<@Z$;,S Z6$"B-AA.T#P8?0ZL&1DPPYH27527
M]L'0DD;^(#,$9\H<$=T%_'C,U)B&=2E7G_B&1TUF^:XQ)RZX^>YPSF?*"=8
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MA9!GVLX[']_%>8ZW- ?I26QL+LCD)%9C[\C5+590<6=>'K@&LXK1D0%\+TM
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MQHU#U,0R;T!R*3.Y@ E68#F673/F#*TH2G5,)R.Y#HJH>1LG<A)_I\3\Q7R
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MTSOYI*,UL4?;O&N[%,%V^;F^R,KB7YGBCY;)]RAGK^6B#6%)+]:T:\.G2?U
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M@V(9Q2,HYZ7CL Q2%@_I.I/6>>X2!:NUVW6\7Z!O#^0>)MUG2N,7;I[ H9(
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M)2E\&8P+Y71RB'45->+3E,V'OZ$Y<GS %9U\[!M:FI[%0Q70H,X_7OTH]'O
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MX;NKD]MCA_C#Z%QN&SC%8)E766D/(Z;ENPIC(K%+;?$>E[-:T#&.6DI]./I
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MS5MR0O%$94LPFL2;%G0Y)\3V8P59#>U%/_LBD"%'WW'2C%8-,_!AK/9C1JW
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M?)?E<,DEW]1%^18F]'6Q7*YS.8NO\@RT/AC1_>,8<WUV+#Y2Q*"#VSWM28)
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M-IAFD2E#[BJYK."HB&&KA L\^XB9G^<;/@)/V$C&<E&#?8CL9@6.@5/C3#,
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M=-UM9K.P0I).-;M:L_NV:^Y;B_NYU&L'@AZ,H="<A=J;E.ATG&I'F*L\8;J
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M@F%TE--+=1FD>E;+1)*<>8+<D#:E#*,,UY.[G&$6#97UT3/8)& \,9@N#E_
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M0G#R>>M\\D6G!=_R!NFT%X=_\[!FO6C>I:E8QL*'M4I=;XXJM/=*NHGE+W&
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M6+5:,OT'GLX'BC(I=\XXCCT:/R5Q%PZD]R9^:HV"Y\%)B_P=O.TXJ30>5,^
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M:M"O,+GD(J3?\1JY67FZ:*JR9JHE#DX]/ON$N)+83(,OFGCD!GCE5;5U+TR
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M@Z+:9N3.()P$4<P"F+ )')[KC.7K0QH6JJ$I'!C0IM\@901NUU-%UU(&;8W
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MZ*E&_*G7;,GJ7B=TV 5D8H@=FH0J3($CR1\QU!.#M%2?J)DW+*Q7D\@6W"B
M9;W",39)8SME$GR63 *$6B;1+M\ A6@:%I&@%]U 8@H+[R+9O[R!OHF,,5:\
M"JW-@$^BM*8KE;# O$CFX:N9LOQ0<_4V),*+5K7]:BJ)R4QJ2A8*!C,:\P,*
M"=U&8A:J5,4..1M$F-L-"UYVVON/%8"G/+W;G!1X8": *%$]=[ON1,%"N[AX
M5>=6TN<<<9ZXR1=BP6+2)6AFE!VD]665-P*4B:KM%3OGB[H5?Y<^\OE"L!IA
MCX(?PCV6Y#7/2:S@8)R5M]!5N,2<>#*[X:P&(3.I64C-Z\= HT9!9=-1%11E
M439X+#%;N@PJ^VP49A?X7PRWHS-;UZM),I2X,8KI.62 %1#\]U,D :!Z!5-8
MK,QDCC4*!I1+3/FIKDI>JN"40@E%@5=I?$6I?UZ+<Z*(F["19%N O3!.KQM%
M=:G@0U21:I6N6WQCA<MP8B.4.1D.?W-/&S[B[1- =S$% <&W(F:<2E6VM0KQ
MN1I'R@45E: FHZS#@7R:.YRSF"6@:(>P""M4$LY=MFJ$W;.!C;3J5-4F"<+]
M8K.3! $LK$3O*:6L)]ZSO9^KG&Y7*4D&V^E6.&V1G\ KKJAT62SS1N-5040)
M^^%&"@;>S3G3>NT++HH4LXJV5Y&:>YM*Z0" &0'#:BDM(.?<IAE2YKY[7S_[
M>FVW>>B%XH1/'D*".B2X\Q 2_);)V06B9,:TT6R0H" C,I#$7I7)9;)3C)?,
MU@BT>SQH;$28J1O)O_R?*_SWBGM=H>O8=UFYU06(!3$:((Z7'L4K%<;XY+M;
M[31]FB-.%NRQ*_J,U,X!R%",TH7 '_$'-608.H.&H:Q'D&9IU9*FI]1X6SH&
M18Q;6=U0 &.0!==K94U_H_5W-X+W8<Y)):F'XI00@CFWCW6]#=B.%'UT,W8%
M/S,[Y%O[DQ6VRVX!HE/258LPR>1DA4&AHN &U&M9.$XS+A #83:8BF1,2@$V
ME:4]PT[4MA;"^T;*M%-_))T2B'*:3((,@WQERTX<FS-WWM:- K6;Z*WT"!1H
MC\<P/ISP\SAR2X5*R80P5S%#44?#&)0BV(,E7@\F?G8A(G5\%L* _^K>7;V0
M(J^"3$NU)83^JD<D[I*DZ@QY^;['I\?N>W.JYJ7VEO/^8/<<7HUL(9.-).1X
MVT\QF4XV3-$1]0$L$]*<22R+LJK\3+>3BEX^Q8OC&T.3MZ66"C]=:&O[<1AD
M6(N!.1Q]#'!I?I-.@ 6'T@!+.%423- BQLW7AZPQ?O4ZOD[RY-?,V^PU+*>6
M,1[J->U%80?/#&]+M9,C=WUEEDVB73+V?46OQQQG!]8A?;FWHVC.Z&3WJ6-/
M+.)H8V0;X_.ZU<$UV_(H@FB+F569.J2OCNKS1GZ"Q7E'M0R:<\ENOZ8EUYES
M)[U%KJ0J=N%EL-V>J]USN],5* ,1Q&,IGQR8-S'O(I_B+>Y3EDN*,C/'P1N0
MPP8V!POF=!VR71.F?8I2[5&^$7J?0:ZK@D'EHV7S.<@*Q#+3__GWA<WZ\;-^
M0U5&.GQGK/0,06SCRH=J<5?%+>[HG^<IY(XD=!D$*!9S. 3,?.U.;]"@9$>@
M^9R$,I\=B@?7.\]]][9Z>X^W9RC=NBFM/'4F+SO!E^FR&!5!,GJ,K0.574ZO
M8$,JC<[MAKCQ6)2E9 3*<Y6C5+BS;F.YK*_N-(P90Q5!QHR9L0NW61ZWV :W
M3N4V;5 ?F*WF6DH=!3ENF\J7ZXLDF6>_NR2;)@(0(0*$E/O$-'VTW(SFXNHS
M5J7$5B#-)\ [O]!.4PIAR.EO4[!Y$[=_O)/5M'8E6&<S-"HPBW3XS#A?4(C?
MJ"RTBHNF.W0S@F3FA$/M0W(4.7Q9%3/QN!8;WV=+'*)_W>.S4 (XB^NOW<%V
M*C5>.$3TG)'-AFET%/TH8VN -@2<FN+XA*VA; MEJ2,":QR67J,RHW6R 45<
M5"QKH]P4G'1*K6+O@I3"$O0*+;OA.1Z2.P[LM&<57XAN"F[:/07E$E .?R#I
M31AN@3A8,!+G6Y#/TC*+& WY;'2*O:V?*1F3&^-RC$62,,7T,WG<^*#[/&=5
M<$!JG%YCE"@J5=0^4#^7BE#J=PE>MQ"]*U\'E25Q&YZ CHEI@1MBVB(VY-:6
MC^*<,M!CG@"2GL-#2T6O)BM(CK80'GTXWCL=+Z?H.S[VW$4H,AVM+M%Y7]G3
MBC0*W=1+"1\I[$$\8=)7KG4G59=@G!9C%:E P<*:LU^*%R@H)&P63P;1S%Y9
M"OE83Y3-8ZK_M./9R"=I@RS8X2KD+B9PUA"KA[(WY6\V%:L^@ E!=126M>DU
MS;F8/]=K*MVH#+[F:5@%=6L5='.)OOC&4PNXGCVE\LR-+LKJ-"NC RJU4QY3
M6\-F&(:*@#OF,\/<QY<&]XIU,S ,J&*\:A?PCO#LT+&2QB'K<E3+,K$HKE[#
M]PT)-<1!)<MT^@WG<97*FS@IWG/K(=YTCDZ;;%CN;>]NP>W;V),P0:_AF&]P
MU1Q* Q-(*$R CU*L=NA94IAUR+(;JR3(5<'?YPEYBI*!J5F<9@H6Q61?X%MU
M_S/5O$^A?DV B9F*0I[ZVK'@A3(>]AXR'G3&P^Y#QL,W3,Z=1&EYJD+)D=<"
M1J)5"$*70I"L*2MX:93HY+@A:8I4G"4LI@C';XOV@DO$L#)VHOB26,LHBM/)
M99HA'"<ER@W"?APEH1V]<+4&JUU!(1PG^6[(W\%RHAP$[RI*8SU%I#L2=P_F
M="6\K9R(,90%A=*QE(LZ*D,E@;PF0XV)B(^4JT\MZ+KJ7?>:",>HOR)^-H1D
M4AGG@@^JH +-1XIB4] [+H*)T2;<*6KKI1>QWJ9C.[K*#M%#<WP<?K@,(ZYU
M8TL\B,V.!*@#&63!=;9&B\1C ]4QW10M2T<1Y=ZW)G;"-@:Z"$"WUC?6*@H-
M!J1")RE_N?A"E)E]JK*EQL#B;2;@NR(Y5$'\S467U7'B(NTCNYG&.# %N*\3
M=DK[!%2)WEIBM(B1FJ#GQ%<0E6DF[;ZQW@36AD18T.@$()/2PL<9ZJ2S(<QN
MPPF$N<2(R7=QR1S?WC?Q3-M)0/W+5-"I54A"M?@YU>B:WCYV!.^(#X<&I*R>
MUFE7P1Y.,X[05G<;YYD4J[1*QRH9OR *5%Z*0R+R^@78C$)VON0D9X/9+&E,
M]J2C7"/[L?/]XB+,)]6$'.5J<FSH%&:X]FRA!)G.KHJH (;L6MR#-,RE1Q!L
MIFU^@GCZUQ34@]TM;E'!V8QS7E?(TJ_7+.-S(CC(7$7#N>VA7>ZIJI+4GT*&
M83&_#P3O&>^+E)8-T\S.?[RQO#4F$(RIYZHOU40;YI*5Z'@JR.VAW&@.\26>
M6JV>@Z0L]*>5H-L%SP;#'=9K>L.9[N7N]T/%+2OO*I:4(QA$Y?)=[NE[Q10=
M4X^$5P@'&63!=8)G<_>%2,/OXI7G@P/5 BB<>DJ@;T ?(X.2X(LQ2BILE!N"
MH\JAS.-D4*U+J*;C#*Y*SA)+"U$!UDJ%YY8[4LED"#N &!RN6GC<S$.56C@\
M/(767"GB(D2,C",R#40A>E"*9RK%@N*>DY%B0<=7"QL,Y2$ =)8FF(]#897$
M/>BRAE3U(M6\CN=BWHFTO%FO=4J5-N34@Z<Y@9&J HD'L3]P&/2IKD9\/ )_
M[=N3'0517( FAR]:#]C?M# Q.$O:>L[,@NIU;AQB/-_L;GK#<$# %^UNY^V1
MZL:VL[4%O/W7SNMP$V, G=>^=WU]O3E(^U-\XR:\K $+!K4DZ7/D5*"5253#
M$U2<5Q6^XNC_8CM@92K.6+GD"8!)R88F$!<;)&)D@)&@^4&54:*W0D7>^LR2
M3 A8V;=F(Z]#2DJ%R447"+J_Z;4U@RS+F\JX]^)$,'\+8 #1=4NK9Q&(5J&4
M!ZZ*CZBN7$ PBFET5MM<EL;ZLZL/!?U7L-PX3J_SC_<S^GVNU!YECF?TZ8-G
M5'M&GZRG9_0KB^X9AA_+IGX<1".%'84)ES<*>YA\A5F4FQ1I"T=GID6I5<$+
M?)MTK)"2 80UK^Q7P79O'%QK3U57P37BAOR19I^6SBKG:%??=O\W)G.K!9R>
MOM.]K76,LS_ZYZ,=9ZIWZ.3V.PI..#8P$F[2:8;X@E5=V^YEIM87%QG9[9&W
M\+#S&>T=YW%O9X7<UN,TJREYC=\1[@&JC1LG8-U,P'+$#CT)/-=@"59]EC,[
M"S[=^OE1]>S=YW87?.S9SS-W<]YVS3[T.S<_W+^YO?GA/(IXA7Z22?@X'P<H
M\9/T.@M@%K/H8/'.XTLFL5LW\HY[IC6]^30TE]R_V0O5&9+[!TT-\0V0736(
MP-":@HG6#^#$X:*]7,(F_#CLIZECEQY3"3KU-0]:D/&LP7Z=19/X'C?LF]T'
M7*FN*%!7BG+]&<]%7[^A_A$C3 KC5Y!<L:X<;7,LS 45=,@I>@J-9?8>+J_?
M[!S#]&L:XJ"MJUI-K:E_-:M\CKW\[,%>UO;RWGK:R^X^?ZW6]K>,V_Y\&?6B
MB=>^_Z%7NF1U;]\<G[[WCM]XYT<'[=,/IYVS]JGWH7EZVCPZ6^G(U4O^=5^O
M>G]5'$M\*""5W[6]T_;;3A?6W#[PWAT?PA;@7IR]ZW35)GC[?WB=LZ[7;+7:
M)V?-HU:[7GL'SQ^_\;WFV]-VNPN/-\_<[W3?-0\/O:-C^';;Z\)[87KP0?=-
M^Q1&@B]VT>.//YT<M@_>X@_'I]Z[/TZ.84ZMYIG\ ;Z,<^R>[_^KW3K#F36/
M_O#>P3<Z1V_]>JW[[O@4!FL>MGT/IM[YO7G6^1U^/CD_H^^W<!8T<+-UUCD^
MXIE^.#X_/("%=\\/S[S.$0W1?O,&1H O>^W6\='Q^T[+.^AT3XZ['?H>[0E,
MI-TZ!PKIP)J!;+RF=P*#'A_4:_#Y\5';>P=$A#O9[KQ]=_:'M[']?,L[:/[1
M;7B=]^_;!QU8V.$?\-7#P^,/L(+"R ?P,6Z-A]O;?(.$>-!^TX%MVG1W%W[$
MK6W_NWW:ZG3)>4./UVM__N-_7CQ]]N+51PR.[VZMVN=^+Q?T/B[C_?$:.O.3
M\]/6NV:W#73U(RQ+4QW>>[A7>%U:Q^_?P\7IGAVW?OM!EMEL'YZ_;_K ,EH_
MQ,5RF,7.WJS1>IB?\G<]SUOSY?GRQMG>Y)%.I, ,^//X'G*Q[B?T@6(;!$"K
M?7K6>=,1Z>M[K2R(+AZ_"^)X.O):@B3Z%@M&Z[7#PY;&-P %@UVEJ&"8'M-!
M+OG<E"B@^_-0W.,#I_]2FU*R,6.L7I=4 RX;R3@)AG[!< G^E[/@*$2?1Y_K
MM1%LPF7NZ8Q,NPF]W9049MCBKW*4Y0">*TP6,R<FG(9%15-[+[>VO/'F:-/7
M,12OA99UG(*53]/Q/4/N]1H*1WM+VJ:(OCQ<;SHAWQCE:%&QD\]9@3W.:L=0
MM],K?J P/F8TU@73%+ZOYT-P. H#EA/$&'3$FF"7GG#G!2]C=$#OIZW-K:VM
M;?0B<%5=U8:JO#/[)>22"8%D A]S2?J;]IB2?68_O^EU5!FSLV'<LFR 0.V)
M9-+U@N03>Q(Y&9\!^S%]P;B >C<8"&,,MA11D^#5*GU#J$XEP"@0GH$GF=L)
M7 U.W^8T)QQ<(V&3*Y/3,?'O,[K&<T44YYMO>@<&.8([8==K4N4G(Q;6[#LI
M>I+)0W0"%T!5+M@ SUR=8/+/[&5B3IBU:$I C;@Z&Z;!:Z=B6WC/3YIR?NV>
MG[S>_O47_ \=/I$)&/V:&@>OT+NFDJQU;VO?0R\%S4JGPJ=];M+6UR6?JA?\
M%><]8;XT-RR!_?SU_+4J<7]*P"8*_)E*0Q@]W:E#=!B)QN2?V/A*!,)OK4-E
M7"=3*L##<(^ -G$=P*T 7 :F;X"<$].H)=D3R]_U4K",7CV!<(YC]\PQ5@R$
MQLNR^04/4Z\AL)C#+V8*F>]/CNZ('%6KO=]4P/MP MPZ\L[FM@Q^;ATX9KDC
MP<.-30WINO3M4#4E_VU4TX_';[,8<C"9!/U+23O$&BCLW-4+N29+H3IP2H-&
MP;93OTHM&5!673"LNC ^B\]0JJAIA\%<3J9&E&U2>5E$]4+I(<S<!;^,;(D@
M=%6_=4R61 <[W2]8"\*A95QCC B2*!C,GZ\CJ[^$%B\B6TEK4]Q$U^"8G$R#
MX6)+B'KM[LI!-8MW-TMQ%,I(E^1A[/Y%^YI.)S-SB$5C0?#Q.4OIATJ#(%B?
M=;MQ5>6W6&+]6+E<9_G&9_BB=0[*SM[/CYPOVY$9RX5.+[LEKH8>8?G7]@@[
M<_QJFV;2>.RTG6):SQ?.:[%]QEP?F-&MB2HSK!I<0#%I8HO7AT&L\F>;.[!\
M]V5Q.$3/OJ45%;]<.?3VMNF((&J70@9+5;*\T4U8P18FRX]M2J"00FTFS+;.
MU[84ZWJ^/OW$VP_]Q'\P"M_9W-&J8$MZC=5K2E5B=; SI.(_J\(IUQ5.MS1*
M]8I]4HNZHOL-UP70Q\13JC4@WI4C%!VI'EC>REWW;.T-E3G3WEE2YBX#NT8$
M?G&44V5-!U=!%),%JC3"RM&DF)+'\^UAP(XG=P@6R2),"Q5<9B'#Y%;JT57.
M$]2-?#X*^$L<A5.U1%>--8<C>NQH&D^B<1P96)RB5>GLCFN+VP;XAB#UJ;%9
M(U9^,4\5!UVI33?M)8 >T:VF*VUA'I85#=8&TI&S9ZP47@97H3&KO0W+'V65
MG%&W/X5E2Y4XUJ3A*]@)USA1".A=U:4X6\X-IHM[8[N%A/X-G9SBO!PKAE#"
MM(S,4L22Q[=M1+ =_W;AF. ;0-QX<CVL,>:-H;PSW-@_FX_W/^)?-IJ-ETN[
M^O3O=E%]J&8!CZNYSYVT+2<5>JFJUSQM:X9BI03W+:K5H]>PY=4)E%62L?#=
M?WH+J5X.AO9+#6+V^X?FB;+)%'KF 3KR%#83&,-CO&?:B60C95G8=*[=KBNJ
M2BP.$7EA5R\=$]MBBS;,9_G2<E<+]#0J*"EBF<[4L5AV!ZC_[XYBO],IE<4N
MJ8)<()>5@08R#;1[B5GM<D?KM:H&WT^WMC9ZC8VGS\DS;%7['[WOSNC\K6KX
M+%P6+&YH>,HE9TU8BK6EP)4QTC66!O,\D 41&=$;-RLB!3YS/([_\@C[8,*?
M</_/JC)M&1OV.NE'8UBIFL5[[DA+H1/DI\RY]N,T1>9YX1UNGFQ:2*XVP!:O
M53<K*U8YUVLSYSV3@C5)"0+R C10)BB2;98ZP'#-*+^N4\*3IJ];D1"K_E.0
MB=TGK0Z]Z.%?D#A+$VNX>-Y58I,EMSY+"TC]$C$YB!K'JK\)%I-R1U>-/R):
M@4C>0EM3LPOUFC4M.MMBC;]S,E(D'U7PM87(-')1@!T?=[TVE+,O'V(UC?P-
MWC/W(*GU3>5)%KF E9>[5%OY0:@O)-3W5R[4RVYDMF]4($9C74C7@@=J^'K4
M\.][H8:2/6$%1'MB2B+SHT">W37;,4Y<<"0QO(S7_]8H;\G0*3!3+JWOW1"(
M-P.X<T!#/P!&O076K3J.Z\\W5TG'=)@+^2M6X"?YDAF(M7C^6@MDE"):]Z1-
M]@4FYX;$FZ^T+#B[0<A1<B.6AU&6ZQ 5U]KCZ:O6;8Q\@4(TS%\25FQ4H<E%
MI+F@Z4YL" ,T:'QR3D%0T.MX/KUH('.J4@UUIPY4[8#\_G>*K7NH]5TF20H!
MP6,9!167VBCHL_6:J)(Z>6+^U#V9^>W:YT8OR(O+0Q6!DG!>O-S=\H+-$3RF
M F/U&D7&<#WD3WCR<FN'8F?F$<\\@<WQ>K35QV>M_[N/L\(?_ETV@.PMQ<8A
M([QOZ#7 %0!+0X>BO<V$[NSN,X-TH1ZTP.86YE/HU(1=?V;0A_A5U$83L+/L
M]# URFK%$-R_A!:1:\*H/$-]7D(%)U'RR3L&ZTU9%!O<I5KZ'Z?919!$_PW$
M6&(8SOZ-G?L")X5NM>$TZ6L,1-/,C^?4X-T?I?F$/%3(035QF[A&%9GGJ9XS
MZ[,#=FH1YA$Q1>RY*.Z^81"ALX\6PME)Q$OUVYTWDPEJWW4N.J0L#"K='X^S
M )@K-MZ*&>(9QKU(TP&.@\7TCMHN?)N M[G%@.XR4(W A<=1[,(!E@V"/O80
M Q5V>#Q1(/=N4)U,7X':"S_#A'/!A10@,65^C(-(<S'Y]O*BNM^E<%@H7/3B
M(3*T[FVEOTOB-IJ/%NX@<"WE1Q3,0K9DI;" %U3K)FO.0"KVF/>E8IM-&J/1
M&EDZ2==1;L>3WWX4);6KH PH'PV)1:4%OJ0_'_W1;7O-$:R\'TA3HJ,@'P3_
MJ[.T;>5(/GH;I[U;/^F2.-0/B+IAU#B>N6XVM"&*MH$[5OT?BIC@L_,7UXVV
MT%?W?1HM@P#;5BRB9Y?-F875;-!U7*?\5[-AZK5@EH5RSS8,@9<N8W/_K@U#
M^0 5._VW;9B 6]0L:L34:U56C'</1DS!@*G7BA:,]Y4,&!(1QH)1O.+RG@T8
MSA@I63#>/1LPWT7VSQFNO#KK :1"L3[%#201,.>-TS')DQN@(RJE<B>%5>XA
M )W!K2ZE)V.B! =P= Z0\F]J]Z>;..Z&A(K)YOI+)>\FAG=I7)-T7K2(Y5$]
MDQD[QN$IJK^X41';28IZ4(636&\C-832)5:ESJ@SQEHS.MW9W-59:D? \HX-
M_BQLU!'P,]PG& 5[F'/2VE$ZP4.W^,<-(^2KSNJ(E1AD!'\LV3FJ&Y55S8,
MV@Q!3.=D1TY[(;)>TY$^@5F07YT[J8M#WW;XAW9-E&*,A8],@S"\>E;NE95(
M9AZ>)IRO5TC/TXW#J%*/M#K\_HBK#G2=HO,=60K'CC'RJM/B=)NMB*L#?"6>
M90%*GZ!JB1DS]<MKY#H [QJ;%> J5E->]'<U\Q4/OHC':&_KP6/T@[7E^I%)
M>E=JZ\Z^2JN]KRZJ=JW:NK=A@AED]=JIU3Y42NPT_Z4<E7>6++ E$.A!:#J(
MMHN4KJI1;8#]R!(;H(W'OJX[4[V??&],#70HS')Y,T;;H%^J R,'@-0(XURP
M#?SE-!G@#,D@O"'DEP9WQR0Y4NCH6:P&U)\6B\_MC#04ISIC;$:>.?Q"BEWW
M\3:VN;=1Y@EPO]#.2/N'4 -5@/[X/:6+[>[N/MYYOO?DZ8L&"2V8 C6]-Y%P
MS-@$XRB(\974'RZU@C6#$#[(JEK!3G3QC*ZQ4;E2^,(>&#"P@D%H]R;%!/ $
MT>Q5)M3MPVYZS<$@PB&QC-IWM$9IW+F]M7'1<*7NAJHZ%B64$E5B454-%32(
MEKBI:(^%>#[M_2?D/&=J+PN41*O*+T%XTURQP#B+K@+6.,93FG6?FLL@)9:+
MQ6$"TWBBVM.&L(GI"'8,(:O3/'(R!JW\2S)#;Q2F8)%<$92(*-/.H#3>*;(S
M'(+<](ZYNX"Q6+:?;S\>4*I9@M9''NCTMWK-_;*Y9.1R),K)55'_*!B8;:/T
M=3 N(I.^00Y:4<CD)EF9<H6,4RK(52T#ZS5N ,ON);S;IDV,*DC REHQGXKY
M?I23I[\F_3L*QE*I(M?81J;FEA,H'0(KU-SJT\<&AI/@,S+7B"C(5]6UA?M#
MV9?X6N:/:LYLL$NFXI!Z)=EM>BD_3T:QN9GX;WII^BGW7&[#IAJ]5M9IYPQB
MF0"(!?V>3/U(KXFC3YAZDYC\9*N+&:CBM+EAN)$W4,4%.L]Q-TU7#]*\R5Z<
M&#0#?L\%\'3,0BX;C/(<[9GI=*P<;U;- _W.7\>Y&&<'U?O#*083Y<Z1%LF&
M&M9.4IO2)UM UVN=$3;VT X/*DY20ELE<\MG%9+9-)GTRCTF(TJB#_IH;!4Y
M+QM7E"E&%UT;4NK-).3YNZX=*%3B9IL58".06ZH^?M+ 3WMCI(?Y51029DE*
ME=[(C&%3>M,)]WRA8BC0+G1'.!E5H@94Q#01V!NXJ%9_TE+'02H0XZ_9;(_:
M!;C,#[TON,-:QI&T9O%HX_HH?NID\+LCKJ6!^42T<7AMO:;9&*.,=(!<[KN]
MYU>_]4\L_?P$2#9"_5P[UX".E-W"5[YK9#B[3 R?*(#%[*HBMULA?C+AM^QN
M*A8!%OM>*9P::WJ6\#9WC>X>=K3WU=5'O)L*BX+;Q".[BOERED$TV+%*W(<5
M@!FCZ]9?PRDV_<JG!(,AW:K& 4N80JTB//Z+W5 9M (7;$C (C",R$1:KY7@
M/[3CE+$I0"YF%V%19I?EM%M^22&JH%BW4BVGE?YG*B@<L;V@L [HVE648:J&
ML;TP3*I)97E7=',++L'7OJU?-HDGEK@^3',0!"W&8NF3:8F7]7Q,CDSN8.<&
M=O!XY'"Q+]DDRH=@E"!&.T7G%!G$:<[!LN$$31KL==-7@;T1"$);HIDCY*;
M%-73 2IG#%S**.&YJJ;B:";",J2PC0S#0=5E6$!!M8F=YS(@ZZ:I=#S[Z1E5
M,AB%55:9TB.=W;"7GSE[(Y?6;DZ.,#?\"Z+YH*>]/\'"6;MQG%2?$>MRM/,?
M"&AJ3\1ODRI$R+F^9O)VSY*WUBZ0&E>6#MZ18:9:>3/*=\47*CFPX]H(2SA'
MEF4.UT5/J@+J,5 H>NPAT-V5EU>PO<A6;G^E(]R6 [2.D*+S]=I!1+P4Y/YC
MKPL*_.3Q^3@W:!':G6)!8?I2ON?H4U:[8C@]2YO:V]RAZKQ>&*?7?N&4K;P
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MXKL.-]=^WMXNKVE^:LD7K;J8&T:6L1K\E_WC@S]>XP_OSMX?OO[_4$L#!!0
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M4[TV UQ,,WEP&BC?RP,UA?E@GC7\PD+8XE<#^"=7!_!<"=C8Q^EAUE$P2=)
M[;W:VE+SS=EF@Q#\(4D_JE:87ZDH&0,J$)R&(J*OU[24=#'2_C0/4P\II6*V
MT2)7<9(CS&G@30!##5QCMAAEXS0<!0I :*BYD!P!EP;C(+R .<-874Z3B# $
M?\^]%-"XF,/[0"5G;WMQH(X7L8\X'T[#%"#&KX;39)'A.(?)(C4/X!?#2\#(
M%=#,11"#GL$<>)TV.)MZ*1 8(!,1#RO)\F3\T5WE@)XH+@X@JM<NO&@1J)^V
M-K>VMK;5'+:>!JO:%1AW@..ZH^"<S0!HSP,.&8\WW3GAG3F0B?OXINI,B !*
M6*_7@+X\((LKE2#:0F!1(R_^B 04QG $\@4^"\\ :-XBGR9I^%_ RPBVV;O$
M+1E'209(A['C N7"X;H"4E'!IR =AQD2>$P0Q'#*8"/'XR#P<1J<FR8F6'#3
MX<>I  7[YXW'2>I[0)GJ,LRG- ;0PRPC.@[C376P2'$@_ 'P&"8^G!@:6F8L
MK9F 58(DY9VG0<#SXB'R/@).Z/LQO9!/@>@ODP5P2YPTC/$ N>O<1"*RJX8_
MPSC,0^ +5WKMW@B($8;YZ?GFUNZ+/=ILH@N5)8:&_=?J3>?M/$TN0A^/^C2Y
M!()+&VB==MX2&(NY+"@9CQ=IBH<5R0"A37AWD43S3&7S8!Q.0L YX ](?A#P
M8IX3T?+Q9RR0F9FI<X2=M[7$?>)QM$!<UFLTOFRFFJ?A.' 6@N>$-G<Q&S$7
M8\)'G (1R-GT>0FTOWJH!M)]%.%3GH]<%T]=Q@<?H+=+68-O]1. %3^8%W=Y
M#*P.2(O7Y;(9 ?D402Z<B?L14/<EA\T,_[.QH0[#(/)?J5/O/'@-(_QG@<0"
M*U,;&^(%>7/0^5V#PF-OY,D<'MF9YWJVC5&2Y\GLE7J.WXW@& :I^6X_\H#5
M;6_N 4!9$H4^@'!:')&@=07UFZ<P:P4 (V#R'S=8L+P"_HA0NT ]KX ) ?W2
M*1W4/$7<,#I^!"UL1[0P3>YW3-S5'I7[T,BJ9][9W);)S\R)K]<.DW2&+ ]X
M=&)Y5Y'#%=@:T-^L+($- ^'1'!'LY;DWG@)K0EX%C&X&$"(?\Q?,^\>+G%6(
M>@W4@WD4R$?E!Q%P0]0O4.18880ZSGF K$^+.D>RX(MS[XK4LT0+<Y>W(?3T
MM;#>48#<T<@7?!DE$8C96(V];$JZW!78)VG.'!;6 B<Z0?8]"<<@PD@5L%]?
MAL#I<P FFP2IT2A$)R.=7\N3-)@#! ')%$0.3,-<'L6LJQ2 K/UBG;):JA>1
MI64*X)V%$TQZD80^X34!Y7*R2 G/,"U*45#(@LD$Q*0HNO#RYY8R#K3F&2 D
M#^_$[9@3UP)JBH(LJ]<T1?*I PKQQ,21G<IRV"HB85"P R%7."@IJ$P 97-,
MM+W]R^XNF4<>/.JC["\>R>(;1>5ZG,#),@I+F&4+4AV!QF ;O2C09T<."9X9
M5GOQ2[;2%)P7YXS"AP(/4**F>A=>&)%NIP]>Y6SU&ND[/%_#G08T9+)60E39
MT&#Q0SA) 2*J4<VNJFP;),$&;P5\$X7!0B^QR"WLY@B[F"VB/)Q'H=;[*K0W
M%SM%)==5;=?P$#AS,^/15BOR.-'_9-AU8D$X(= C&KTI*"AARG XZNH.1CS.
MWA9PQF=OZET$5G]5:XZYJ)(14"]1VSK9)TD,V\AVLPLTO%*O+6)KGLR3E&8M
M6>"P,!C%6\:-:W )_5LZZ2-<!6$!2T0.QOP>U'Q_P;2^%@(Z_B ^LA:&Z_0S
MO '$C3LWRKTP9L3X(5@&B-A_-#?V_XG?K#777]W:T:=_M\/X)BQ@HYK[#,D]
MWFIWNZ?-@X/.R=&O3[:>T.?!:;.E/PN8EZ&?3Q'.K;^]5E\*,VN%6Q5:(6E_
M;X9]/0WN?0BR0R\(7L1XW9OA00D0'11Z.CQX6_7K#OT,**<G1)^TSU4%G4KO
M_JK*@U=:#<CVYG LQTBFKY ^B"9^?]\\U:)OF'I$"0=H(<]F8$<#5P6=8X[G
MS->V,/EZA!78$551/5+AA.VQ)1:WMKT.^FD^+6@R#EL$Q0*Y'9G-RX<60643
MGDQ7S3(+H -S6=L!ZO^KL[AC@F&*S)B/60(F(EF($RT\0!@M(B]%+89> 5T@
MS>2,UFMKQ/<G=.* 0_47@*[G6UMKH_6UYR_)Y=*G]PF$DW<#/,? 18';H&EK
M!-HD@+_@L&=63$7>9;:NM.WK -S@4^\)[R(MJEZ376.>![(@)%UE[>J.2('W
M'+?COSS#/FA*)"0,**X?2L\-N(['X1Q6JJ%XYZ4?@YP=F\A/F7/M1TF"S/-<
M=3=/-_%7&93]F.Y:?TXSW(I,R,'P8W3*K()[)04;DO+9070#&E@F*))MCCI0
MKZ$*B?+K,D'RY=<=1R5LJ':: $WD851ZDA\BCP6ZSFY(G$N P;FY_FPT1'*;
MO;2.EFR:7,9,C7,2>^B&2\:+&7F/M ]*:P4B>8NFBK)8J-<<L&AO!5E72W8*
M[DR#""T,*_C:C<@TG!2>+3B3ZK6)[/WR)E;3R%_@/9_=2%!!5^QDF0N\9LGP
M=-C'?U",/@KU>Q3J^W<NU)>M=;9OM,<3N0<)D-=(@X_4\#6IX8][H89E3[F-
M-(S$E$3F1QYS8PR6C1-ARC )F@MB>%GGRK7ADR5#I\1,U240)0J!6>#%]+C'
M?B/S !CU4V*!7BR_D1446!_DW=$Q;>:-_!5WX"?Y,Q"(M7CVU@ADE")&]R0D
M-\CB1O'JFT 5AUK\@,-/5BQ/PC0SGL!)$D7))>[^./(6F28G$J)!!E:$MZX%
M9T&3"S..W$4AL2'T@Z'QR=$ZKZ37,3PC )]AJE(-M2N$5#L@O_\L@HRDYIK\
M$ =([;FCH.)2UTOZ;+TFJJ2)2GX>="607Z]]KHV\K+P\5!$H1/[+J]TMY6W.
MX#'M?ZS7R &)ZR%_PK-76SODHK2/*/O$.NCS(T)U;]CZ?_L(%?[QQ[(!Y*+T
M(HE ]X+SAEX#7 &P-(Q.N&@&.,IXIM-*>M -D%N"IV!E M#CE?0A?A6-:+ (
M#*9ILV4]%5.@YCSA162&,"KWT.R74,%I&']4/;#>M$6!"_14%LY"5)"3]-R+
MP_]Z8BS!3^=!/+YRH\JP4^A6FRSB,0>P 8L\"SG%":9UQOXL 8PAPI"#&N*V
M$?DJ,L\2 S/KLSX[M5#!3H@I C?4[KZ)%Z*SCQ;"87_BI6;TPLAD@KIG'7@K
M,A*,=B*$L&NI!\P5H LBT$C95#U/$A_GR:=@3KMJN_#MF??O)$4J17<CBJ[
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MR!>IK0L6J )_O2$ML4CRVTI8TIAB*B F-T:: )@TEEH+\#_KTMTIGH24_U$
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M8QB#S_CZ'+[2"PN(Z(H+IW[=U!U<@W>T>U4<8!:.EUYQA <4J=0D.GUN$!K
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M.YAG"[P'EQ*.LWD2.XWGZ&YC0+)VGYO(W<0;EWN;(I8E*H#^<ZRK3FWDW(M
M3S<9K4$,/Y[;;&IS]P'R+&":%W=>&WU?FV!\TFO9NCI:>(BI(/#ON.3VWIC5
M<5L-.D<GS>%9O[TV6%>#X]Y9]T#MM]716;/?/!FVV_#I@VJ>J':W<]0!<[=>
MDY]Z?=4Y&0P[P[-AIW>BUO:;)[\-8/IAK_7;?K_W6[N/GYJ_=TZ.!C# @>KV
M8)CF8-!K=9KX"G_;ZK</.D-U=D+?O.\,C]6[]KM]>/NX<PHSX-S-T]-^[W<
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MBYP7B=@Q;5I$">,C7=5<+>+#IPGCS(I*9EKE3>8@FP4!9G%T$H;_07Z*DRO
M:*P69JH-=IV)A-F,ESPMQ7#@1%8H7>J9!#(08)5.90D1WCA=:2>O<7UPDK!<
M3(6R@CWF5;W'N##:UIQTD=LT2F;<(4P2'T/?&JY<4WF#&HJL!&Z4\P4>AMC+
MO=/4(=28G@X'7 5OFAOIG%"L#N&FVW!#-$Z2R<N=Y,76,V8+;F N[DEG5_P6
MZSO@0IH%/?]E9XS#P-[#.V-V68BE4FE7_'PA19G#E+HV^KNLN!/EPG- %3D
M6,ZP;PO].A,BMP@-8-;32.J DO4P=!NB)[FT&?;NPB.R65H+I79\WRY[KS32
MK1))1"(F%8 !G V\A8Y9";<$;&IT17>)7R-FY'7 #;#0K[2Q4@E@G(MK4>JZ
M0I0S,860@T$\OX8'DQS,;*8\<XW7X?5; AX+VZ:N(>Y!%B:$@O=.XK!LZ:9S
M;:X\HV6\EHZ7_N9,*&%PW=E1-Z;6T/Q SNE$ 1>EA,>!S:4K_"&UIY&P'M6P
M@EO$0VDU_!XA'>.V\VN$%6?;FR,*;5T'A#4!EN%%R-7T<_O9)'FY\P)'ETL2
M ;;+^.W'[D^#$X=4XA08A$&T6<$F+P/3@LR:]"O$:*T,NP0P9L%(FK00._IE
M[9A][-[=:=_M;]:(3(#N<N8)X!IV0B.5!CV6&0Y">J2=XM68!X^B_T#[%9R]
MS:! 0<U$Q^U!N*5O[#8D5+;,IVM\Y/U79?U-Q_0R'@XN",-"ES@*4 HX2&F'
M+7QKI EO.WXE&.TKN#SC$(. ;4I'R/N#;"N?$ \K2<:2E0@GF5T1>_XHOP\'
M<Y C]%9<$H6'/></)%B.#)>ST7M>@MOH= A*JA,ML[I<#000%+)ISX$?" 0'
M.-L9O,0$!K4.:=%S,GZ\14'!+D9;$"FY\U1*CE<(!*H564.I#^O/.;%Y5G+R
M3% Y<<^U8.G">]SG\<48!G72Y(G';>P<=7F2/2'AZ( 7QT=M'/6"(T:UYQ&+
M#-,SH0)#48"D@DXN3_##^)O^M'S62)O%3=,AS[-,U(C(A*H*O!5VB,"H0GK[
M 3RI0/A"0[=?Q.QE(:EVH*P"Q 1Q)*@0X4.F@:D N6L<16VPRR<S@><Z5MD:
M-1&8QB^%&.[+P?RPJZ 1XN"$-#" Y:6(,;^&"V+6"Y#9M,I7/+"Y#(R!A_-"
M EG;X']^I63-!A-TSW53YK1:HTH^GS;E$JL5>' +M6$II[%<' YZ+<32*NBP
M87^+L/:M]CV0 +OTE;"F&B-?9C_/J@"TXCGQ/PI1A$LEN+*^,Z425U.=[QHD
MMB-=RY!/0UG=/NFT3%'2Y\MDC_"A,$MPO"BU^367OAM(?$1 7*<.;(XW?+6V
M0H)MJGMG=%,/!Z>G1V@/J&*G$]EEQ\@_;K&6$(''9#)A%[K!^A]0(1;LPADA
M''""N&#;.YL)&FU4);R&>T'^[ /;V7FV.4D\2R!6ZD(K0<7]D^=;DZ=L>_O9
MZ/GVYB;Y1+H8#BC]E/1XN?G?LJ*LQ@C",3LN<<=H-"F(LE6H1"DKJ:ABZ,%&
M!609PIC8" P0LF*L-%?0]=41Q5F+HF^0(\I=&IV+U-).86'A7+V[L3&?S\=P
M^?%,7S\01Z812XHS9K'/9=3FWN.8Y'_3X,2VQ()K<4%EKQ:=>X46VJ(%],FP
M[?2Z]IA*RS)>(VZC2A3+K,8=(2A!<N9[<OFM$<2?RSY'K+?[A809C2]SJ<4?
M]5I\WWJCW<Q7WQD.J*LUZ(@LY4UDY)D8Y9)7@DH8%-*>J:F+*JB/-B*6O:"?
MANC)#PBXM:,J5+I0;?K;#R5\-U/P#40(-.TI(M340A5DXW#0-YBPHK&$6.WL
M0 #:4?*)J<C;1&D"HJ%S1(LW\T79;=#*KH_T(D@D1O"J].36=G@ 1><X2D]V
M5.H7@J.VX,9198 D>('6A[-#;E)NX-9'E,"T49('F I?6?L4-=+3$;8[PKMK
M#6J&=*^,)C8ZP1* 65F_=U\*K1T2G6P?1:)E"0;*:+9QS8T4CBH7%DZ!;,S*
MQO<2RZD-.Y5O#LZ3;I[SP_G-P?G&[^=AQA/G-@F[X;@H7EK_EY2B_&&2HP O
M44Y#:FF"TZYZZ1H,O.:P!SDB\4F/MD+DN]QLZ,FBD&\G@Y,P@YR2PV>,=MHM
MZJYKX2PUFI.C^[X&SVGE+I/>?]_^5XRQ^XNM+/./T8B]I;G5+OO$9V(/NG &
M""@LR4:C^.%E_\W)[ZT]8961TS5$)K5KUQTAT. \N^PYW4NU06'6W3LL.5K:
MK?$.3*,*,(<EGU8U>KO[9+R_@55O,2!%"%Z-PN1LE]7>ZKY1SV^QB0S]LTOV
MH-D@; (<#\</T'W-N<E'IUK3& LU5>P][ -*NJBPNI[*D[&[V4.UR6HXH#X*
MS\$[/C]0LIA&E,J(TE);LN1-, FRW(QI:IMH"?!&TE^X;7#;[F]]3!+&-B'Y
M4,N#%7T%0.DDYDH4^#+4 ""M>$_[025XD_AP10<)U26G*]^=DJ*6VGJ3T62-
M7WT611*U@1N#V9J:!L_07@N2D_)#(PA(=2T(+AN;YOZ>VZ%2#U!:"$TQ:CR4
M"005R:3<=R[J5F#0TQD_P>UM+D&]CO.E4B3:B9U]#1/)'GK>VC9))\!*F!XX
MX:@LJG=4,=0&^+U2C<*SL*%_@<)LZ!^!89P<()4F[>>5>(O*^*0;9\6;&76T
M-R1ONVF+V^XBD:)-KF'1^A/X+C6P-VZW%=(MIN"^:FXH"I"NWPT#^!O:X4HW
M#?&@K]].T1+!P6Z8T1Y9)__34X!Q%*/AN. DOGPD/\YIE]-VU/*SZ.2E [2S
MPCLANL_AX,?2-#VAGC6JG=/1C]D7W;!P/%X'0,C\T*ZAJ4TI>9RM_D1M*C(>
MOV,L*%AT>0V:N5)ZKN(GGG!MI+V"R?1MRY =-,:(Y8FU354'O^VJ:BJB9.8G
ML88J.PVDT#KZ<B>X1^C/L2&K*U2\"#'H2\5"WSZG1<T( (PN4?F""W@9)[UA
M\A5J-M;6_JCFXV<8FJ@'T'X&PMKDF#/55"GTX3H&6Y]* ]50'TBMM8N?!3U
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M_#T@_=G@_P!02P$"% ,4    "  #B'Q:3RE6I"D#  #<"P  $0
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M+FAT;5!+ 0(4 Q0    (  .(?%HD7>"SY,L  *Z(!  ;              "
M 4DP  !E83 R,S4Y-#,P,65X,2TQ7V%E;'5M82YH=&U02P$"% ,4    "  #
MB'Q:XF3=>2TK   HWP  &P              @ %F_   96$P,C,U.30S,#%E
M>#0M,5]A96QU;6$N:'1M4$L! A0#%     @  XA\6K_=.:\6#   )"H  !P
M             ( !S"<! &5A,#(S-3DT,S Q97@Y.2TQ7V%E;'5M82YH=&U0
M2P$"% ,4    "  #B'Q:F@H?81<+   ]*   '               @ $<- $
M96$P,C,U.30S,#%E>#DY+3)?865L=6UA+FAT;5!+!08     "  ( # "  !M
%/P$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>ea0235943-8k_aeluma_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="almu-20250326.xsd" xlink:type="simple"/>
    <context id="AsOf2025-03-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001828805</identifier>
        </entity>
        <period>
            <startDate>2025-03-26</startDate>
            <endDate>2025-03-26</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-03-26" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-03-26" id="Fact000004">0001828805</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-03-26" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-03-26" id="Fact000010">2025-03-26</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-03-26" id="Fact000011">Aeluma, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-03-26" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-03-26" id="Fact000013">001-42570</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-03-26" id="Fact000014">85-2807351</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-03-26" id="Fact000015">27 Castilian Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-03-26" id="Fact000016">Goleta</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-03-26" id="Fact000017">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-03-26" id="Fact000018">93117</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-03-26" id="Fact000019">805</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-03-26" id="Fact000020">351-2707</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-03-26" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-03-26" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-03-26" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-03-26" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-03-26" id="Fact000025">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-03-26" id="Fact000026">ALMU</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-03-26" id="Fact000027">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-03-26" id="Fact000028">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2025-03-26" id="Fact000029">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
